Skip to content
Artwork for Tick Boot Camp
MedicineAlternative Health

Tick Boot Camp

Matt Sabatello and Rich Johannesen

Tick Boot Camp is a Lyme disease and tick-borne illness podcast featuring interviews with leading doctors, researchers, scientists, patients, advocates, and experts. Explore Lyme disease symptoms, testing, diagnosis, treatment, recovery, chronic Lyme disease, coinfections, PANS/PANDAS, MCAS, neurological symptoms, emerging research, and the latest advances in tick-borne disease care. Through expert education and powerful patient stories, Tick Boot Camp provides hope, validation, practical information, and a community for people navigating Lyme disease and complex chronic illness.

Play
  • 79 episodes
  • daily
  • Avg 49 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • S1 · E634
    Today · 12 min

    Episode 634: Chronic Lyme Disease, Coinfections & New Testing – Dr. Sam Shor | LIVE from ILADS

    What has changed in Lyme disease treatment over the past 15 years? Could herbal supplements, emerging medications, and new diagnostic technologies help physicians better understand persistent symptoms and complex tick-borne infections? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Dr. Samuel "Sam" Shor, MD, FILADS, a pioneering Lyme disease physician, researcher, former president of the International Lyme and Associated Diseases Society (ILADS), and recipient of the 2025 Pioneer in Lyme Award. Recorded at the 2025 ILADS Conference in San Antonio, Texas, this conversation explores Dr. Shor's decades of experience studying chronic fatigue syndrome, Lyme disease, and associated tick-borne infections. Dr. Shor discusses the evolution of his clinical approach, including the growing role of nutraceuticals, research into disulfiram for Borrelia persister cells, and the increasing recognition of patients with multiple tick-borne infections. He also explains how clinicians can use symptom patterns to investigate the three Bs—Borrelia, Bartonella, and Babesia—and discusses emerging laboratory technologies such as PCR, FISH, and urine antigen testing. The interview concludes with a celebration of Dr. Shor's contributions to Lyme disease research, medical education, and patient advocacy as he prepares to receive one of ILADS' most significant honors. For patients who have spent years searching for answers, Dr. Shor's work represents decades of commitment to understanding persistent illness and advancing the conversation around Lyme disease. Meet Dr. Samuel Shor, MD, FILADS Dr. Samuel Shor is an internal medicine physician whose interest in chronic fatigue and complex illness began in the late 1980s. His clinical experiences eventually led him to investigate possible relationships between chronic fatigue syndrome and Lyme disease. Over the following decades, he became involved in Lyme disease research, medical education, and advocacy. His professional contributions include: Serving as president of ILADS Contributing to peer-reviewed research on Lyme disease Leading the development of an ILADS definition of chronic Lyme disease Investigating the relationship between chronic fatigue syndrome and Lyme disease Studying integrative treatment approaches involving nutraceuticals Educating clinicians about Lyme disease and associated infections Advocating for greater recognition of patients with persistent symptoms Dr. Shor has also participated in public policy and educational initiatives, including presentations on Capitol Hill and service on the Virginia Governor's Task Force on Lyme Disease. His contributions have helped shape discussions about the diagnosis, treatment, and research priorities surrounding persistent Lyme disease symptoms. From Chronic Fatigue Syndrome to Lyme Disease Research Dr. Shor explains that his interest in complex chronic illness began early in his medical career. During the late 1980s, he encountered patients experiencing persistent fatigue and other symptoms that were difficult to explain. He became particularly interested in chronic fatigue syndrome, now commonly referred to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Over time, he began investigating whether Lyme disease might be contributing to symptoms in some of these patients. During the interview, Dr. Shor references research involving more than 200 patients with chronic fatigue syndrome. He explains that his findings suggested an association between Lyme disease and symptoms experienced by a substantial portion of this patient population. His work contributed to his growing interest in chronic Lyme disease and the need for further research into persistent symptoms. ME/CFS and Lyme disease are distinct diagnoses, and research has not established that most cases of ME/CFS are caused by Lyme disease. However, overlapping symptoms such as fatigue, cognitive difficulties, pain, and reduced physical functioning can make differential diagnosis challenging. Dr. Shor's experience illustrates how investigating unexplained symptoms can generate important clinical and research questions. How Lyme Disease Treatment Has Evolved Rich asks Dr. Shor how his treatment approach has changed over the past 15 years. Dr. Shor explains that his understanding of Lyme disease and associated infections has evolved alongside new research. He continues to recognize antimicrobial medications as an important component of treatment for appropriately diagnosed bacterial infections. However, he also discusses the growing role of complementary approaches in his practice. One area of particular interest is nutraceuticals, including herbal products and nutritional supplements. Dr. Shor describes using these products as adjunctive therapies and, in some circumstances, as part of longer-term management strategies. He emphasizes that he does not want to use antibiotics longer than necessary. His goal is to consider different treatment options while balancing potential benefits and risks. The effectiveness of individual nutraceuticals for persistent Lyme disease symptoms remains uncertain, and supplements should not be assumed to eliminate Borrelia or other infections. What Are Nutraceuticals? During the interview, Rich asks Dr. Shor to explain the term nutraceutical. Dr. Shor describes nutraceuticals as products such as: Herbal preparations Nutritional supplements Other nonprescription products used to support health These products are sometimes incorporated into integrative treatment plans. Dr. Shor explains that he has become increasingly interested in their potential role alongside or following conventional antimicrobial treatment. However, over-the-counter availability does not establish that a product is safe or effective. Herbal products and supplements can cause adverse effects, interact with medications, and vary in quality and composition. Patients should discuss supplements with qualified healthcare professionals, particularly when managing multiple medications or medical conditions. Disulfiram and Borrelia Persister Cells One of the most scientifically interesting portions of the interview focuses on disulfiram, a medication traditionally used in the treatment of alcohol use disorder. Dr. Shor explains that laboratory researchers have investigated disulfiram's activity against Borrelia burgdorferi. He is particularly interested in research involving bacterial persister cells. Persister cells are bacterial populations that can survive exposure to certain antimicrobial treatments under laboratory conditions. Researchers have investigated whether these cells may contribute to difficulties eliminating Borrelia under some circumstances. Dr. Shor describes laboratory findings suggesting that disulfiram may have activity against certain Borrelia forms. These discoveries have encouraged further investigation into whether the medication might have clinical applications for patients experiencing persistent symptoms after Lyme disease treatment. An important distinction: Activity against bacteria in a laboratory does not establish that a medication is effective or safe for treating patients. Disulfiram is not FDA-approved for Lyme disease. A small published pilot study involving patients with persistent symptoms after Lyme disease treatment identified possible improvements in some participants but also significant tolerability and safety concerns. Disulfiram can cause serious adverse effects, including neurological complications, liver injury, and interactions with alcohol and other substances. Its use for Lyme disease remains investigational and requires careful medical oversight. Are Patients Being Diagnosed With More Tick-Borne Coinfections? Rich raises a question based on Tick Boot Camp's extensive interview experience. After speaking with hundreds of patients, he has observed that more recent guests frequently report diagnoses involving multiple infections rather than Borrelia alone. He asks Dr. Shor whether the change reflects: More pathogens circulating in ticks Increased exposure to infected ticks Improvements in diagnostic testing Greater clinical awareness of coinfections Dr. Shor believes several factors may be contributing. He explains that researchers are identifying multiple organisms in ticks and that clinicians are increasingly evaluating patients for additional infections. He also emphasizes the importance of recognizing clinical features that may suggest particular pathogens. The frequency of multiple positive test results in a specialty practice or podcast population does not establish that most Lyme disease patients have several active infections. Nevertheless, coinfections are an important consideration when a patient's symptoms, exposure history, and diagnostic findings support further evaluation. The Three Bs: Borrelia, Bartonella, and Babesia Dr. Shor discusses three organisms frequently considered during evaluations for Lyme disease and associated infections. He explains that different infections may produce overlapping symptoms but can also have distinguishing clinical features. Borrelia: Migrating Joint Pain Borrelia burgdorferi is the primary cause of Lyme disease in the United States. Dr. Shor highlights migratory polyarthralgia, meaning pain affecting multiple joints that changes location. For example, a patient might experience pain in one knee on a particular day and pain in an elbow or another joint later. Migrating joint pain can occur in Lyme disease, although it is not exclusive to Lyme and does not establish a diagnosis on its own. Bartonella: Foot Pain and Urinary Symptoms Dr. Shor describes observing certain symptoms among patients he evaluates for Bartonella, including: Pain in the bottoms of the feet Urinary urgency Urinary frequency Bladder irritation He explains that these features may prompt him to investigate Bartonella. However, these symptoms have many potential causes and are not validated diagnostic indicators of Bartonella infection. Bartonella species can cause several recognized human diseases, but their proposed role in many chronic multisystem symptom presentations remains under investigation. Babesia: Night Sweats and Air Hunger Babesia is a group of parasites that infect red blood cells. Dr. Shor highlights two symptoms he considers particularly relevant: Profuse sweating: Some patients experience significant night sweats, sometimes requiring them to change clothing. Air hunger: Patients may describe difficulty taking a satisfying deep breath. Babesiosis can cause fever, chills, sweats, fatigue, and other symptoms. Severe cases may involve anemia and serious complications. Air hunger is a nonspecific symptom and can also occur with cardiovascular, pulmonary, autonomic, and other medical conditions. New or significant breathing difficulties require prompt medical evaluation. Dr. Shor emphasizes that patients do not need to experience every characteristic symptom to have a particular infection. Why Clinical History Matters Dr. Shor explains that recognizing symptom patterns can help clinicians determine which infections to investigate. A patient with migrating joint pain may warrant evaluation for Lyme disease when the exposure history and clinical findings are consistent. Another patient with fever, sweats, and appropriate tick exposure may require evaluation for babesiosis or other infections. The purpose of recognizing patterns is to guide further investigation, not replace diagnostic testing or establish a diagnosis from symptoms alone. His discussion reinforces the importance of combining medical history, physical examination, exposure assessment, and appropriate laboratory testing. The Limitations of Lyme Disease Antibody Testing Rich asks Dr. Shor about developments in diagnostic testing. Dr. Shor discusses the traditional two-tier antibody testing approach used in Lyme disease diagnosis. Conventional two-tier testing involves an initial immunoassay followed by a second antibody test when indicated. Modified two-tier testing using two immunoassays is also recommended in appropriate circumstances. Dr. Shor expresses concern about the sensitivity of antibody-based testing and argues that some infections may be missed. He cites an approximately 50% sensitivity figure during the interview. That figure should not be interpreted as the overall sensitivity of all currently recommended Lyme disease testing methods. Sensitivity varies substantially by disease stage and clinical presentation. Antibody tests are less sensitive early in infection, before a measurable immune response develops, but perform substantially better in many later manifestations. An important limitation of antibody testing is that antibodies can remain detectable after an infection has resolved. Therefore, a positive antibody result does not necessarily establish active infection. For more information, visit Tick Boot Camp's Lyme Disease Testing Resource. PCR Testing for Lyme Disease Dr. Shor discusses polymerase chain reaction (PCR) testing as an approach that detects genetic material from microorganisms. PCR can be useful for diagnosing certain infections when performed on appropriate specimens. Unlike antibody testing, PCR attempts to detect pathogen DNA directly. However, detecting DNA does not always establish that living organisms are present or that an infection is currently active. PCR testing for Lyme disease also has important limitations, including variable sensitivity depending on the specimen and clinical presentation. A negative PCR result cannot reliably exclude Lyme disease in many circumstances. Dr. Shor believes molecular testing represents an important area for continued diagnostic development. FISH Testing and Direct Detection Another technology discussed is fluorescence in situ hybridization (FISH). FISH uses fluorescent probes designed to identify specific genetic sequences. Dr. Shor describes this approach as another method for investigating infectious organisms. Although FISH has established applications in laboratory medicine, its performance for diagnosing particular tick-borne infections depends on the specific assay and organism. Not all specialty FISH tests have established clinical utility. Results should be interpreted alongside other medical findings rather than treated as automatically definitive evidence of active infection. Urine Antigen Testing and the Nanotrap Technology Dr. Shor also discusses emerging antigen detection methods. He specifically references Nanotrap technology, which has been investigated as a method for concentrating and detecting pathogen-associated proteins in biological samples. During the interview, he describes research involving urine-based testing. The appeal of urine antigen testing is that it may offer a relatively convenient way to investigate the presence of microbial components. Dr. Shor explains that he participated in early research related to this technology. However, detecting microbial antigens does not automatically establish viable organisms or active infection. Urine antigen testing for Lyme disease remains an area of investigation and is not a replacement for established diagnostic approaches. Additional independent validation is necessary to determine how these methods should be used in clinical practice. Defining Chronic Lyme Disease: Dr. Shor's Research Contributions One of Dr. Shor's most important research contributions is his role as lead author of the 2019 publication: Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group Published in the peer-reviewed journal Antibiotics, the paper proposes an ILADS definition of chronic Lyme disease. The authors describe chronic Lyme disease as a multisystem illness involving persistent or recurring symptoms associated with ongoing Borrelia infection. The proposed definition includes both previously untreated and previously treated patients. The publication was intended to clarify terminology, support future research, and encourage greater recognition of patients experiencing prolonged illness. The definition reflects ILADS' interpretation of the evidence. The cause of persistent symptoms following recommended Lyme disease treatment remains an area of scientific debate, and other medical organizations distinguish post-treatment Lyme disease syndrome from confirmed active infection. Read the 2019 ILADS Working Group publication on chronic Lyme disease. For related patient education, explore Tick Boot Camp's Lyme Persists Resource. Why Persistent Lyme Disease Symptoms Deserve Continued Research Dr. Shor's career reflects a longstanding interest in patients whose symptoms continue despite previous medical evaluation or treatment. These patients may experience fatigue, pain, cognitive difficulties, sleep disturbances, and reduced daily functioning. Persistent symptoms can significantly affect employment, relationships, independence, and quality of life. Researchers continue investigating multiple possible explanations, including immune changes, tissue injury, autonomic dysfunction, other medical conditions, and whether persistent infection contributes in some circumstances. Dr. Shor believes research into chronic Lyme disease and associated infections remains essential. His work highlights the importance of developing better diagnostic tools, evaluating treatments rigorously, and taking patients' experiences seriously. Patients deserve validation and continued medical investigation even when the cause of their symptoms remains uncertain. Honoring Dr. Sam Shor: The 2025 Pioneer in Lyme Award The interview concludes with a special moment. Rich congratulates Dr. Shor on being recognized at the 2025 ILADS conference. Dr. Shor explains that he is receiving an award honoring his contributions to the Lyme disease community. The International Lyme and Associated Diseases Educational Foundation (ILADEF) officially identifies Dr. Samuel M. Shor as the recipient of its 2025 Pioneer in Lyme Award. The award recognizes professionals who have made significant contributions to advancing Lyme disease research, medical education, and patient care. Dr. Shor reflects on the recognition with gratitude. He discusses his years of involvement with ILADS, including his service as president and his work developing a published definition of chronic Lyme disease. For Rich, the interview represents an opportunity to thank a physician whose contributions have helped shape the Lyme disease community. The recognition celebrates not only Dr. Shor's professional accomplishments but also his commitment to patients who have struggled to find answers. Learn more about the ILADEF Pioneer in Lyme Award and its recipients. Key Takeaways From Dr. Sam Shor Dr. Shor has studied chronic fatigue and Lyme disease for decades. His interest began in the late 1980s. Persistent symptoms deserve serious medical attention. Patients with prolonged fatigue and other disabling symptoms need thoughtful evaluation. Nutraceuticals are an area of clinical interest. Dr. Shor discusses their use alongside conventional treatment, although effectiveness varies and evidence remains limited. Disulfiram has demonstrated laboratory activity against Borrelia. Its clinical role in Lyme disease remains investigational, with important safety concerns. Coinfections can complicate tick-borne illness. Borrelia, Bartonella, and Babesia require different diagnostic and treatment considerations. Migrating joint pain can be associated with Lyme disease. It is one potential clinical clue, not a standalone diagnostic criterion. Bartonella symptoms are an evolving research topic. Dr. Shor discusses foot pain and urinary symptoms as observations from his practice. Babesiosis may cause significant sweating and systemic illness. Symptoms and appropriate laboratory testing guide evaluation. Lyme disease testing has limitations. Test performance varies by method, disease stage, and specimen. Molecular and antigen testing remain important research areas. PCR, FISH, and Nanotrap technologies have different capabilities and limitations. Dr. Shor helped develop an ILADS definition of chronic Lyme disease. His 2019 publication contributed to ongoing discussions about persistent illness. His contributions were recognized with the 2025 Pioneer in Lyme Award. The honor reflects decades of work in research, education, and patient advocacy. Resources Mentioned in This Episode Dr. Samuel Shor and His Research 2025 ILADEF Pioneer in Lyme Award – Dr. Samuel Shor Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group Dr. Shor's Research Publication on PubMed Pilot Study of Disulfiram for Persistent Symptoms After Lyme Disease Treatment Lyme Disease Education and Related Resources International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Lyme Disease Testing Resource Tick Boot Camp Lyme Persists Resource Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Podcast – Patient Stories and Expert Interviews About This LIVE from ILADS Episode Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features Dr. Samuel "Sam" Shor, MD, FILADS, a pioneering Lyme disease physician, researcher, and former ILADS president. In conversation with Tick Boot Camp co-host Rich Johannesen, Dr. Shor discusses his decades of research into chronic fatigue syndrome and Lyme disease, the evolving use of nutraceuticals, investigations into disulfiram and Borrelia persister cells, and the clinical importance of recognizing possible coinfections involving Borrelia, Bartonella, and Babesia. The conversation also explores Lyme disease diagnostic testing, including two-tier antibody testing, PCR, FISH, and emerging urine antigen technologies. Dr. Shor reflects on his contributions to defining chronic Lyme disease and his recognition as the 2025 ILADEF Pioneer in Lyme Award recipient. For people living with persistent symptoms and searching for answers, Dr. Shor's story is a reminder that dedicated physicians and researchers continue working to advance understanding, improve diagnostic tools, and explore new approaches to care.

  • S1 · E633
    Yesterday · 17 min

    Episode 633: Could Lyme Be Behind Fibromyalgia, POTS & Long COVID? Dr. Jade Stefano | LIVE from ILADS

    What if some patients living with fibromyalgia, POTS, chronic pain, or Long COVID have an overlooked tick-borne infection? And what happens when a physician begins investigating infections that were never previously considered? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Dr. Jade Stefano, ND, a Seattle-based naturopathic physician specializing in integrative medicine, complex chronic illness, Lyme disease, and associated infections. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores Dr. Stefano's growing interest in Borrelia, Bartonella, Babesia, and other vector-borne infections among patients experiencing persistent, often disabling symptoms. Dr. Stefano shares how her mother's complicated medical history inspired her to investigate tick-borne illnesses more closely. What began with one family member quickly expanded. Over approximately one year, Dr. Stefano reports identifying evidence of tick-borne infections in 11 family members and more than 20 patients previously being treated for complex chronic illnesses. Many of these patients had diagnoses or symptoms involving fibromyalgia, postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos syndrome (EDS), mast cell activation syndrome (MCAS), chronic pain, or Long COVID. She also discusses specialized laboratory testing, potential relationships between viral illness and other infections, and her experiences treating patients with severe medical complications. The conversation concludes with an intriguing discussion about neuroplasticity, ketamine-assisted psychotherapy, psychedelic integration, and the possibility of incorporating brain-focused therapies into complex chronic illness care. Could a broader diagnostic approach help some patients discover previously overlooked medical conditions? Dr. Stefano believes clinicians should remain curious, investigate plausible explanations, and avoid assuming that patients with complex symptoms have exhausted their options. Meet Dr. Jade Stefano, ND Dr. Jade Stefano is a licensed naturopathic physician practicing in Seattle, Washington, with additional licensure in Vermont. She completed her naturopathic medical training at Bastyr University and holds a biology degree from Reed College. Her clinical interests include: Lyme disease and associated tick-borne infections Complex chronic illness Integrative cardiology Chronic pain and inflammatory conditions Environmental medicine Integrative mental health Botanical and pharmaceutical medicine Ketamine-assisted psychotherapy Psychedelic integration and harm reduction Medical cannabis During the interview, Dr. Stefano explains that she works with patients who have complicated medical histories, including individuals receiving palliative and supportive care. Her approach combines conventional medical evaluation with selected naturopathic and integrative therapies. Learn more about her practice at Dr. Jade Stefano's official website and read her professional biography. How Her Mother's Illness Changed Her Medical Career Dr. Stefano explains that her growing focus on tick-borne infections began with her mother. Originally from the East Coast, her mother had been diagnosed with Lyme disease approximately 20 years earlier. According to Dr. Stefano, she received an extended course of doxycycline under the care of Dr. Leo Galland. Although her Lyme disease treatment eventually ended, she continued experiencing chronic health problems. Over the years, she consulted multiple healthcare professionals without finding a satisfactory explanation for all her symptoms. Dr. Stefano eventually decided to revisit the possibility of vector-borne infections. She ordered additional testing, which she reports identified evidence of Babesia odocoilei. The result prompted her to investigate other family members who had experienced unexplained symptoms. She describes discovering additional positive laboratory findings and becoming increasingly interested in the possibility that tick-borne infections had been overlooked. Her mother's experience became a turning point in her clinical career. Eleven Family Members and More Than 20 Patients One of the most striking moments in the interview occurs when Dr. Stefano describes the scale of her discoveries. Over approximately 11 months, she reports identifying tick-borne infection markers in 11 family members and more than 20 patients from her existing practice. These were not necessarily patients who initially came to her seeking Lyme disease treatment. Many had longstanding diagnoses involving chronic pain, autonomic dysfunction, fibromyalgia, or other complex conditions. She explains that some had spent years receiving treatments focused primarily on symptom management. Her observations led her to question whether additional infectious disease evaluation might be appropriate for certain patients. These findings reflect Dr. Stefano's experience in a highly selected group of family members and patients. They do not establish the prevalence of tick-borne infections among people with fibromyalgia, POTS, EDS, MCAS, or Long COVID. Positive specialty laboratory findings also require careful interpretation and do not automatically establish active infection or causation. Why Lyme Disease Can Be Overlooked in the Pacific Northwest Rich and Dr. Stefano discuss the perception that Lyme disease is primarily an East Coast problem. Dr. Stefano explains that tick-borne infections were not a major focus of her initial naturopathic education or early clinical work in Seattle. She describes encountering patients whose symptoms had been evaluated extensively without much attention to possible vector-borne exposures. Her personal experiences eventually prompted her to pursue additional training through ILADS. She also recalls discovering a tick crawling on her leg while sitting on her front porch in Seattle. The tick was submitted for testing and reportedly tested negative. The experience reinforced her awareness that tick encounters are not limited to remote forests or hiking trails. Tick species, infection prevalence, and disease risk vary considerably by region. Although locally acquired Lyme disease is much less common in Washington than in the Northeast, exposure is possible, and travel history remains important. Patients and clinicians should consider geography, exposure history, symptoms, and validated testing when evaluating possible tick-borne infections. For practical prevention information, explore the Tick Boot Camp Tick Bite Blueprint. Lyme Disease, Bartonella, and Babesia: Understanding the Three Bs Rich asks Dr. Stefano about the increasing number of Tick Boot Camp guests who report diagnoses involving multiple organisms. The discussion centers on the three Bs: Borrelia, Bartonella, and Babesia. Borrelia Borrelia burgdorferi is the primary bacterial cause of Lyme disease in the United States. Lyme disease can affect multiple body systems and may cause fever, fatigue, joint symptoms, neurological complications, and other manifestations. Bartonella Bartonella is a group of bacteria associated with several human diseases, including cat-scratch disease. Some Bartonella species are transmitted by fleas, lice, or other established routes. The extent to which ticks transmit Bartonella to humans remains uncertain, and positive Bartonella tests do not automatically establish that a patient's chronic symptoms are caused by active infection. Babesia Babesia organisms are parasites that infect red blood cells. Certain species cause babesiosis, a tick-borne illness that can range from asymptomatic infection to severe disease. Dr. Stefano specifically discusses Babesia odocoilei, an organism historically associated with deer and other animals. Its role in human disease remains an emerging and disputed area of investigation. Other Possible Infections Dr. Stefano also discusses tick-borne relapsing fever organisms and the possibility of multiple infections or exposures. Her clinical observations emphasize the importance of considering more than one diagnosis when symptoms and exposure histories warrant investigation. However, multiple infections should not be assumed without appropriate evidence. Specialized Lyme and Coinfection Testing: What Is FISH? Dr. Stefano expresses particular enthusiasm for fluorescence in situ hybridization, commonly called FISH testing. FISH is a laboratory technique that uses fluorescent probes to identify specific genetic sequences within a specimen. During the interview, she describes using specialty laboratory tests to investigate Babesia and Bartonella. She reports that a substantial proportion of selected patients tested positive using certain FISH assays. Dr. Stefano believes these findings have helped her identify infections that were previously overlooked. However, diagnostic performance varies by organism, assay, laboratory, and clinical setting. A positive FISH result should not automatically be considered definitive evidence of active infection, and sensitivity or specificity claims require validation for the specific test being used. For Lyme disease, recommended two-tier antibody testing remains an important diagnostic method. Different tick-borne infections require different testing strategies. Learn more through Tick Boot Camp's Lyme Disease Testing Resource. Could Bartonella Be Connected to Long COVID? One of the most provocative topics involves Dr. Stefano's patients with persistent symptoms following COVID-19. She explains that some patients initially diagnosed with Long COVID had undergone evaluations for other possible contributors, including Epstein-Barr virus. When symptoms persisted, she began investigating additional infectious possibilities. Dr. Stefano reports finding positive Bartonella laboratory results in some of these patients. She raises the possibility that SARS-CoV-2 infection or associated immune changes might influence previously acquired infections. She also references a Mount Sinai document discussing possible Bartonella reactivation. These are hypotheses and clinical observations rather than established evidence that COVID-19 routinely reactivates Bartonella or that Bartonella causes Long COVID. Long COVID is a complex condition with multiple proposed biological mechanisms, and further research is necessary to determine whether particular coinfections contribute to symptoms in specific patients. The discussion illustrates the importance of investigating plausible medical explanations without assuming that every positive test identifies the cause of illness. Fibromyalgia, POTS, EDS, and MCAS: When Symptoms Overlap Dr. Stefano describes caring for patients with severe chronic conditions, including: Fibromyalgia Postural orthostatic tachycardia syndrome (POTS) Ehlers-Danlos syndrome (EDS) Mast cell activation syndrome (MCAS) Chronic pain syndromes Autonomic nervous system dysfunction Long COVID Some patients require extensive supportive care, medications, mobility assistance, or implanted vascular access devices. Dr. Stefano explains that she became interested in whether previously unrecognized infections could contribute to symptoms in certain individuals. These conditions can overlap clinically, but they are not interchangeable. EDS is a group of connective tissue disorders, while POTS involves abnormal orthostatic heart-rate regulation. MCAS, fibromyalgia, and Long COVID have distinct diagnostic considerations. The presence of one condition does not establish an underlying tick-borne infection. Dr. Stefano's observations highlight the need for individualized evaluation that considers both established diagnoses and other medically plausible contributors. A Patient With Severe Illness Begins Improving Dr. Stefano shares a particularly memorable patient story. The patient had an extraordinarily complicated medical history involving severe joint problems, numerous spinal surgeries, autonomic dysfunction, and multiple organ-related complications. According to Dr. Stefano, the patient had undergone approximately 20 spinal surgeries and experienced recurrent serious infections, including osteomyelitis and sepsis. The patient also had diabetes and significant bladder and gastrointestinal problems. Dr. Stefano explains that she subsequently investigated possible tick-borne infections and initiated a complex treatment approach that included multiple antibiotics. She reports that the patient experienced meaningful improvements. Among the changes she highlights: The patient was able to drive again after years without driving. Diabetes management reportedly improved. Overall functioning improved. The patient expressed greater optimism about daily life. Dr. Stefano describes the experience as deeply rewarding. This is an individual clinical account, not a controlled study. It does not establish that tick-borne infections caused the patient's underlying disorders or that the antibiotic regimen was responsible for all improvements. Complex antibiotic regimens can carry significant risks and require careful medical oversight. Nevertheless, the story captures why Dr. Stefano is passionate about continuing to investigate difficult cases. Treating Older Adults With Complex Chronic Illness Rich and Dr. Stefano also discuss the challenges of treating elderly patients. She describes working with individuals in their 80s and 90s who have longstanding chronic symptoms. For these patients, treatment decisions can be especially complicated. Age, frailty, existing medications, organ function, quality of life, and personal preferences may all influence the balance between potential benefits and risks. Dr. Stefano explains that aggressive treatment is not always appropriate. She discusses taking a more conservative approach with some older patients, including the use of herbal preparations. The conversation highlights the importance of individualized decision-making rather than assuming that every patient should receive the same treatment. Herbal therapies can also have side effects and drug interactions, particularly in older adults. Ketamine-Assisted Psychotherapy and Psychedelic Integration Near the end of the interview, the conversation shifts toward another area of Dr. Stefano's work: ketamine-assisted psychotherapy and psychedelic integration. Dr. Stefano is a certified psychedelic-assisted therapy provider who has pursued additional training through the Integrative Psychiatry Institute. She discusses the potential role of psychedelic-assisted approaches in changing patterns of thought, emotional responses, and psychological distress. Rich expresses interest in exploring whether these approaches might complement neuroplasticity and nervous system rehabilitation strategies. The discussion includes: Ketamine-assisted psychotherapy Psychedelic integration Neuroplasticity Brain retraining Emotional and behavioral patterns Potential applications in complex chronic illness Dr. Stefano believes that certain therapies may help selected patients work through entrenched psychological patterns. However, ketamine-assisted psychotherapy is not an established treatment for Lyme disease, Bartonella, Babesia, or other tick-borne infections. Research into ketamine and neuroplasticity is ongoing, and its benefits, risks, and appropriate uses depend on the condition being treated. Ketamine can cause significant adverse effects and requires appropriate screening, monitoring, and medical supervision. For related conversations, listen to Cathleen King on Primal Trust and Nervous System Regulation and Ben Ahrens on Neuroplasticity and re-origin. Could Neuroplasticity Support Chronic Illness Recovery? Rich discusses his interest in brain retraining and nervous system regulation. He notes that some people with severe chronic illness may struggle to participate in demanding rehabilitation programs because of fatigue, cognitive symptoms, or limited physical capacity. He wonders whether additional therapeutic approaches could help selected patients engage in rehabilitation. Dr. Stefano agrees that this is an interesting area for further discussion. They briefly explore the possibility of combining psychological therapies with other aspects of complex chronic illness care. The conversation does not establish that neuroplasticity exercises, ketamine, or psychedelics improve immune function, eliminate infections, or accelerate recovery from Lyme disease. However, addressing mental health, emotional distress, and functional limitations can be an important part of comprehensive care for people living with chronic illness. Integrative Cardiology and Complex Chronic Illness Dr. Stefano also identifies integrative cardiology as one of her professional interests. Cardiovascular symptoms can occur in a range of medical conditions, including autonomic disorders and certain infectious diseases. During the interview, she discusses patients with POTS and other forms of autonomic dysfunction. Although the conversation does not explore her cardiology approach in detail, Rich expresses interest in returning to the topic during a longer interview. Her official website includes information about integrative cardiology and related services. How to Connect With Dr. Jade Stefano Dr. Stefano practices in Seattle, Washington, and offers certain telemedicine services for eligible patients in Washington and Vermont. During the interview, she explains that her prescribing authority and available services differ by state. Her official website provides updated information about appointments, licensure, services, and scheduling. Dr. Jade Stefano, ND Jade Medicine PLLC 5306 Ballard Avenue NW, Suite 322 Seattle, WA 98107 Phone: 206-578-3494 Visit Dr. Jade Stefano's Official Website Learn About Her Lyme Disease and Associated Infection Services Explore Her Ketamine-Assisted Psychotherapy Services Key Takeaways From Dr. Jade Stefano Tick-borne infections deserve consideration when exposure history and clinical findings support testing. Dr. Stefano describes expanding her evaluations after her mother's experience. Family experiences can influence clinical interests. Her mother's longstanding illness prompted her to investigate vector-borne infections more closely. Complex chronic illnesses often involve overlapping symptoms. Fibromyalgia, POTS, EDS, MCAS, and Long COVID require careful differential diagnosis. Babesia and Bartonella are important infectious disease topics. Their diagnosis and clinical significance depend on the organism, test, and patient's presentation. Specialized testing requires careful interpretation. FISH and other molecular assays have limitations and require organism-specific validation. Long COVID and infection reactivation remain active research topics. Dr. Stefano discusses possible relationships that have not yet been established. Treatment must be individualized. Age, medical complexity, medication risks, and patient preferences influence decisions. Patient improvements deserve attention and further study. Individual case reports can generate research questions but do not establish treatment effectiveness. Mental health and neurological rehabilitation are important aspects of comprehensive care. Their roles should be distinguished from antimicrobial treatment. Ketamine-assisted psychotherapy is a separate area of clinical investigation. It is not an established treatment for tick-borne infections. Continuing education matters. Dr. Stefano credits personal experience and professional learning with expanding her clinical interests. Patients deserve curiosity, compassion, and careful evaluation. Persistent symptoms should be taken seriously even when their causes remain uncertain. Resources Mentioned in This Episode Dr. Jade Stefano Dr. Jade Stefano – Official Website Dr. Jade Stefano – Professional Biography Lyme Disease and Chronic Infections Ketamine-Assisted Psychotherapy Lyme Disease Education and Related Interviews International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Lyme Disease Testing Resource Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Tick Bite Blueprint Cathleen King on Primal Trust and Nervous System Regulation Ben Ahrens on Neuroplasticity and re-origin About This LIVE from ILADS Episode Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features Dr. Jade Stefano, ND, a Seattle-based naturopathic physician specializing in integrative medicine, complex chronic illness, and vector-borne infections. In conversation with Tick Boot Camp co-host Rich Johannesen, Dr. Stefano discusses her family's experience with Lyme disease and Babesia, her growing interest in Bartonella and other infections, and the challenges of evaluating patients with longstanding symptoms attributed to fibromyalgia, POTS, EDS, MCAS, or Long COVID. She also shares patient experiences, discusses specialized testing and individualized treatment decisions, and introduces her work involving ketamine-assisted psychotherapy and psychedelic integration. The episode concludes with Rich inviting Dr. Stefano to return for a longer conversation, potentially in Tick Boot Camp's New York studio. For people navigating complex chronic illness, this conversation offers a reminder that unanswered questions deserve thoughtful investigation—and that compassionate, individualized healthcare can make a meaningful difference.

  • S1 · E632
    Tuesday · 20 min

    Episode 632: Beyond Lyme Disease: Bartonella, Babesia & Whole-Body Healing – Dr. Meagan McLaughlin | LIVE from ILADS

    Could Lyme disease, Bartonella, or Babesia be contributing to symptoms that have been attributed to fibromyalgia, hormonal changes, chronic fatigue, or other conditions? And why might addressing an infection be only one part of a patient's recovery journey? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Dr. Meagan McLaughlin, DNP, FNP-C, IFMCP, a functional medicine nurse practitioner at Aurora Integrative Medical Clinic in Mount Vernon, Iowa. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores the growing recognition of tick-borne diseases in the Midwest, the complexity of Lyme disease and coinfections, and the importance of a comprehensive, individualized approach to patient care. Dr. McLaughlin discusses her experience evaluating patients with Lyme disease, Bartonella, Babesia, anaplasmosis, and tick-borne relapsing fever. She also explains why her clinical assessments extend beyond infectious disease testing to consider nutrition, gastrointestinal health, hormones, thyroid function, sleep, and other factors that can influence overall health. But one of the most important themes of the conversation is the relationship between patients and healthcare professionals. Dr. McLaughlin believes that patients should be active partners in their healthcare, understand why treatments are recommended, and feel empowered to participate in decisions about their recovery. Together, Rich and Dr. McLaughlin explore how education, communication, comprehensive medical histories, and collaborative care can help transform the patient experience. Meet Dr. Meagan McLaughlin, DNP, FNP-C, IFMCP Dr. Meagan McLaughlin is an advanced nurse practitioner specializing in functional and integrative medicine at Aurora Integrative Medical Clinic in Mount Vernon, Iowa, near Cedar Rapids and Iowa City. Originally from Anchorage, Alaska, she eventually settled in Iowa, where she developed an interest in autoimmune disease, chronic illness, and the potential role of infections and environmental factors in complex medical conditions. Dr. McLaughlin earned her Doctor of Nursing Practice degree at Clarke University and is certified through the Institute for Functional Medicine. Her professional interests include: Lyme disease and associated tick-borne infections Autoimmune conditions Chronic inflammatory illnesses Thyroid and hormone dysfunction Nutritional and gastrointestinal health Integrative and functional medicine Individualized approaches to complex chronic illness She has also completed physician training through ILADS and participates in continuing education related to Lyme disease and associated conditions. Learn more about her background through the clinic's official provider biographies. How Autoimmune Disease Led Her to Functional Medicine Dr. McLaughlin explains that her interest in functional medicine began with her family's experiences. Several family members had autoimmune conditions, and her daughter was diagnosed with an autoimmune illness at a young age. These experiences motivated her to investigate why certain individuals develop chronic illnesses. She became interested in genetics, environmental exposures, immune regulation, and other factors that may influence disease. As she expanded her education, she began exploring the potential role of infections, including tick-borne pathogens, in some complex clinical presentations. This eventually led her to ILADS and additional training in Lyme disease and associated infections. Dr. McLaughlin emphasizes the importance of continuing education and remaining open to new information when patients are not improving. Lyme Disease in Iowa: Why Tick-Borne Illness Isn't Just a Northeast Problem Rich asks Dr. McLaughlin about the patients she encounters in Iowa. Although Lyme disease is often associated with the Northeast, tick-borne infections are also important public health concerns in parts of the Midwest. Dr. McLaughlin explains that her practice serves a diverse population. Some patients live in rural communities, work on farms, hunt, or spend substantial time outdoors. Others come from suburban areas, college communities, and nearby cities. She describes seeing patients from Mount Vernon, Cedar Rapids, Iowa City, and surrounding communities. Her experience challenges the assumption that tick-borne diseases affect only people who regularly hike or spend time in wooded environments. Tick exposure can occur in many everyday outdoor settings, including residential yards. Lyme Disease Symptoms That Can Resemble Other Conditions Dr. McLaughlin discusses the wide range of symptoms she encounters among patients being evaluated for possible tick-borne infections. Some report persistent fatigue, insomnia, joint pain, or generalized aches. Others experience more complicated symptoms involving the nervous system or cardiovascular system. Examples discussed include: Chronic fatigue Joint and muscle pain Symptoms resembling fibromyalgia Sleep disturbances Brain fog and cognitive difficulties Heart palpitations Postural orthostatic tachycardia syndrome (POTS) Autonomic nervous system dysfunction Symptoms that overlap with perimenopause Recurrent or severe illness episodes Dr. McLaughlin describes Lyme disease as a condition that can sometimes be difficult to recognize because its symptoms overlap with other illnesses. However, these symptoms are not specific to Lyme disease. POTS, fibromyalgia, hormonal changes, thyroid disorders, autoimmune diseases, and other conditions can have independent causes. A comprehensive medical evaluation is important to determine which diagnoses are supported by a patient's history, examination, and appropriate testing. Beyond Borrelia: Bartonella, Babesia, and Other Tick-Borne Infections One of the central topics is the possibility of multiple infections. Rich discusses how Tick Boot Camp guests increasingly describe complex diagnostic histories involving several organisms. He refers to the three Bs: Borrelia, Bartonella, and Babesia. Dr. McLaughlin explains that her practice evaluates patients for multiple tick-borne pathogens when clinically appropriate. She discusses encountering patients with laboratory findings involving: Borrelia: Bacteria associated with Lyme disease and certain relapsing fever illnesses Babesia: Parasites that infect red blood cells and cause babesiosis Bartonella: Bacteria associated with several human diseases, including cat-scratch disease Anaplasma: Bacteria responsible for human granulocytic anaplasmosis Tick-borne relapsing fever pathogens: Borrelia species associated with relapsing fever She particularly highlights Babesia and anaplasmosis among infections encountered in her regional patient population. Dr. McLaughlin also discusses the importance of considering travel and exposure histories, including connections between Iowa, Wisconsin, and Minnesota. During the interview, she estimates that a high percentage of patients selected for testing in her specialty practice have positive findings. These figures reflect her experience with a highly selected clinical population and should not be interpreted as infection prevalence in Iowa or the general public. Likewise, multiple positive laboratory findings do not automatically establish multiple active infections. Each result requires appropriate clinical interpretation. Understanding Lyme Disease and Coinfection Testing Dr. McLaughlin describes using specialized laboratory testing as part of her clinical evaluations. She mentions IGeneX and ArminLabs as laboratories her practice has used. Her approach emphasizes gathering information that may help guide individualized treatment decisions. She also explains that some patients undergo additional testing over time as their clinical picture changes. Not all Lyme disease or coinfection tests have the same clinical validation, sensitivity, or specificity. Testing methods should be selected according to the suspected infection, symptoms, exposure history, and current diagnostic guidance. For Lyme disease, validated two-tier antibody testing remains an important diagnostic approach. Other infections, including babesiosis and anaplasmosis, may require different laboratory methods. A positive test does not always establish active infection, and a negative result must be interpreted in the context of the disease being evaluated. Learn more through Tick Boot Camp's Lyme Disease Testing Resource. Why Treating Lyme Disease May Require Looking at the Whole Patient Dr. McLaughlin explains that her approach to complex chronic illness involves more than identifying possible pathogens. She also considers factors that may influence a patient's symptoms, general health, and ability to tolerate treatment. These include: Nutritional status Sleep quality Thyroid function Hormonal health Gastrointestinal symptoms Kidney and liver function Medication and supplement use Other diagnosed medical conditions She gives the example of a patient with poor sleep, sleep apnea, nutritional problems, and hormonal concerns. Even when an infection is appropriately diagnosed and treated, those additional medical issues may continue contributing to symptoms. Her broader message is that patients deserve a comprehensive assessment rather than an assumption that every symptom has one explanation. Treating a confirmed infection and addressing other health conditions are complementary goals, not competing approaches. Supportive lifestyle and nutritional care can be important, but they do not replace appropriate antimicrobial treatment for infections that require it. The Importance of Nutrition, Gut Health, Hormones, and Sleep Dr. McLaughlin describes laboratory evaluation as an important part of her practice. Depending on the patient's history and symptoms, she may assess nutritional deficiencies, thyroid function, hormone levels, and organ function. She also discusses gastrointestinal health and the microbiome. Her goal is to identify additional medical concerns that may complicate recovery or contribute to persistent symptoms. For example, untreated sleep apnea, thyroid disease, or a nutritional deficiency can produce fatigue and other symptoms that overlap with those attributed to Lyme disease. Evaluating these possibilities can help clinicians develop more complete treatment plans. Not every patient requires extensive hormone, microbiome, or specialty testing. The usefulness of individual tests depends on the clinical situation, and some commercial functional medicine tests have limited evidence of clinical utility. What Happens During a First Appointment? Rich asks Dr. McLaughlin to explain what a new patient can expect when contacting her practice. She emphasizes the importance of a detailed medical history before the initial appointment. Her clinic asks patients to complete intake information in advance so the care team can review their experiences and previous evaluations. This may include: Current symptoms and concerns Previous diagnoses Medical and family history Prior laboratory testing Previous treatments Medications and supplements Lifestyle and environmental information Treatment goals Dr. McLaughlin explains that many patients arrive after visiting multiple healthcare providers. Some have already completed extensive testing or tried different treatment approaches. Reviewing those records helps her identify what has been evaluated, what remains uncertain, and which additional steps may be appropriate. Depending on the presentation, she may recommend further evaluation or discuss treatment options. For certain acute tick-borne illnesses, prompt treatment can be important and should not be delayed while waiting for every laboratory result. Why Patients Should Be Partners in Their Healthcare One of the most meaningful conversations in the interview centers on patient responsibility and collaboration. Rich shares how his perspective changed after working with Dr. Casey Kelley, an ILADS-trained physician who required him to complete a detailed medical questionnaire. Initially, he found the paperwork frustrating. But as he worked through it, he realized that the process was encouraging him to reflect on his medical history and take a more active role in his care. He began to see healthcare as a partnership rather than something he could simply delegate to a physician. Dr. McLaughlin agrees. She explains that clinicians can provide medical knowledge, treatment recommendations, and support, but patients also contribute essential information about their symptoms, experiences, and goals. A successful partnership requires communication and shared decision-making. Importantly, patients should receive the support they need to participate at a level that is realistic for their circumstances. Severe illness, cognitive impairment, disability, and financial barriers can make participation difficult. Patient empowerment should mean being supported and heard—not being blamed when treatment is unsuccessful. Dr. Casey Kelley and the Value of Mentorship During the conversation, Dr. McLaughlin reveals that Dr. Casey Kelley served as a mentor during her ILADS physician training. Rich is particularly excited by this connection because Dr. Kelley had also influenced his understanding of collaborative healthcare. He recognizes similarities between their approaches. Both emphasize comprehensive medical histories, patient education, and an active partnership between patients and clinicians. Dr. McLaughlin also discusses the importance of continuing to consult colleagues and learn from other healthcare professionals when patients are not improving. She sees ILADS as a community where clinicians can exchange ideas, pursue additional education, and work toward better patient outcomes. Why Patient Education Matters During Treatment Dr. McLaughlin explains that patient education occupies a substantial portion of her appointments. She describes showing patients medical studies, illustrations, and other educational materials to explain her clinical reasoning. Topics may include infections, immune responses, treatment mechanisms, and emerging research. She believes patients are more likely to understand and participate in treatment when they know why a particular intervention is being recommended. Rather than simply handing someone a list of medications or supplements, she wants patients to understand the goals and rationale behind their care. She also acknowledges that different patients prefer different levels of detail. Some want to review studies and explore the science. Others prefer a simpler explanation and clear next steps. The goal is to communicate in a way that respects each patient's needs. Moving Beyond Medical Dismissal Toward Collaboration Rich and Dr. McLaughlin discuss the frustration many patients experience when they feel their symptoms have not been adequately understood. They also explore the pressures facing healthcare professionals. Dr. McLaughlin notes that clinicians working in conventional medical settings may have limited appointment time and may not have received extensive training in every aspect of complex chronic illness. Rich emphasizes that improving relationships between patients and healthcare professionals can benefit both groups. Their conversation encourages greater communication, mutual respect, and continued education. Patients deserve to have their symptoms taken seriously, even when an explanation is not immediately available. At the same time, clinicians benefit from accurate medical histories, open communication, and opportunities to pursue additional training. Respectful collaboration does not require patients to ignore dismissive experiences or accept inadequate care. Patients can advocate for themselves, seek second opinions, and ask questions while maintaining constructive relationships with their healthcare teams. Pediatric Neuroinflammation, PANS, and PANDAS Near the end of the interview, Dr. McLaughlin discusses the expansion of pediatric services at Aurora Integrative Medical Clinic. She mentions the addition of a pediatric nurse practitioner with an interest in neuroinflammatory conditions, including PANS and PANDAS. These conditions can involve abrupt-onset neuropsychiatric symptoms and require careful medical assessment. The clinic's official provider information identifies Dr. Erin Mitchell, DNP, CPNP-PC, as a pediatric nurse practitioner with experience in pediatric care and additional integrative medicine training. For more on the relationship between pediatric complex illness, tick-borne disease, and neuropsychiatric symptoms, listen to Dr. Somer DelSignore on Pediatric Lyme Disease, Autism Regression, PANS/PANDAS, and Root-Cause Healing. How to Connect With Aurora Integrative Medical Clinic Dr. McLaughlin practices at Aurora Integrative Medical Clinic in Mount Vernon, Iowa. During the interview, she explains that the clinic offers in-person appointments and certain telehealth opportunities, including for eligible patients in Wisconsin. She notes that some services or treatments may require in-person evaluation. Telehealth availability depends on clinician licensure, the patient's location, and the services requested. Patients interested in learning more can visit the clinic's website for current scheduling information. Aurora Integrative Medical Clinic 713 1st Avenue NW Mount Vernon, Iowa 52314 Phone: 319-895-4080 Visit Aurora Integrative Medical Clinic Meet Dr. Meagan McLaughlin and the Aurora Care Team Key Takeaways From Dr. Meagan McLaughlin Tick-borne illnesses are not limited to the Northeast. Dr. McLaughlin discusses patients in Iowa and neighboring Midwestern states. Lyme disease symptoms can overlap with other conditions. Fatigue, pain, sleep disturbances, and autonomic symptoms require careful evaluation. Coinfections deserve consideration when clinically appropriate. The discussion includes Bartonella, Babesia, anaplasmosis, and tick-borne relapsing fever. Testing must be interpreted carefully. Laboratory findings should be considered alongside symptoms, exposure history, and validated diagnostic criteria. Comprehensive care looks beyond one diagnosis. Sleep, nutrition, thyroid function, and other health conditions can influence how patients feel. A detailed intake can improve communication. Medical histories and prior records help clinicians understand complicated cases. Patients deserve a collaborative relationship with their providers. Shared decision-making helps people understand their options. Education can support informed treatment decisions. Dr. McLaughlin emphasizes explaining the reasoning behind recommendations. Healthcare professionals benefit from collaboration and continuing education. Mentorship and professional communities can help clinicians expand their knowledge. Pediatric complex illness requires specialized attention. The clinic is expanding services for children, including those with neuroinflammatory concerns. Tick prevention matters in everyday environments. Exposure can occur around homes and other familiar outdoor spaces. Hope and advocacy can coexist with scientific rigor. Patients deserve compassionate care, accurate information, and treatment plans grounded in their individual needs. Resources Mentioned in This Episode Guest and Clinic Aurora Integrative Medical Clinic – Official Website Dr. Meagan McLaughlin – Official Provider Biography Aurora Integrative Medical Clinic – Functional Medicine Lyme Disease Education International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Lyme Disease Testing Resource Tick Boot Camp Tick Bite Blueprint Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Podcast – Patient Stories and Expert Interviews Dr. Somer DelSignore on Pediatric Lyme Disease and PANS/PANDAS About This LIVE from ILADS Episode This episode was recorded at the 2025 ILADS Conference in San Antonio, Texas, where Tick Boot Camp co-host Rich Johannesen interviewed Dr. Meagan McLaughlin, DNP, FNP-C, IFMCP, of Aurora Integrative Medical Clinic in Mount Vernon, Iowa. The conversation explores Lyme disease and tick-borne coinfections in the Midwest, including Borrelia, Bartonella, Babesia, anaplasmosis, and tick-borne relapsing fever. Dr. McLaughlin explains her integrative approach to complex chronic illness, emphasizing comprehensive medical histories, individualized laboratory evaluation, nutrition, hormonal health, sleep, and patient education. Rich and Dr. McLaughlin also discuss the importance of collaborative healthcare, her mentorship under Dr. Casey Kelley, the value of ILADS training, and the clinic's expanding pediatric services. For patients navigating Lyme disease or unexplained chronic symptoms, this conversation reinforces an important message: you deserve to be heard, informed, and actively involved in your healthcare.

  • S1 · E631
    Monday · 8 min

    Episode 631: Misdiagnosed With Epilepsy? Lyme Disease, AI & Patient Advocacy – Payton Bradsky | LIVE from ILADS

    What happens when unexplained seizure-like episodes lead to an epilepsy diagnosis, but the tests don't provide clear answers? And could artificial intelligence help Lyme disease patients navigate the medical system with greater confidence? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen interviews Payton Bradsky, Lyme disease survivor, former Google employee, and co-founder of LymeLess Health, an AI-powered platform designed to support people navigating Lyme disease and associated tick-borne illnesses. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation follows Rich's interview with Payton's brother and business partner, Carter Bradsky. Payton shares her experience with sudden seizure-like episodes during her senior year of college, an epilepsy diagnosis that was eventually withdrawn, and approximately four years of treatment for Lyme disease and coinfections. She also explains how her family's experiences inspired her and Carter to leave their careers and create LymeLess Health, a technology platform designed around the needs of patients. At the center of LymeLess is Ella, an AI companion that helps patients organize symptoms, track treatments, receive reminders, maintain health histories, and prepare reports for medical appointments. Their goal is to give patients the kind of support and organization they wish they had during their own Lyme disease journeys. Episode 576: Can AI Transform Lyme Disease Care? Carter & Payton Bradsky of LymeLess From South Dakota to New York City, Google, and LymeLess Originally from South Dakota, Payton eventually moved to New York City, built a career at Google, and later relocated to North Carolina. During the interview, Rich congratulates her on her engagement and move. Payton explains that she spent approximately five years working at Google while navigating her own health challenges. Her technical background would eventually become central to her next professional chapter. But before becoming a healthcare technology entrepreneur, Payton experienced firsthand how difficult navigating Lyme disease could be. Her family's experience began with her mother, who spent years searching for answers to unexplained symptoms. Her brother Carter subsequently became ill, experiencing debilitating brain fog, memory difficulties, and other symptoms that ended his opportunity to play competitive college basketball. Then Payton developed symptoms of her own. Seizure-Like Episodes and an Epilepsy Diagnosis Payton recalls that her symptoms became especially concerning during her senior year of college. She began experiencing unexpected seizure-like episodes. These events led to an epilepsy diagnosis and treatment with anti-seizure medication. However, Payton describes receiving negative or inconclusive results from the tests and scans performed during her neurological evaluation. She says her neurologist eventually acknowledged that her symptoms did not clearly resemble epilepsy but was reluctant to withdraw the diagnosis or discontinue medication. Payton found the uncertainty and medication effects difficult to manage. Because her mother and brother had already experienced Lyme disease, her family wondered whether a tick-borne illness might be contributing to her symptoms. She sought evaluation from a naturopathic provider familiar with Lyme disease and reports that she subsequently received a Lyme disease diagnosis. Her epilepsy diagnosis was eventually withdrawn. Looking back, Payton recognized additional symptoms, including brain fog and headaches, that she believed were connected to her illness. Her story illustrates the importance of continuing appropriate medical evaluation when symptoms remain unexplained. Seizure-like episodes can have many causes, and Lyme disease is not a common explanation. Such symptoms require qualified neurological assessment, and anti-seizure medication should never be stopped without medical supervision. Four Years of Lyme Disease Treatment Payton describes spending approximately four years undergoing treatment for Lyme disease and associated infections. During that time, she graduated from college and began her career. Her brother Carter was also navigating his recovery, and the siblings supported one another throughout their overlapping health journeys. They frequently discussed the challenges of managing symptoms, medications, treatment protocols, medical records, and uncertainty. Even though their family was already familiar with Lyme disease, Payton explains that navigating the illness remained extremely difficult. She recognized that other patients might face even greater obstacles without a knowledgeable family member or supportive network. This realization became a major motivation behind LymeLess Health. Why Payton and Carter Founded LymeLess Health Payton and Carter began discussing how technology could help address the problems they had encountered. Both understood the burden of managing complicated treatment plans while experiencing symptoms such as fatigue and cognitive difficulties. They also recognized how difficult it could be to identify reliable resources and understand changes in symptoms over time. Payton's experience at Google helped her recognize opportunities involving artificial intelligence, machine learning, and digital health technology. Eventually, the siblings decided to leave their jobs and pursue their vision. They founded LymeLess Health, a patient-focused platform designed to make the Lyme disease journey more organized, informed, and manageable. Payton explains that their goal is to build something that supports patients throughout their everyday experiences—not simply provide another source of general health information. Meet Ella: The AI Companion for Lyme Disease Patients At the center of LymeLess is Ella, an artificial intelligence companion designed to help patients manage their health information. Payton explains that Ella incorporates Lyme-related educational resources and information provided by individual patients. The platform is designed to bring together several tools that patients might otherwise manage separately. Symptom Tracking Patients can record symptoms and monitor how they change over time. This may help them recognize patterns and communicate more clearly with healthcare providers. Treatment Tracking and Reminders LymeLess allows users to record treatments, receive reminders, and maintain a history of their care. These tools are intended to help patients manage complex routines involving medications, supplements, and other interventions. Personal Health Records Patients can organize information about previous treatments, symptoms, and medical experiences. Having this information in one place may reduce the need to reconstruct health histories from memory. AI-Powered Insights Ella helps patients explore their recorded information and identify patterns that may be useful to discuss with their clinicians. These insights are informational and do not establish diagnoses or treatment effectiveness. Medical Appointment Reports One of the features Payton highlights is the ability to generate organized reports for healthcare appointments. Rather than struggling to remember months of symptoms and treatments during a short visit, patients can bring a structured summary to their provider. The goal is to help patients become more informed and organized participants in their healthcare. Ella is not a substitute for a qualified medical professional, and AI-generated information should be reviewed critically. Turning Patient Experiences Into Research Opportunities Payton's vision extends beyond helping individuals organize their health information. She hopes LymeLess can eventually contribute to research by bringing together appropriately collected patient experiences. People with Lyme disease and associated conditions may experience different symptoms, follow different treatment protocols, and report different outcomes. Payton believes that technology could help researchers explore these differences and identify patterns worth investigating. She discusses the possibility of examining patient groups with similar characteristics, including laboratory results, health histories, and treatment experiences. These insights could potentially inform future research questions. However, patient-reported experiences cannot independently establish whether a treatment is safe or effective. Scientific validation, reliable data collection, privacy safeguards, and appropriate study designs are essential before drawing clinical conclusions. Built With Feedback From Lyme Disease Patients Payton explains that the LymeLess team interviewed more than 100 patients while developing the platform. These conversations helped the founders understand the challenges people encounter during diagnosis, treatment, and ongoing care. She emphasizes that the company wants to continue learning from patients. Rather than building features based solely on assumptions, Payton wants users to share what is working, what is not, and what would make their daily lives easier. Her approach reflects the company's origins as a platform created by people with firsthand experience navigating Lyme disease. The goal is to develop technology around the needs of patients rather than expecting patients to adapt to complicated technology. The Role of Family and Community Support Payton repeatedly emphasizes how important her mother's support was during her illness. Her mother had already navigated a difficult diagnostic journey and was able to help both children recognize potential health concerns and identify resources. Payton and Carter want LymeLess to provide some of that same organizational and educational support to people who may not have a family member with similar experience. They recognize that many patients feel isolated or overwhelmed while trying to understand their symptoms and treatment options. The platform is intended to help make relevant information easier to access. No one should have to navigate a complicated illness entirely alone. Tick Boot Camp and LymeLess: A Shared Commitment to Patient Experiences During the interview, Rich explains why the LymeLess concept resonates with Tick Boot Camp's mission. Tick Boot Camp was created to give people affected by Lyme disease a platform to share their experiences and help others learn from their journeys. Through hundreds of interviews with patients, physicians, researchers, and advocates, Tick Boot Camp has built an extensive educational library. Rich explains that these interviews include guest profiles, transcripts, and searchable content intended to help patients discover information relevant to their experiences. He suggests that this collection of patient stories could potentially contribute to the educational resources used by LymeLess. Payton welcomes the possibility of exploring a collaboration. The conversation is exploratory, and no formal partnership is announced. Both platforms share an interest in making patient experiences more accessible and helping people navigate Lyme disease with greater knowledge and support. Explore the Tick Boot Camp Podcast Library to hear firsthand experiences from people navigating Lyme disease and tick-borne illnesses. Could AI Help Improve the Future of Lyme Disease Care? Payton believes that AI and machine learning may eventually help patients, healthcare professionals, and researchers better understand complex chronic illness. Her immediate focus is on providing practical support through symptom tracking, treatment organization, and appointment preparation. Over time, she hopes the platform can help connect patients, clinicians, and researchers. The potential is exciting, but important questions remain about data quality, privacy, clinical validation, and the limitations of AI-generated recommendations. Payton's work represents an effort to bring patient experiences into the development of new healthcare tools. Key Takeaways From Payton Bradsky Unexplained neurological symptoms deserve careful evaluation. Payton describes seizure-like episodes that led to an epilepsy diagnosis she says was eventually withdrawn. Lyme disease can affect entire families. Payton, Carter, and their mother all experienced significant health challenges. Chronic illness can disrupt education and careers. Payton navigated years of treatment while graduating from college and working at Google. Managing complex treatment plans is challenging. Tracking symptoms, medications, appointments, and medical records can become overwhelming. Patient experiences can inspire innovation. Payton and Carter founded LymeLess to address problems they encountered themselves. Ella is designed to help patients stay organized. The AI companion supports symptom tracking, treatment reminders, health histories, and appointment preparation. AI may help identify patterns in patient information. These observations can support conversations with healthcare professionals but do not establish medical conclusions. Patient feedback matters. LymeLess interviewed more than 100 patients during development. Patient-generated information may support future research. Carefully collected data could help researchers investigate new questions. Community and family support are powerful. Payton credits her family's experiences with helping her navigate her illness. Technology should support medical care, not replace it. Professional evaluation remains essential for diagnosis and treatment. Healing can create new purpose. Payton and Carter transformed difficult personal experiences into a mission to help others. Resources Mentioned in This Episode LymeLess Health LymeLess Health – Official Website Learn About LymeLess and Its Founders Lyme Disease Education and Advocacy International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Podcast – Patient Stories and Expert Interviews Tick Boot Camp Lyme Disease Testing Resource Tick Boot Camp Doctors Podcast Collection About This LIVE from ILADS Episode Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features Payton Bradsky, Lyme disease survivor, former Google employee, and co-founder of LymeLess Health. In conversation with Tick Boot Camp co-host Rich Johannesen, Payton shares her experience with seizure-like episodes, an epilepsy diagnosis that was later withdrawn, approximately four years of Lyme disease treatment, and her transition from Google to healthcare entrepreneurship. She introduces Ella, the AI companion developed by LymeLess, and explains how the platform aims to help patients track symptoms, manage treatments, organize medical records, and prepare for appointments. The discussion also explores patient-generated data, the future of AI in Lyme disease research, and a potential collaboration between LymeLess and Tick Boot Camp. For anyone who has felt overwhelmed or isolated while navigating Lyme disease, Payton's story offers hope that patient experiences can inspire meaningful innovation and help build a more supportive future for others.

  • S1 · E630
    Saturday · 1 hr 23 min

    Episode 630: Reaching Recovery: Lyme Disease Healing, Herbs, Nervous System Support & the Long Game

    Read transcript This episode is a little different from a typical Tick Boot Camp Podcast interview. Matt Sabatello and Rich Johannsen joined Liza from Vital Plan for a live community event titled “Reaching Recovery: What It Takes to Get There and Stay There,” originally presented as part of Vital Plan’s Cellular Healing Bootcamp. In this candid conversation, Matt shares the story of going from an extremely active long-distance runner to being bedbound with severe neurological symptoms, seizures, cognitive dysfunction, chronic pain, and profound fear about his future. He explains how his recovery unfolded gradually over several years and how community, belief, nervous system support, herbal medicine, movement, lifestyle changes, and learning from hundreds of Tick Boot Camp guests helped him rebuild his life. Rich shares what it was like to watch Matt’s transformation firsthand and reflects on the patterns he has observed after more than 600 interviews with people navigating Lyme disease, tick-borne illness, chronic illness, and recovery. A major focus of the discussion is Matt and Rich’s experience with Dr. Bill Rawls’ herbal approach and Vital Plan, including Restore180, HPA Balance, nervous system regulation, gut support, movement, sleep, stress management, and what long-term maintenance can look like after significant recovery. Matt also tells a deeply personal story he had never publicly shared before: while hospitalized and extremely ill, his mother and grandmother were praying for him when the giant word “HEALED” appeared on the television in his hospital room. At the time, Matt did not believe recovery was possible. Years later, connecting with people through Tick Boot Camp who had regained their health helped him slowly replace fear and doubt with hope. In This Episode Matt and Rich discuss: Matt’s progression from early exercise-induced symptoms to being completely bedbound Seizures, neurological symptoms, hallucinations, vision problems, chronic pain, and cognitive dysfunction Matt’s Lyme disease diagnosis and his personal experience with IV antibiotics Why recovery continued long after his initial antibiotic treatment The fear of trying new treatments when you are already extremely sick Starting slowly with herbs and gradually building tolerance Matt’s experience with Vital Plan’s Restore Kit, now part of Restore180 HPA Balance and the role Matt and Rich say it played in stress regulation and sleep How fear, hypervigilance, and the nervous system can become part of the chronic illness experience Why Matt believes community was essential to rebuilding hope Rich’s perspective on moving gradually from doubt toward belief that recovery is possible What it means to be “healed” or “recovered” when nobody feels perfect every day Going from being unable to participate consistently in the podcast to working full time, exercising, traveling, attending events, and living an active life Matt’s gradual return to walking and eventually running again The difference between active treatment and long-term maintenance Matt and Rich’s current approach to herbs and supplements Diet, sleep, stress management, movement, boundaries, and nervous system support How Matt handles demanding days without immediately fearing a major relapse Why setbacks do not necessarily mean starting over The importance of listening to your body and adjusting over time Restore180 and Vital Plan’s approach to long-term herbal support Questions from the live audience about body buzzing, leg pain, sleep, tinnitus, Lyme testing, herbs, and maintenance Matt’s personal experience with changing autoimmune-related laboratory markers during his recovery Why Matt and Rich emphasize agency, education, community, and hope Matt’s Recovery Philosophy One of the central themes of this conversation is that Matt’s recovery did not happen overnight. There was no single morning when he woke up and suddenly declared himself healed. Instead, progress happened gradually. He began showing up for more Tick Boot Camp interviews. He started walking farther. His cognitive function improved. He returned to a demanding professional career. Eventually, he was able to exercise and run again. And at some point, Lyme disease was no longer the center of his daily life. For Matt, that became an important part of what recovery means. Herbs, Restore180 & Dr. Bill Rawls Matt and Rich also share their personal experiences with the herbal protocols developed by Dr. Bill Rawls. Matt describes beginning extremely cautiously because he was afraid of triggering a setback. Rather than rapidly starting a full protocol, he gradually introduced herbs over several months and paid close attention to how his body responded. The conversation explores the idea that herbal medicine may be approached not only through the lens of targeting microbes, but also through supporting broader aspects of wellness such as stress response, sleep, cellular health, gut health, and immune function. Learn more about Vital Plan’s Restore180 program: Explore Restore180 from Vital Plan Watch the Original Vital Plan Community Event This conversation was originally recorded live for the Vital Plan community as part of its Cellular Healing Bootcamp. View the Reaching Recovery event page More with Dr. Bill Rawls on Tick Boot Camp Dr. Bill Rawls was one of the earliest guests on the Tick Boot Camp Podcast and has returned for multiple conversations covering Lyme disease, herbal medicine, cellular wellness, chronic illness, immune health, and recovery. Explore all Tick Boot Camp interviews with Dr. Bill Rawls A Message for Anyone Still in the Thick of It One of the strongest themes of this live conversation is that recovery can be gradual, nonlinear, and difficult to recognize while it is happening. Matt went from being unable to walk to the bathroom safely to working full time, exercising, traveling, attending Lyme community events, producing Tick Boot Camp, and living a life he once could not imagine. The message from Matt and Rich is simple: keep learning, keep making thoughtful decisions, surround yourself with people who give you hope, and do not let a difficult day convince you that progress is impossible. Sometimes recovery begins by doubting the possibility of healing just a little bit less. Learn more about Lyme disease, recovery stories, doctors, researchers, and hundreds of patient journeys at Tick Boot Camp.

    • Transcript
  • S1 · E629
    Saturday · 10 min

    Episode 629: Lyme Disease Ended His Basketball Dreams. Now He's Helping Patients With AI – Carter Bradsky | LIVE from ILADS

    He was preparing to play college basketball when Lyme disease changed everything. Now he's using artificial intelligence to help other patients navigate the journey he wishes he never had to face alone. In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Carter Bradsky, Lyme disease survivor and co-founder of LymeLess Health, to discuss how a devastating family experience with Lyme disease, Bartonella, and Babesia inspired an innovative patient-built healthcare platform. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores the challenges of living with chronic illness as a young adult, losing athletic opportunities, navigating college with debilitating brain fog, and struggling to find reliable information and community support. Carter shares how his mother's prolonged search for a Lyme disease diagnosis helped his family recognize his own symptoms and connect with a healthcare provider. After approximately two and a half years of treatment and recovery, Carter and his sister, Payton Bradsky, decided to build something they wish had existed during their own illnesses. The result is LymeLess Health, an AI-powered care management platform designed specifically for people navigating Lyme disease and associated tick-borne infections. Their mission is to make the Lyme disease journey less isolating, less confusing, and more manageable by bringing together patient experiences, health information, educational resources, and technology. What if patients didn't have to spend years searching for the information, support, and guidance that others have already discovered through their own experiences? That's the question driving Carter and Payton's work. Episode 576: Can AI Transform Lyme Disease Care? Carter & Payton Bradsky of LymeLess A Family's Journey Through Lyme Disease Carter explains that his family's experience with Lyme disease began approximately a decade before this interview. His mother developed debilitating symptoms while living in Arizona and spent years searching for an explanation. According to Carter, she underwent more than 100 medical tests and encountered multiple physicians before receiving a diagnosis. During that time, she experienced medical dismissal and was told that her symptoms might be psychological. At one point, multiple sclerosis was considered as a possible explanation. A chance conversation with the mother of one of Carter's high school friends—who was a naturopathic provider familiar with Lyme disease—encouraged the family to investigate tick-borne illness. That encounter eventually helped his mother connect with a physician who diagnosed and treated her. Carter emphasizes how much luck played a role in his mother's journey. Without that unexpected connection, he wonders how much longer she might have continued searching for answers. Her experience would later become critically important when Carter developed symptoms of his own. From Competitive Basketball to Debilitating Brain Fog As a high school senior in South Dakota, Carter was preparing for an exciting transition. He was graduating, heading to college, and had an opportunity to play competitive basketball at the university level. Basketball had been an important part of his identity. Then his health began to deteriorate. Carter describes developing symptoms that included: Severe brain fog Memory loss Dissociation Anxiety Difficulty concentrating Cognitive challenges affecting academic performance Fear and physical discomfort associated with athletic activity He remembers going from feeling confident and engaged on the basketball court to experiencing anxiety about returning to play. The sport that had once brought him tremendous happiness became something he could no longer participate in. Because his mother had already experienced Lyme disease, she recognized similarities in his symptoms and encouraged him to seek evaluation. They traveled to Northern California to see the physician who had helped her. Carter reports that Bartonella and Babesia were identified as significant components of his illness. He describes undergoing approximately two and a half years of treatment involving antibiotics, herbal support, and other interventions before regaining his health. His treatment experience is personal testimony, not evidence that the same regimen is appropriate or effective for every patient. Losing the College Experience to Chronic Illness One of the most emotional parts of the conversation centers on what Lyme disease took away from Carter during college. He explains that he had to abandon competitive athletics. But the loss extended far beyond basketball. While classmates were enjoying college life, making friends, attending social events, and pursuing academic goals, Carter was struggling simply to get through the day. He recalls attending philosophy classes and being unable to remember assigned reading. When professors called on him, he sometimes struggled to answer questions because of his cognitive symptoms. He describes feeling embarrassed, isolated, and disconnected from the experiences his peers were having. Instead of enjoying a typical college social life, Carter focused on three priorities: Getting through class, spending time at church, and sleeping. His academic goal shifted from excelling to simply being able to complete his coursework. For a young adult who had previously been active, confident, and competitive, the experience was deeply challenging. Carter explains that he did not know where to find Lyme disease support groups, educational resources, or organizations such as ILADS. He felt as though he were navigating an overwhelming illness without a community that understood what he was experiencing. That isolation eventually became one of the primary problems he wanted LymeLess to address. The Hidden Burden of Managing Lyme Disease Treatment Carter also discusses the practical challenges of managing complex treatment plans while attending college. He remembers trying to organize numerous medications and supplements while keeping his illness private. For patients managing multiple prescriptions, supplements, appointments, and changing symptoms, the organizational burden can become substantial. Carter describes the experience of having a kitchen counter filled with bottles and trying to remember what to take and when. At the same time, he was struggling with brain fog and memory difficulties. The very symptoms he was experiencing made managing his care more difficult. He also recalls uncertainty about whether his treatments were helping and whether he was making the right decisions. Questions frequently occupied his thoughts: Am I receiving the right care? Are these treatments helping? What should I do next? Are other patients experiencing similar symptoms? Where can I find reliable information? Will I ever get better? These challenges helped shape his vision for a technology platform that could support patients with organization, education, and care navigation. Meet LymeLess Health: Built by Patients, for Patients After Carter and Payton experienced their own Lyme disease journeys, they began discussing how technology could help address problems they had encountered. They founded LymeLess Health, a patient-centered platform focused on Lyme disease and associated tick-borne infections, which the company collectively refers to as Lyme+. Their goal is to help patients manage the complexity of chronic illness by bringing important information into one place. During the interview, Carter describes the platform as a personalized AI companion informed by Lyme-related educational resources, individual health information, and insights from the patient community. Rather than requiring patients to search across multiple websites, social media groups, medical records, and personal notes, LymeLess aims to make relevant information easier to organize and access. The company's philosophy is rooted in a simple idea: Patients should not have to rely on luck to find helpful information and support. Carter and Payton want to use technology to make the experiences and knowledge accumulated throughout the Lyme disease community more accessible to others. Learn more about LymeLess Health and its mission. Meet Ella: An AI Companion for Lyme Disease Patients At the center of LymeLess is Ella, an AI-powered companion designed to help people navigate Lyme disease and complex treatment journeys. Carter describes the concept as creating a digital resource that could provide some of the organizational and informational support his mother offered him during his illness. The platform is designed to help patients better understand their own health experiences while preparing for conversations with healthcare professionals. LymeLess describes capabilities involving: Symptom and Treatment Tracking Patients can record symptoms, treatments, and changes in how they feel over time. Tracking this information may help individuals identify patterns worth discussing with their healthcare providers. Organizing Medical Information The platform is designed to bring medical history, treatment details, and other health information into a more accessible format. This may be particularly useful for patients who struggle with brain fog, memory difficulties, or extensive medical records. Educational Support Ella provides access to Lyme-related information and resources intended to help patients become more informed about their conditions. Preparing for Medical Appointments By organizing symptoms, treatment histories, and questions, patients may be better prepared to communicate with their healthcare professionals. Learning From Community Experiences LymeLess aims to use aggregated patient experiences to help identify patterns and provide additional context for people navigating similar challenges. The company hopes this approach will eventually support more personalized care and research. These are platform capabilities and goals described by LymeLess, not independently established evidence that AI can identify effective treatments or improve clinical outcomes. Ella is a care management and educational tool, not a replacement for a licensed healthcare professional. Can Artificial Intelligence Help Patients Navigate Lyme Disease? Rich and Carter discuss how artificial intelligence could change the way patients access information. Many people with Lyme disease spend substantial time researching symptoms, comparing treatment experiences, looking for specialists, and searching online communities for answers. This process can become exhausting, especially for patients experiencing cognitive difficulties. Carter believes AI may help reduce that burden by organizing information and making relevant resources easier to find. He describes a future in which patients can draw on educational materials, personal health data, and insights from people with similar experiences. The goal is not to replace medical judgment but to help patients arrive at appointments better informed and prepared. AI-generated health information can still be incomplete or inaccurate, and patient experiences do not establish whether a treatment is safe or effective. Treatment decisions should remain grounded in appropriate medical evaluation and discussions with qualified healthcare professionals. Learning From the Lyme Disease Community One of Carter's most ambitious goals involves the collective knowledge of the Lyme disease community. He explains that patients frequently discover useful resources only after spending months or years searching. Some find organizations, physicians, research, or support networks through chance encounters. Others learn about potential treatment approaches through conversations with fellow patients. Carter wants LymeLess to help people access relevant information earlier in their journeys. He also believes that patient-reported experiences could eventually contribute to a better understanding of complex chronic illness. By organizing information across many patients, the company hopes to identify patterns that could inform future research and care navigation. This approach raises important questions about data quality, privacy, consent, and how patient-reported outcomes should be interpreted. But it also reflects a growing interest in involving patients more directly in healthcare innovation. People living with chronic illness have valuable experiences that deserve to inform research, technology development, and healthcare conversations. Making Lyme Disease Support More Accessible During the interview, Carter explains that LymeLess had recently moved from private beta testing into an open beta phase. He describes spending approximately 18 months speaking with patients, clinicians, and organizations, including members of ILADS and the Lyme Clinical Trials Network, to better understand what patients needed. The platform was designed with accessibility and affordability in mind. Carter discusses a subscription model, scholarship opportunities, and the longer-term goal of obtaining insurance coverage for services like LymeLess. He recognizes that many people with complex chronic illness already face substantial financial burdens. The company's goal is to make supportive technology available to as many patients as possible. Since this interview, LymeLess has continued developing its platform. Its current website and app listings provide information about availability, features, and subscription options. Explore the LymeLess Health website or find the app through the Apple App Store and Google Play. A Potential Collaboration With Tick Boot Camp During the interview, Rich expresses enthusiasm for Carter and Payton's work. He recognizes the similarities between the mission of LymeLess and Tick Boot Camp's commitment to educating and empowering people affected by Lyme disease. Rich discusses how Tick Boot Camp has built an extensive library of interviews featuring patients, physicians, researchers, advocates, and other members of the Lyme disease community. He suggests that this educational content could potentially contribute to the resources available through LymeLess. Carter welcomes the idea of exploring collaboration and explains that partnerships with trusted voices in the Lyme community are important to the company's mission. The discussion is exploratory; no formal partnership is announced during the interview. Rich also invites Carter and Payton to return for a longer Tick Boot Camp interview to explore their experiences and technology in greater depth. Their conversation highlights a shared belief that access to information, community, and patient experiences can help people feel less alone while navigating illness. From Lyme Disease Patient to Healthcare Entrepreneur Perhaps the most inspiring part of Carter's story is how his perspective changed after recovering. He explains that losing basketball and struggling through college were painful experiences. But those challenges also gave him a new sense of purpose. He and Payton began thinking about how they could use their experiences to help others avoid similar difficulties. Rather than allowing their illnesses to define their futures, they decided to build something for the community. Carter's experience also illustrates the importance of family support. His mother's persistence helped him recognize his symptoms and access medical care. Today, he wants LymeLess to offer some of that same sense of support and direction to patients who may not have someone in their lives with similar knowledge or experience. His story is a reminder that healing is possible, and the experiences of people who have lived through Lyme disease can become powerful tools for helping others. Key Takeaways From Carter Bradsky Lyme disease can affect entire families. Carter's mother, Carter, and his sister Payton all experienced significant health challenges. Medical dismissal can delay answers. Carter describes his mother's lengthy diagnostic journey and the importance of finding a provider who considered tick-borne illness. Lyme disease can disrupt major life milestones. Carter lost the opportunity to play competitive college basketball and struggled academically and socially. Brain fog and cognitive symptoms can be debilitating. Memory loss and concentration difficulties affected his ability to participate in college life. Chronic illness can be profoundly isolating. Carter remembers feeling disconnected from classmates and unaware of available support resources. Treatment management can become overwhelming. Organizing medications, supplements, appointments, and symptoms adds another burden to patients already feeling unwell. Family and community support matter. Carter credits his mother's experience and guidance with helping him navigate his illness. Patient experiences can inspire innovation. Carter and Payton created LymeLess to address challenges they personally encountered. AI may help organize complex health information. LymeLess aims to support symptom tracking, education, and preparation for medical appointments. Technology should support—not replace—medical care. AI-generated insights require appropriate clinical interpretation. Affordability is an important part of access. LymeLess is exploring ways to reduce barriers for patients who need support. Recovery can create new purpose. Carter transformed a difficult personal experience into a mission to help the Lyme disease community. Resources Mentioned in This Episode LymeLess Health LymeLess Health – Official Website Meet Carter and Payton Bradsky – The LymeLess Story LymeLess Health on the Apple App Store LymeLess Health on Google Play Lyme Disease Education and Community Resources International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Podcast – Lyme Disease Patient Stories and Expert Interviews Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Lyme Disease Testing Resource Tick Boot Camp Tick Bite Blueprint About This LIVE from ILADS Episode This episode was recorded at the 2025 ILADS Conference in San Antonio, Texas, where Tick Boot Camp co-host Rich Johannesen interviewed Carter Bradsky, Lyme disease survivor and co-founder of LymeLess Health. Carter shares his family's experience with Lyme disease, his reported Bartonella and Babesia coinfections, the loss of his college basketball opportunity, and the challenges of managing chronic illness while attending university. He also introduces LymeLess, the AI-powered platform he founded with his sister Payton to help patients organize health information, track symptoms, access educational resources, and navigate complex care. Their discussion explores the future of patient-centered technology, the value of lived experience, and the importance of making reliable information and supportive communities more accessible. For anyone who has felt overwhelmed, isolated, or uncertain while navigating Lyme disease, Carter's story offers a message of hope: your experience matters, your voice deserves to be heard, and your journey may one day help someone else find their way forward.

  • S1 · E628
    Friday · 16 min

    Episode 628: Can Ozempic Help MCAS and Chronic Lyme? Dr. Tania Dempsey's New Research | LIVE from ILADS

    Could medications best known for weight loss and diabetes offer a new way to manage mast cell activation syndrome (MCAS), inflammation, and symptoms experienced by some patients with chronic Lyme disease? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen reunites with Dr. Tania Dempsey, MD, a physician specializing in complex chronic illness, mast cell activation syndrome, and tick-borne diseases, for an exciting discussion about emerging research into GLP-1 medications and immune system dysfunction. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation centers on Dr. Dempsey's recently published research investigating GLP-1 receptor agonists—medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—as potential treatments for patients with MCAS. Dr. Dempsey discusses a 47-patient case series in which 87% of participants reportedly experienced a positive response to GLP-1-based treatment. She explains why these medications may have effects beyond blood sugar regulation and weight management, including potential influences on mast cell activity and inflammation. The interview also explores how mast cell dysfunction may interact with other components of the immune system, why Dr. Dempsey questions relying exclusively on antibody testing when evaluating certain complex patients, and how emerging molecular diagnostic methods could influence the future of tick-borne disease care. Throughout the conversation, Dr. Dempsey emphasizes the importance of individualized treatment, continuing research, and helping both patients and healthcare professionals better understand complicated chronic illnesses. Could GLP-1 medications represent a new direction in MCAS research? And what might that mean for patients living with Lyme disease, Bartonella, and overlapping inflammatory symptoms? This episode explores those questions while distinguishing promising early clinical observations from treatments that have been conclusively established through larger controlled studies. Meet Dr. Tania Dempsey, MD: MCAS and Complex Chronic Illness Dr. Tania Dempsey is a physician known for her clinical work with patients experiencing mast cell activation syndrome, Lyme disease, tick-borne infections, and other complex chronic conditions. Her interests include the relationship between immune system dysfunction, inflammation, environmental exposures, and persistent symptoms. Dr. Dempsey has become an increasingly prominent voice in discussions about MCAS and its potential relationship with other chronic illnesses. During this interview, she shares how appearing on major podcasts, including Dave Asprey's podcast, has helped her reach a broader audience. She explains that although she loves working directly with patients, her larger mission is to share information with healthcare professionals and patients around the world. Dr. Dempsey also discusses her involvement with the International Lyme and Associated Diseases Society (ILADS). At the time of this interview, she had served on the ILADS Board of Directors for two years and had recently been reelected for another two-year term. She describes physician education, research, and public awareness as important priorities for her continued work with the organization. For an in-depth discussion of her clinical interests, listen to her previous Tick Boot Camp appearance: Dr. Tania Dempsey on MCAS, Chronic Lyme Disease, GLP-1 Agonists, Biofilms, and Precision Medicine. New Research: GLP-1 Medications for Mast Cell Activation Syndrome One of the biggest developments Dr. Dempsey shares is her recently published research on GLP-1 receptor agonists and MCAS. GLP-1 receptor agonists are medications primarily used for conditions such as type 2 diabetes and obesity. Some of the medications discussed include: Ozempic: Semaglutide Wegovy: Semaglutide Mounjaro: Tirzepatide Zepbound: Tirzepatide Semaglutide acts on GLP-1 receptors, while tirzepatide acts on both GLP-1 and GIP receptors. Although these medications are widely associated with weight management, researchers are also investigating their broader metabolic and inflammatory effects. Dr. Dempsey explains that her research explores whether these effects could benefit certain patients with mast cell activation syndrome. She presented findings from the research at the ILADS conference and describes receiving enthusiastic feedback from other clinicians interested in the potential applications. Importantly, GLP-1 medications are not established or FDA-approved treatments for MCAS. The findings discussed in this episode are preliminary and require further research to determine effectiveness, safety, appropriate patient selection, and dosing. The 47-Patient GLP-1 and MCAS Case Series Dr. Dempsey highlights findings from a published case series involving 47 patients. According to her description: The case series included 47 patients receiving GLP-1-based treatment. Approximately 87% reportedly experienced a significant positive response. Some patients reported improvements in joint pain. Others experienced reductions in brain fog and additional symptoms. Certain patients reported noticeable changes within hours of treatment. Treatment approaches were individualized, including the use of low doses in some patients. These observations have generated interest because MCAS can be challenging to manage, particularly in patients who report sensitivities to multiple medications or supplements. Dr. Dempsey describes the results as especially encouraging for patients whose symptoms have persisted despite other interventions. However, a case series does not establish that a medication caused the reported improvements. Without a randomized control group, it is difficult to distinguish treatment effects from other influences, including natural symptom fluctuations, concurrent treatments, and selection bias. The reported 87% response rate should therefore be understood as a finding from this particular patient group—not a predicted success rate for everyone with MCAS. Larger, well-controlled clinical studies are needed. What Is Mast Cell Activation Syndrome (MCAS)? Rich asks Dr. Dempsey to explain MCAS in terms that patients without medical training can understand. She begins by describing the normal function of mast cells. Mast cells are immune cells that help the body respond to infections, allergens, and other potential threats. When activated, they release substances called mediators, which participate in immune signaling and inflammation. These mediators include histamine, cytokines, and other biologically active compounds. Under normal circumstances, mast cell activation is part of the body's protective response. Dr. Dempsey explains that in people with MCAS, mast cells may activate inappropriately or release mediators in ways that produce recurring symptoms. Because mast cells are present throughout the body, abnormal activation can affect multiple organ systems. MCAS is a recognized clinical condition, but diagnosing it requires more than the presence of nonspecific symptoms. Accepted diagnostic approaches consider characteristic episodes affecting multiple organ systems, objective evidence of mast cell mediator release, and response to appropriate treatment. Is MCAS an Overactive or Underactive Immune System? Rich asks whether MCAS should be understood as an overactive immune system, an underactive immune system, or an autoimmune disorder. Dr. Dempsey explains that she views the problem as potentially involving both excessive activation and impaired regulation. She describes how mast cells communicate with other immune cells through chemical signals. In her explanation, persistent mast cell activation may contribute to inflammatory activity while also influencing how other components of the immune system respond. She suggests that some patients may experience excessive inflammatory signaling alongside less effective immune responses in other areas. This proposed interaction is particularly important to her approach to patients with complex chronic illness. However, MCAS is not universally defined as a combination of overactive and suppressed immunity, and the specific mechanisms connecting mast cell activation with persistent tick-borne infections remain under investigation. Dr. Dempsey's explanation reflects her clinical interpretation of a complicated and evolving area of immunology. MCAS, Lyme Disease, Bartonella, and Chronic Inflammation Dr. Dempsey discusses how mast cell activation may intersect with conditions such as Lyme disease, Bartonella infection, and environmental exposures. She explains that her clinical approach considers both potential triggers and the patient's immune response. For example, she may evaluate suspected infections or environmental concerns while also addressing symptoms she attributes to mast cell activation. Her goal is to reduce inflammatory symptoms while investigating other possible contributors to illness. Dr. Dempsey emphasizes that patients with complex chronic conditions may have multiple overlapping problems that require different approaches. The relationship between MCAS and persistent symptoms attributed to Lyme disease or Bartonella is an active area of clinical interest, but it has not been established that MCAS is the underlying cause of persistent symptoms in most such patients. Patients with chronic symptoms benefit from a comprehensive evaluation that considers confirmed infections, other medical conditions, medication effects, and additional potential explanations. Can Mast Cell Dysfunction Affect Lyme Disease Antibody Testing? One of the interview's most thought-provoking discussions concerns the interpretation of antibody tests. Rich asks whether immune dysfunction could affect the reliability of laboratory tests that depend on detecting antibodies. Dr. Dempsey explains that antibody production depends on immune system activity and raises questions about how abnormal immune responses might affect test interpretation. She outlines three possible scenarios from her clinical perspective. Scenario 1: Antibody Production and Potential False Positives Dr. Dempsey describes patients who produce certain antibodies without having the disease most commonly associated with those antibodies. For example, she discusses antinuclear antibodies (ANA), which can be found in patients with autoimmune conditions but can also occur in people without a corresponding autoimmune diagnosis. She questions whether some antibody-based infectious disease results could be influenced by abnormal immune activity. This is an important distinction: the presence of an antibody does not always establish an active disease. However, a positive ANA does not by itself demonstrate that Lyme disease antibody tests are unreliable because of MCAS. Scenario 2: Reduced Antibody Responses and Potential False Negatives Dr. Dempsey also discusses patients who may have impaired antibody responses. She suggests that immune dysfunction could contribute to negative antibody results in some patients despite suspected infection. She references situations in which patients have limited reactivity on Lyme disease immunoblots and do not meet established interpretation criteria. Antibody tests can indeed be negative early in Lyme disease before an adequate antibody response develops. However, isolated immunoblot bands are not sufficient to diagnose Lyme disease, and there is not established evidence that MCAS routinely causes false-negative Lyme serology. Scenario 3: Antibody Tests That Accurately Reflect Exposure Dr. Dempsey acknowledges that antibody testing can also produce clinically useful results. She emphasizes the importance of understanding what a particular test measures and how it should be interpreted. For Lyme disease, validated two-tier serologic testing remains a central diagnostic tool, particularly in patients with later manifestations. Antibodies may remain detectable long after an infection has been treated, meaning a positive result does not necessarily indicate ongoing active infection. The central takeaway is that laboratory results must be interpreted within the patient's clinical context rather than viewed in isolation. For more information, visit Tick Boot Camp's Lyme Disease Testing Resource. Molecular Testing vs. Antibody Testing for Tick-Borne Infections Dr. Dempsey explains that she often prefers testing methods intended to identify an organism or its genetic material rather than relying exclusively on antibody measurements. She discusses molecular testing as an important area of diagnostic development. Molecular tests, such as polymerase chain reaction (PCR), can detect genetic material from certain pathogens. These methods can be particularly useful for some infections and clinical situations. However, their performance depends on factors including the organism, specimen type, timing, disease stage, and laboratory method. For example, a negative blood PCR test does not reliably exclude Lyme disease, and molecular testing is not universally more accurate than recommended serologic testing. Dr. Dempsey's discussion highlights her interest in improving diagnostic methods while raising important questions about how immune function may affect test interpretation. Rich also references conversations with laboratories working on tick-borne disease diagnostics, including IGeneX and Galaxy Diagnostics. The episode underscores the need for continued development and independent validation of diagnostic technologies. How Might GLP-1 Medications Affect Mast Cells? Returning to her research, Dr. Dempsey explains her proposed mechanism for why GLP-1 medications might help some patients with MCAS. She discusses receptors on the surface of mast cells and the possibility that medications interacting with these pathways may influence mast cell activation. In her explanation, GLP-1-related signaling could reduce the release of inflammatory mediators. This could potentially influence symptoms associated with excessive mast cell activity. She also describes broader immune-modulating effects that may contribute to symptom improvement. These mechanisms are biologically interesting, but their relevance to human MCAS treatment remains under investigation. The interview should not be interpreted as establishing that GLP-1 medications directly stabilize mast cells in patients or reliably reverse MCAS-related immune dysfunction. Ozempic vs. Mounjaro: Is Tirzepatide Better for MCAS? Rich asks Dr. Dempsey whether she has observed differences between semaglutide and tirzepatide. Dr. Dempsey explains that both medications have been used in her clinical experience, but she has recently observed encouraging responses with tirzepatide. She discusses the differences between the two drug classes. Semaglutide, marketed as Ozempic and Wegovy, acts on GLP-1 receptors. Tirzepatide, marketed as Mounjaro and Zepbound, acts on both GLP-1 and GIP receptors. Dr. Dempsey suggests that this dual activity may contribute to differences in inflammatory responses. She reports that some patients have responded particularly well to tirzepatide. However, the interview does not present controlled comparative data demonstrating that tirzepatide is more effective than semaglutide for MCAS. Her observations are preliminary and should not be interpreted as a recommendation to select one medication over another for this unapproved use. Can GLP-1 Medications Help Patients Who Don't Need to Lose Weight? One of the most interesting aspects of Dr. Dempsey's discussion involves patients who are not overweight. She explains that some individuals in her clinical experience have little or no weight to lose. For these patients, she discusses using very low doses of GLP-1-related medications while carefully monitoring their response. Dr. Dempsey emphasizes the importance of avoiding unwanted weight loss and muscle loss. She reports that some patients have experienced improvements in symptoms without substantial changes in body weight. This raises an important research question: Could some of the effects of GLP-1 medications on inflammation and immune signaling occur independently of weight loss? Researchers are investigating the broader physiological effects of these medications, but their use for MCAS in people without an approved indication remains experimental. GLP-1-related medications can cause significant adverse effects, including gastrointestinal symptoms, dehydration, gallbladder problems, and other complications. They are not appropriate for every patient. Very-low-dose or microdosing approaches for MCAS have not been established through large clinical trials. Patients should not begin, modify, or discontinue prescription medications based on this interview. Why Individualized Treatment Matters Dr. Dempsey repeatedly emphasizes that patients with MCAS can be unusually sensitive to medications and supplements. She explains that treatment decisions require careful consideration of each patient's health history, symptoms, tolerability, and medical needs. She also acknowledges that GLP-1 medications have side effects. Her research interests focus on identifying treatments that may help patients whose symptoms have been difficult to manage. However, she does not suggest that every patient with MCAS should receive a GLP-1 medication. The conversation reinforces the importance of individualized medical assessment, appropriate monitoring, and informed discussions about potential benefits and risks. Taking MCAS Research to a Larger Audience Rich congratulates Dr. Dempsey on her growing visibility through major podcast appearances. They discuss her interview with Dave Asprey and how larger platforms can introduce complex medical topics to audiences who may never have encountered them before. Dr. Dempsey explains that reaching more people is central to her mission. Although she continues to care deeply about her own patients, she recognizes that she cannot personally treat everyone seeking help. Through education, research, professional collaboration, and public conversations, she hopes to improve awareness and encourage other clinicians to learn more about complex chronic illness. She also expresses appreciation for Tick Boot Camp's role in sharing patient experiences and conversations with healthcare professionals. The Future of MCAS, GLP-1 Research, and Lyme Disease Care The interview concludes with excitement about the potential implications of Dr. Dempsey's research. Her 47-patient case series provides preliminary observations that may help generate hypotheses for future studies. Important unanswered questions include: Can GLP-1 medications improve MCAS symptoms in randomized controlled trials? Which patients, if any, are most likely to benefit? Do benefits differ between semaglutide and tirzepatide? Are observed improvements independent of weight loss? What mechanisms might explain changes in inflammatory symptoms? What are the long-term risks of using these medications in patients without diabetes or obesity? Can improved diagnostic methods help distinguish immune dysfunction from active tick-borne infection? How should clinicians evaluate patients with overlapping symptoms involving MCAS, Lyme disease, and other chronic conditions? Dr. Dempsey's work highlights why continued scientific investigation is important. Early findings can generate meaningful questions, but larger studies are necessary before new treatment approaches can become established medical practice. Key Takeaways From Dr. Tania Dempsey GLP-1 medications are being investigated for MCAS. Dr. Dempsey discusses research exploring their potential effects on mast cell activity and inflammation. A 47-patient case series reported an 87% positive response rate. This is a preliminary observation, not proof of effectiveness or a generalizable success rate. MCAS involves inappropriate mast cell activation. Mast cells release mediators that can contribute to symptoms across multiple organ systems. Immune regulation is complex. Dr. Dempsey discusses possible interactions between mast cell signaling and other components of the immune system. Lyme disease testing requires careful interpretation. Antibody tests have strengths and limitations, and results must be considered alongside clinical findings. Molecular testing offers additional diagnostic tools. Its usefulness depends on the infection, specimen, timing, and validation of the method. Semaglutide and tirzepatide act through different receptor pathways. Whether one is more effective for MCAS remains unknown. Weight loss is not the only effect being studied. Researchers are investigating possible metabolic and inflammatory effects beyond weight management. Safety matters. GLP-1 medications can cause significant side effects, and their use for MCAS remains investigational. Patients with complex chronic illness need individualized evaluation. Similar symptoms can arise from different conditions and may require different treatments. Physician education and research collaboration are essential. Dr. Dempsey hopes to expand awareness through ILADS and other professional platforms. Promising research offers reasons for continued investigation. New findings can inspire hope while still requiring rigorous scientific validation. Resources Mentioned in This Episode Related Tick Boot Camp Episodes Dr. Tania Dempsey: MCAS, Chronic Lyme Disease, GLP-1 Agonists, Biofilms, and Precision Medicine Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Podcast – Patient Stories and Expert Interviews Educational and Professional Resources International Lyme and Associated Diseases Society (ILADS) Tick Boot Camp Lyme Disease Testing Resource Tick Bite Blueprint – Prevention and Post-Bite Guidance About This LIVE from ILADS Episode Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features returning guest Dr. Tania Dempsey, MD, discussing emerging research into GLP-1 receptor agonists and mast cell activation syndrome. Together with Tick Boot Camp co-host Rich Johannesen, she explores mast cell biology, inflammation, immune system dysfunction, Lyme disease and Bartonella testing, molecular diagnostics, and her clinical observations involving semaglutide and tirzepatide. The conversation also highlights her recently published 47-patient case series, her continued involvement with ILADS, and her efforts to educate a wider audience about complex chronic illness. For people navigating MCAS, Lyme disease, or persistent unexplained symptoms, this episode offers a look at an emerging area of research—and a reminder that scientific progress begins with asking better questions. Listen to more conversations exploring Lyme disease, tick-borne illness, medical research, and recovery experiences on the Tick Boot Camp Podcast.

  • S1 · E627
    November 12 · 30 min

    Episode 627: Why Lyme Patients Feel Dismissed: How to Get Doctors to Listen – Dr. Kirsten FitzGerald | LIVE from ILADS

    What do you do when you're sick, your Lyme disease test comes back negative, and your doctor tells you everything is fine—even though you know something is wrong? For many people living with Lyme disease, tick-borne infections, and complex chronic illness, the search for answers can involve years of unexplained symptoms, multiple specialists, frustrating medical appointments, and feeling dismissed by the healthcare system. But what if improving the patient-doctor relationship could become one of the most important steps toward finding answers? In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen sits down with Dr. Kirsten P. FitzGerald, DNP, FNP-BC, a board-certified family nurse practitioner and functional medicine provider based in Ridgefield, Connecticut, to discuss Lyme disease awareness, missed diagnoses, patient advocacy, and the importance of building collaborative relationships between patients and healthcare professionals. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores how Dr. FitzGerald transitioned from conventional primary care into functional and integrative medicine after recognizing that some patients with persistent symptoms were not finding the answers or support they needed. Dr. FitzGerald shares her experiences working with patients affected by Lyme disease, long COVID, mast cell-related concerns, and pediatric neuroinflammatory conditions, including PANS and PANDAS. Together, Rich and Dr. FitzGerald develop a practical framework for helping patients prepare for medical appointments, communicate more effectively, participate in treatment decisions, and work with their providers toward better health outcomes. Their central message: Patients deserve to be heard, and meaningful progress often begins when patients and clinicians work together as partners. Meet Dr. Kirsten P. FitzGerald, DNP, FNP-BC Dr. Kirsten P. FitzGerald is a Doctor of Nursing Practice and board-certified Family Nurse Practitioner with more than 25 years of healthcare experience. She is the founder of FitzGerald Health and Wellness, an integrative and functional medicine practice in Ridgefield, Connecticut. She also collaborates with the team at New Frontiers Functional Medicine & Nutrition, led by Dr. Kara Fitzgerald in Sandy Hook, Connecticut, and works alongside pediatric naturopathic physician Dr. Lindsey Wells, ND, in Trumbull, Connecticut. Her clinical interests include: Lyme disease and tick-borne infections Persistent and complex chronic symptoms Long COVID and post-infectious illness Functional and integrative medicine Mast cell activation syndrome (MCAS) PANS and PANDAS Metabolic health and lifestyle medicine Patient education and collaborative care Dr. FitzGerald grew up on a trout farm in Connecticut and has spent much of her life around animals, including horses, chickens, cats, and dogs. Despite living in a region historically associated with Lyme disease, she explains that her understanding of the complexity of tick-borne illness changed significantly after attending a professional presentation. That experience ultimately helped redirect her medical career. Learn more about Dr. Kirsten FitzGerald and her clinical background. From Conventional Primary Care to Functional Medicine Dr. FitzGerald describes a pivotal moment at an advanced practice registered nurse (APRN) conference in Connecticut. A presentation by fellow clinician Pam Cipriano challenged her understanding of Lyme disease and prompted her to reconsider patients she had previously encountered. She began thinking about people whose Lyme disease test results had been negative despite symptoms and exposure histories that continued to raise clinical questions. Dr. FitzGerald explains that conventional primary care often relies on established diagnostic pathways, laboratory testing, and specialist referrals. These tools are essential, but she became increasingly concerned about patients whose symptoms remained unexplained after multiple evaluations. During the COVID-19 pandemic, she encountered additional patients struggling with persistent symptoms, including long COVID. One experience was particularly influential. A patient who was also a nurse became emotional during an appointment and asked Dr. FitzGerald to stop sending her to additional specialists. The patient wanted someone to take responsibility for understanding her overall health picture rather than continuing a cycle of referrals without satisfactory answers. For Dr. FitzGerald, that conversation reinforced the need to expand her knowledge and explore different approaches to complex chronic illness. She eventually transitioned toward functional and integrative medicine, including working with Dr. Kara Fitzgerald's New Frontiers team. The conversation illustrates why continuity of care, clinical curiosity, and thoughtful follow-up matter when patients experience symptoms that do not fit neatly into one diagnosis. Why Lyme Disease Can Be Difficult to Recognize Dr. FitzGerald expresses frustration that Lyme disease and other tick-borne illnesses are not always considered during evaluations of patients with unexplained symptoms—even in Connecticut. She describes how patients may visit several specialists for seemingly unrelated problems without anyone initially recognizing a possible connection. Symptoms discussed include: Persistent fatigue Brain fog and cognitive difficulties Headaches and migraines Tremors and neurological complaints Joint and muscle pain Changes in mood or irritability Symptoms initially attributed to aging or menopause Other unexplained changes in physical functioning Dr. FitzGerald explains that patients may see orthopedic specialists for pain, neurological specialists for tremors, and other providers for fatigue or cognitive concerns. Each specialist may focus on a particular symptom or organ system. Her concern is that clinicians can sometimes miss the broader pattern. Could several seemingly unrelated symptoms have a common explanation? Lyme disease and other tick-borne infections are among the conditions that may warrant consideration when a patient's history and clinical findings support that possibility. However, these symptoms are not specific to Lyme disease. Many other medical conditions can produce similar complaints, and appropriate evaluation should consider alternative explanations. Dr. FitzGerald's message is not simply to test everyone for Lyme disease, but to remain attentive to exposure history, symptom patterns, and unresolved clinical questions. For more information about the strengths and limitations of available tests, explore Tick Boot Camp's Lyme Disease Testing Resource. When Lyme Disease Tests Are Negative but Symptoms Continue One of the challenges discussed in the episode is the interpretation of Lyme disease testing. Dr. FitzGerald recalls patients whose initial tests were negative even though she remained concerned about the possibility of tick-borne illness. Rich and Dr. FitzGerald discuss the frustration patients can experience when a negative test result ends the conversation despite ongoing symptoms. Lyme disease testing has important limitations, particularly early in infection, when antibodies may not yet be detectable. At the same time, persistent symptoms and negative testing do not automatically establish an undiagnosed Lyme infection. The appropriate next step depends on the patient's symptoms, exposure history, examination, timing of testing, and other potential diagnoses. This episode encourages patients to ask informed questions about test results rather than assuming that one result always tells the complete story. Why Dr. FitzGerald Attends ILADS Conferences Dr. FitzGerald explains that attending the ILADS conference helps her expand her understanding of tick-borne illnesses and connect with healthcare professionals who encounter complex cases. She values opportunities to learn from other clinicians, explore research, and discuss diagnostic challenges. She also hopes to bring information back to her colleagues in conventional medical settings. Throughout the interview, Dr. FitzGerald emphasizes that changing medical practice requires education, open dialogue, and a willingness to consider new evidence. She believes that increasing awareness among primary care providers, nurse practitioners, pediatricians, and other healthcare professionals can help patients receive more informed evaluations. The conference also provides an opportunity to connect with clinicians who share her interest in patient-centered care. The Patient-Doctor Relationship: A Partnership, Not a One-Way Conversation The conversation takes an important turn when Rich asks Dr. FitzGerald a question that patients do not always hear: What can patients do to help their doctors provide better care? Rather than focusing exclusively on the shortcomings of the healthcare system, Rich suggests that patients may benefit from approaching medical appointments as active participants. Dr. FitzGerald agrees. She explains that patients can contribute valuable information that may not be immediately apparent from laboratory results or a brief office visit. Together, they discuss how a collaborative relationship allows both the patient and clinician to make better use of their time, knowledge, and resources. This does not mean patients are responsible for diagnostic errors, inadequate access to care, or dismissive treatment. Instead, the conversation offers practical ways for patients to strengthen communication and advocate for themselves within the healthcare system. Step 1: Prepare Thoroughly Before Your Medical Appointment Dr. FitzGerald explains that her initial consultations typically last at least two hours and sometimes extend to three hours. Before those appointments, she asks patients to complete detailed medical history and intake forms. She acknowledges that this paperwork can feel overwhelming, particularly for patients already struggling with fatigue, brain fog, or other symptoms. However, she explains that comprehensive intake information helps her begin understanding the patient's health history before they meet. The forms may reveal important details about previous illnesses, symptoms, medications, treatments, and medical events. They also allow her to identify questions she wants to explore during the appointment. Rich shares his own experience completing extensive intake paperwork before seeing a Lyme-focused physician. Initially, he found the process frustrating. But as he worked through the forms, he began recalling medical events and health concerns he had not previously considered relevant. The experience changed how he approached his medical care. Instead of arriving at an appointment expecting the doctor to gather all the information and provide an immediate solution, he began seeing himself as an active partner. Dr. FitzGerald encourages patients to approach medical history forms thoughtfully. Practical Ways to Prepare Before an appointment, consider organizing: A timeline of symptoms and when they began Previous diagnoses and medical evaluations Important laboratory results and imaging reports Current medications and supplements Previous treatments and responses Relevant travel, tick exposure, and environmental history Changes in physical, cognitive, or emotional functioning Questions and concerns you want to discuss A trusted family member or caregiver may be able to help patients who have difficulty organizing information because of illness. The goal is not to create a perfect medical record. It is to help your healthcare provider understand your experience as accurately as possible. Step 2: Share Your Complete Story Without Embarrassment Dr. FitzGerald offers one of the episode's most important messages: “Don't hold back. Put it all on the table.” She encourages patients to discuss their symptoms openly, even when those symptoms feel embarrassing, confusing, or difficult to explain. She wants to know how patients feel physically and emotionally, what has changed over time, and what they have experienced during previous medical evaluations. Dr. FitzGerald acknowledges that many patients arrive at her office after disappointing encounters with other healthcare professionals. Some are exhausted. Others are frustrated or fearful. Some become emotional while describing years of illness. She explains that these reactions are welcome in her office and that she keeps tissues available for patients who need them. Patients should not feel pressured to minimize symptoms, hide concerns, or present themselves as doing better than they actually are. Honest communication helps clinicians understand both the medical and personal impact of illness. For people who have repeatedly felt dismissed, finding a healthcare professional who listens can be an important part of rebuilding trust. Step 3: Participate in Developing Your Treatment Plan Rich and Dr. FitzGerald agree that patients should be involved in decisions about their healthcare. A treatment plan should not simply be a collection of instructions handed to someone at the end of an appointment. Instead, patients should understand what is being recommended, why it is being recommended, and what outcomes they should monitor. Important questions may include: What diagnoses are we considering? What is the purpose of this test or treatment? What benefits and risks should I understand? What alternatives are available? How will we measure progress? What should I do if symptoms change? When should I follow up? Dr. FitzGerald emphasizes that patients need to understand their responsibilities and feel comfortable participating in decisions. Rich describes this as a partnership in which both sides contribute. The clinician brings medical training, diagnostic reasoning, and professional judgment. The patient brings personal experience, symptom history, preferences, and feedback about how treatment affects daily life. Working together can help create a plan that is both medically appropriate and realistic for the individual. Step 4: Follow Through—and Speak Up When Something Isn't Working Dr. FitzGerald explains that medical appointments are only one part of the care process. Patients spend most of their time outside the clinic, where they must manage medications, follow recommendations, and monitor changes in their health. She discusses the importance of following agreed-upon treatment plans, including lifestyle recommendations when appropriate. However, she also stresses that patients should not continue suffering silently when a treatment is not helping. If symptoms worsen, side effects develop, or a plan becomes difficult to follow, patients should contact their healthcare provider. Rich and Dr. FitzGerald emphasize that follow-up communication is an essential part of the partnership. Patients should share both improvements and setbacks. Dr. FitzGerald recalls how meaningful it can be when someone contacts her simply to say they are feeling better. These updates provide feedback about the patient's experience and help clinicians understand how their recommendations are working. Progress should be evaluated through ongoing communication—not assumptions. Why Lyme Patients May Need Additional Support Rich asks whether people with Lyme disease should approach medical appointments differently from other patients. Dr. FitzGerald explains that many people seeking care for suspected tick-borne illness have already experienced years of frustration. Some have been told their symptoms are caused by stress, aging, menopause, or other conditions. Others have visited multiple specialists without finding a clear explanation. These experiences can make patients hesitant to trust another healthcare professional or share their complete history. Dr. FitzGerald encourages patients to describe their symptoms comprehensively rather than presenting each concern as an isolated problem. She believes that understanding the full pattern can help clinicians determine whether Lyme disease, another tick-borne illness, or a different condition warrants investigation. For patients who have struggled to find answers, she emphasizes the importance of working with someone willing to listen, explain their reasoning, and consider appropriate next steps. Lyme Disease, Brain Fog, and Neuropsychiatric Symptoms Another important discussion involves the neurological and psychological dimensions of Lyme disease and complex chronic illness. Rich introduces Tick Boot Camp's patient-informed description of Lyme disease as: A polymicrobial, multisystemic, chronic infectious or post-infectious disease. Dr. FitzGerald responds positively but suggests that neurological and neuropsychiatric symptoms deserve greater emphasis. She discusses concerns involving cognition, mood, and neurological functioning. Rich acknowledges the importance of these symptoms and explains how Tick Boot Camp's understanding has evolved through interviews with patients and healthcare professionals. The conversation raises broader questions about how clinicians distinguish active infection, post-infectious symptoms, other tick-borne diseases, and unrelated medical conditions. Neurological manifestations of Lyme disease are recognized, and some patients experience persistent symptoms after recommended treatment. However, the mechanisms and appropriate management of persistent symptoms remain areas of ongoing research and clinical discussion. Tick Boot Camp's proposed description is an advocacy framework discussed during the interview, not an established consensus medical definition. For another perspective on neurological symptoms and cognitive recovery, explore Dr. Jacqueline Becker's work on brain fog and cognitive rehabilitation. PANS, PANDAS, and Pediatric Complex Chronic Illness Dr. FitzGerald also discusses collaborating with Dr. Lindsey Wells, ND, in Trumbull, Connecticut. Their work includes supporting families navigating PANS and PANDAS. These conditions involve sudden-onset or significant neuropsychiatric symptoms in children and can present complex diagnostic and treatment challenges. The interview does not explore pediatric testing or treatment protocols in detail, but Dr. FitzGerald's collaboration reflects her interest in the relationship between physical illness and neuropsychiatric symptoms. For a more detailed discussion, listen to Tick Boot Camp's interview with Dr. Lindsey Wells on Lyme disease, autism, PANS/PANDAS, and folate receptor alpha autoantibodies. Long COVID, MCAS, and Overlapping Symptoms Dr. FitzGerald describes how her interest in complex chronic illness expanded during the COVID-19 pandemic. She encountered patients experiencing persistent symptoms after infection and became increasingly interested in understanding why some individuals were not recovering as expected. She also identifies mast cell-related conditions among her clinical interests. Lyme disease, long COVID, and other chronic conditions may share symptoms such as fatigue, cognitive difficulties, sleep disturbances, and reduced physical functioning. These similarities can complicate diagnosis. The presence of overlapping symptoms does not mean the conditions share the same cause or require the same treatment. The discussion reinforces the importance of individualized evaluation and careful consideration of alternative diagnoses. For a related conversation, listen to Dr. Tania Dempsey on MCAS, chronic Lyme disease, inflammation, and precision medicine. Why Tick Prevention Must Become Part of Everyday Life Toward the end of the interview, Rich shares stories about growing up on Long Island in a family that practiced routine tick checks. He recalls how his mother required the children to check for ticks before entering the main living areas of their home. Although some of the tick removal methods used decades ago were based on outdated advice, the family's commitment to regular tick checks became a lifelong habit. Rich explains that he continues checking for ticks regularly and has passed these habits along to his family. Dr. FitzGerald relates to this experience because she grew up in Connecticut around animals and outdoor environments where ticks are common. They discuss how families can make tick prevention part of everyday routines. Important prevention practices include: Checking yourself, children, and pets for ticks after outdoor exposure Using appropriate EPA-registered tick repellents Wearing protective clothing in tick habitats Using veterinarian-recommended tick prevention products for pets Removing attached ticks promptly with fine-tipped tweezers Seeking medical advice when a tick bite presents a meaningful risk or symptoms develop Do not use petroleum jelly, heat, matches, or burning to remove attached ticks. These methods are not recommended. Rich's experience also illustrates why tick identification matters: different tick species are associated with different health risks. Testing a removed tick may identify organisms in that tick, but it cannot determine whether a person has become infected and should not replace clinical evaluation. For step-by-step prevention and post-bite guidance, visit the Tick Boot Camp Tick Bite Blueprint. How One Tick Bite Helped Inspire Tick Boot Camp Rich shares a personal story about discovering an engorged tick and seeking medical care. At the time, he had already been involved in helping a friend navigate serious challenges related to chronic Lyme disease. His friend's experience had motivated him to learn more about tick-borne illness. When Rich later found a tick attached to his own body, he became concerned about the possibility of infection. He describes difficulty obtaining a timely appointment and frustration with the medical advice he received. The tick was eventually identified as a lone star tick. Rich also recounts sending the tick for laboratory analysis and receiving a report identifying an infectious organism. His experience reinforced how important it is for patients and clinicians to understand tick species, potential infections, testing limitations, and appropriate post-bite care. The story also helped motivate the creation of Tick Boot Camp as a platform dedicated to Lyme disease awareness, education, and patient advocacy. Lone star ticks are associated with several health concerns, including ehrlichiosis and alpha-gal syndrome, but are not established vectors of the bacterium responsible for classic Lyme disease. Additionally, finding a pathogen in a tick does not establish transmission to the person bitten. Changing the Conversation About Lyme Disease Throughout the interview, Dr. FitzGerald expresses appreciation for Tick Boot Camp's efforts to educate patients and healthcare professionals. She believes greater awareness can help people recognize potential tick exposures, ask better questions, and seek appropriate medical evaluation. Rich emphasizes that Tick Boot Camp was built around patient experiences and a desire to improve the way people navigate complex chronic illness. Their conversation moves beyond identifying problems in healthcare and toward practical solutions. How can patients prepare more effectively? How can clinicians listen more carefully? How can both sides communicate with greater honesty and respect? And how can education help prevent future tick-borne infections? For Dr. FitzGerald, these questions are central to improving patient care. Key Takeaways From Dr. Kirsten FitzGerald Negative Lyme disease testing does not always end the diagnostic discussion. Test timing, exposure history, symptoms, and alternative diagnoses all matter. Patients deserve to be heard. Persistent symptoms should be taken seriously, even when the cause is not immediately clear. Prepare before medical appointments. A detailed medical history can help clinicians identify patterns and make informed testing decisions. Be open about your symptoms. Patients should feel comfortable discussing physical, cognitive, and emotional concerns. Build a collaborative relationship. Patients and healthcare providers can work together to understand treatment options and establish realistic goals. Understand your care plan. Ask questions about recommendations, potential risks, and how progress will be assessed. Communicate changes. Report improvements, worsening symptoms, side effects, and treatment difficulties rather than waiting silently for the next appointment. Look at the complete clinical picture. Symptoms affecting different parts of the body may require coordinated evaluation. Consider neurological and cognitive symptoms. Brain fog, headaches, and other neurological complaints deserve appropriate medical assessment. Healthcare professionals benefit from continued education. Dr. FitzGerald values conferences and collaboration as opportunities to strengthen clinical knowledge. Tick prevention is a lifelong skill. Regular tick checks and evidence-based prevention strategies can reduce exposure risks. Hope and advocacy can coexist. Patients can seek answers, advocate for better care, and work toward improved health without carrying responsibility for failures of the medical system. Resources Mentioned in This Episode Guest and Professional Resources FitzGerald Health and Wellness – Dr. Kirsten FitzGerald's Practice Meet Dr. Kirsten FitzGerald Dr. Kirsten FitzGerald at New Frontiers New Frontiers Functional Medicine & Nutrition International Lyme and Associated Diseases Society (ILADS) Related Tick Boot Camp Episodes and Educational Resources Dr. Lindsey Wells on Lyme Disease, Autism, PANS/PANDAS, and FRAA Dr. Tania Dempsey on MCAS, Chronic Lyme Disease, and Precision Medicine Lyme Disease Testing and Diagnostic Challenges Tick Bite Blueprint: Tick Prevention and What to Do After a Bite Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Podcast About This LIVE from ILADS Episode This episode was recorded at the 2025 ILADS Conference in San Antonio, Texas, where Tick Boot Camp co-host Rich Johannesen interviewed Dr. Kirsten P. FitzGerald, DNP, FNP-BC, a Connecticut-based family nurse practitioner specializing in functional and integrative medicine. Their conversation explores Lyme disease awareness, diagnostic challenges, patient dismissal, long COVID, neurological symptoms, PANS/PANDAS, the patient-provider relationship, medical appointment preparation, shared decision-making, and tick prevention. The episode also features Rich's personal experiences navigating medical care after a tick bite and his reflections on how patient advocacy helped inspire Tick Boot Camp. If you've ever left a doctor's appointment feeling unheard, confused, or unsure what to do next, this conversation offers practical ideas for becoming a more informed, confident participant in your healthcare. You deserve a healthcare relationship built on listening, respect, and collaboration. And you are not alone in your search for answers.

  • S1 · E626
    November 11 · 19 min

    Episode 626: Why Treating Lyme Disease Requires More Than Antibiotics – Dr. Sigrid Blehle | LIVE from ILADS

    What happens when Lyme disease treatment focuses on infections, but patients continue struggling with debilitating symptoms? Could mold exposure, gut health, immune dysfunction, or other underlying health challenges be complicating recovery? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen welcomes Dr. Sigrid Blehle, MD, MBA, PhD, Medical Director of Alviasana in Augsburg, Germany, to explore her integrative approach to Lyme disease, chronic infections, and complex chronic illness. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation examines why Dr. Blehle believes that identifying and treating infections is only one part of helping patients with complicated medical histories. Dr. Blehle discusses her approach to evaluating environmental exposures, mold, heavy metals, gut microbiome health, immune function, nutritional status, and possible tick-borne infections before developing individualized treatment plans. She also shares her experience with antibiotic therapy, herbal medicine, intravenous treatments, and other integrative interventions, while explaining how her multidisciplinary clinic works with patients from Europe, the United States, Africa, and Asia. One of her most striking examples involves a patient who had already consulted 48 physicians before arriving at her clinic. The central message of this interview is that patients with complex symptoms deserve careful listening, comprehensive medical histories, and individualized evaluation rather than assumptions about what is causing their illness. Meet Dr. Sigrid Blehle: Lyme Disease Physician in Germany Dr. Sigrid Blehle, MD, MBA, PhD, is a German physician and Medical Director of Alviasana, an integrative medical clinic based in Augsburg, Germany. Her clinical interests include: Lyme disease and other tick-borne infections Complex and persistent symptoms following infectious illnesses Post-COVID conditions Environmental exposures, including mold Heavy metal exposure Mast cell activation syndrome (MCAS) Gut microbiome health Nutritional and metabolic concerns Genetic and immune-related factors Dr. Blehle describes her clinic's approach as comprehensive, emphasizing that patients frequently arrive with overlapping health concerns rather than a single clearly identified diagnosis. She explains that many of her patients have already visited numerous physicians, undergone extensive testing, and tried multiple treatments before seeking care at Alviasana. For these patients, her goal is to investigate potentially relevant contributors to their symptoms and develop a personalized treatment strategy. When You're the 49th Doctor: The Challenges of Complex Chronic Illness Early in the conversation, Dr. Blehle shares the story of a patient who had already seen 48 doctors before visiting her clinic. Dr. Blehle became the patient's 49th physician. The example illustrates a familiar experience for many people living with persistent, unexplained symptoms: years of medical appointments, conflicting explanations, unsuccessful treatments, and uncertainty about what to do next. Dr. Blehle believes that patients with complex chronic illness often require a broader assessment of their health history. Rather than assuming that every symptom has the same cause, she considers possible infections alongside environmental, nutritional, immune, and other medical factors. Rich and Dr. Blehle discuss why listening carefully to the patient's experiences is an essential first step. For people who have struggled to find answers, a comprehensive evaluation can provide an opportunity to revisit overlooked questions and identify areas that may warrant additional investigation. Why Dr. Blehle Believes Lyme Disease Treatment Requires a Broader Approach One of the interview's central themes is Dr. Blehle's belief that treating suspected infections alone may not address every factor contributing to a patient's illness. She explains that her clinical approach considers the broader health picture, including possible environmental exposures and underlying medical conditions. For example, a patient may have a history of tick exposure while also experiencing gastrointestinal problems, nutritional deficiencies, or symptoms associated with another illness. Dr. Blehle believes these issues should be considered together when developing a treatment plan. Her approach reflects her clinical experience and treatment philosophy. The interview does not establish that all the factors discussed cause persistent Lyme disease symptoms or that treating them improves outcomes for every patient. Step One: A Comprehensive Patient History Before ordering laboratory tests, Dr. Blehle begins with an extensive medical history. She wants to understand not only the patient's symptoms, but also their environment, travel history, previous illnesses, and treatment experiences. Questions may include: Where does the patient live? Have they experienced known or suspected tick bites? Have they been exposed to mosquitoes or other biting insects? Have they traveled internationally? Did symptoms begin after an infection or travel? Have they lived or worked in buildings with water damage or visible mold? Have they received antibiotics or other treatments? What medical diagnoses have previously been considered? Which symptoms have persisted or changed over time? Dr. Blehle describes how travel history can provide important clues. For example, a patient may have become ill during or after traveling abroad, with symptoms continuing long after returning home. She believes that understanding the timing and circumstances of symptom onset helps determine which diagnostic tests may be appropriate. Her guiding principle is to use the medical history to select targeted investigations rather than ordering the same extensive laboratory panel for every patient. Mold Exposure and Environmental Factors in Chronic Illness Rich asks Dr. Blehle about the relationship between environmental exposures and chronic symptoms. In particular, they discuss mold exposure in homes and workplaces. Dr. Blehle explains that she asks patients about their living environments and considers possible mold exposure during the initial assessment. When environmental concerns arise, she may recommend investigating the home for moisture damage or visible mold, including areas behind wallpaper or walls. She also discusses using laboratory testing in her clinical evaluation. Rich emphasizes the importance of identifying and reducing ongoing environmental exposures rather than focusing exclusively on testing the patient. Does Mold Exposure Affect Lyme Disease Treatment? Dr. Blehle shares her clinical belief that addressing suspected mold-related problems before antimicrobial treatment may improve the effectiveness of her broader treatment plan. She describes using a similar sequence when she suspects heavy metal-related concerns. These are her reported clinical practices, not established evidence that mold or heavy metal treatment improves Lyme disease outcomes. Mold exposure can contribute to recognized health problems, particularly respiratory symptoms and allergic conditions. However, testing for mold-related illness is complex, and some commercially marketed body tests have not been validated for diagnosing illness caused by indoor mold. The conversation raises important questions about environmental health while highlighting the need for appropriate medical assessment and evidence-based testing. Heavy Metals, Genetic Factors, and Metabolic Health In addition to mold, Dr. Blehle discusses investigating potential heavy metal exposures and selected genetic or metabolic concerns. She explains that testing depends on the patient's history and clinical presentation. Her approach includes considering whether certain medical conditions or exposures may be contributing to symptoms. Rich asks whether she evaluates the body's ability to process or eliminate substances. Dr. Blehle describes using genetic testing in selected circumstances rather than routinely ordering it for everyone. This portion of the interview highlights the importance of distinguishing between documented toxic exposures, established medical conditions, and unproven explanations for chronic symptoms. Heavy metal testing and treatment should be guided by clinically meaningful exposure histories and validated methods. Gut Microbiome Health and Lyme Disease One of the most detailed sections of the interview focuses on the gut microbiome, the community of microorganisms living in the digestive tract. Dr. Blehle explains that many of her patients have previously undergone antibiotic treatment. Because antibiotics can affect intestinal bacteria, she considers gastrointestinal health when planning additional treatment. She believes the gut microbiome is an important part of evaluating patients with complex chronic illness. Research has established connections between the intestinal microbiome and immune function, although the clinical significance of many commercial microbiome test results remains uncertain. How Does Dr. Blehle Test the Gut Microbiome? Dr. Blehle describes using stool testing to evaluate aspects of intestinal microbial composition. She also discusses measuring substances such as histamine in stool samples. She explains that she may address identified gastrointestinal concerns before beginning additional antimicrobial treatment. Her goal is to consider digestive health and previous treatment effects as part of the overall care plan. However, there is currently no universally accepted stool microbiome profile that defines optimal immune health or reliably predicts Lyme disease treatment outcomes. The interview presents Dr. Blehle's clinical approach rather than establishing that routine microbiome testing is necessary for Lyme disease patients. Fecal Microbiota Transplantation: Could Restoring Gut Bacteria Help? Rich asks Dr. Blehle about fecal microbiota transplantation (FMT), a procedure that transfers processed stool-derived microorganisms from a donor into a recipient's gastrointestinal tract. Dr. Blehle shares that she has treated one patient who underwent the procedure and appeared to benefit. She emphasizes that this experience involved only one patient. Rich also recalls interviewing patients who described improvements after undergoing fecal microbiota transplantation during their recovery journeys. The discussion raises questions about the relationship between the gut microbiome, antibiotic exposure, and long-term health. FMT has established clinical applications for selected cases of recurrent Clostridioides difficile infection. It is not an established treatment for Lyme disease or post-treatment Lyme disease symptoms, and it carries infectious and other risks. Dr. Blehle's anecdote should not be interpreted as evidence that FMT is effective for Lyme disease. Evaluating Liver, Kidney, Thyroid, and Nutritional Health Dr. Blehle explains that her initial evaluation commonly includes laboratory testing to assess general health and organ function. Depending on the patient, this may involve: Liver function tests Kidney function tests Complete blood count Differential white blood cell count Vitamin and nutritional assessments Thyroid-related testing Selected metabolic or genetic investigations She also describes using an electrocardiogram (ECG) and abdominal ultrasound as part of her clinic's evaluation. These assessments can provide information about a patient's overall medical condition and help clinicians consider treatment risks. Dr. Blehle emphasizes that she wants a broad understanding of each patient's health before making treatment decisions. Testing for Lyme Disease and Tick-Borne Coinfections After reviewing the patient's history and general health, Dr. Blehle discusses testing for infections. She explains that she considers a variety of bacterial, viral, fungal, and parasitic conditions depending on the patient's symptoms and exposure history. Organisms and infections discussed include: Tick-Borne Bacteria and Parasites Borrelia species, associated with Lyme disease and other borrelial infections Babesia species, which can cause babesiosis Bartonella species Ehrlichia species Anaplasma species Other Bacterial Infections Yersinia Chlamydia pneumoniae Chlamydia trachomatis Campylobacter Viral Infections Epstein-Barr virus (EBV) Cytomegalovirus (CMV) Human herpesvirus 6 (HHV-6) Parvovirus Other Potential Conditions Toxoplasmosis Selected parasitic infections Candida-related conditions Dr. Blehle explains that she does not routinely order one standardized infectious disease panel for every patient. Instead, she selects tests based on her assessment of the patient's medical history and symptoms. An important distinction: Not every organism mentioned is transmitted by ticks, and a positive antibody test does not necessarily establish an active infection. Test results must be interpreted alongside symptoms, exposure history, examination findings, and the known accuracy of the test. For additional information about diagnostic challenges, explore Tick Boot Camp's Lyme Disease Testing Resource. Why Dr. Blehle Uses ArminLabs for Lyme Disease Testing Rich asks Dr. Blehle which laboratories she uses when evaluating Lyme disease and potential coinfections. She explains that she frequently works with ArminLabs, a laboratory based in Germany. Dr. Blehle describes having a longstanding professional relationship with the laboratory and familiarity with its testing methods. She also uses other laboratories when additional information is needed. Rich shares his positive experiences speaking with Dr. Armin Schwarzbach and expresses appreciation for his work in tick-borne disease diagnostics. The conversation highlights the importance of understanding which tests are being ordered, what they measure, and how their results inform clinical decisions. Different laboratory methods have different strengths, limitations, and levels of clinical validation. Patients should discuss the implications of testing with qualified healthcare professionals. Building an Individualized Lyme Disease Treatment Plan Once the medical history, examination, and testing have been completed, Dr. Blehle schedules a follow-up discussion to review the results. She explains that the next step is developing a personalized treatment plan. Depending on her assessment, the plan may include: Prescription antimicrobial medications Herbal treatments Nutritional support Selected supplements Management of identified medical conditions Monitoring of symptoms and laboratory findings Additional interventions offered at her clinic Dr. Blehle describes preparing separate plans for prescription medications and supplements when appropriate. She also explains that treatment decisions are discussed with other members of her clinical team. The goal is to tailor care to the patient's presentation rather than assume that everyone requires the same treatment. Antibiotics vs. Herbal Treatments for Chronic Lyme Disease Rich asks Dr. Blehle how she approaches antimicrobial treatment. She explains that her clinic uses both prescription antibiotics and herbal treatments. According to Dr. Blehle, some patients receive antibiotic-based treatment plans, while others pursue herbal approaches. She describes her typical treatment timelines as: Antibiotic-based approaches: Approximately 8–12 months Herbal approaches: Approximately 18–24 months These durations represent Dr. Blehle's reported clinical practices, not standard treatment recommendations or evidence that prolonged therapy is effective for every patient. Established antibiotic regimens for Lyme disease are generally substantially shorter and depend on the specific clinical manifestation. Prolonged antimicrobial treatment can carry important risks, and the evidence does not support routinely extending antibiotics for persistent nonspecific symptoms after recommended Lyme disease treatment. Likewise, herbal products vary in composition, safety, and supporting clinical evidence. Patients should discuss treatment decisions with appropriately qualified clinicians. IV Antibiotics, Infusions, and Integrative Therapies Dr. Blehle describes several interventions available at Alviasana. These include: Intravenous antibiotic treatment in selected cases Vitamin C infusions Amino acid infusions Ozone therapy Magnetic field therapy Light-based therapies Other individualized supportive treatments She also mentions a temperature-based treatment transcribed as “hypothermia.” The recording does not make clear whether she intended to describe hypothermia or hyperthermia, so the exact intervention would need confirmation. Dr. Blehle explains that she does not believe every patient requires intravenous antibiotics. She reserves them for selected situations based on her clinical assessment. It is important to distinguish between therapies with established medical indications and experimental or insufficiently validated approaches. For example, IV antibiotics may be indicated for certain manifestations of Lyme disease, but they are not automatically necessary for persistent symptoms. Ozone therapy and magnetic field therapies are not established treatments for Lyme disease. The interview provides an overview of services described by Dr. Blehle rather than evidence that each intervention is safe or effective for Lyme disease. What Does Recovery From Lyme Disease Look Like? Toward the end of the interview, Rich asks Dr. Blehle how her team determines whether a patient has recovered. She explains that her clinic considers both symptoms and follow-up testing. Dr. Blehle describes using a period of at least four months without symptoms and with negative test results as part of her clinic's approach to assessing recovery. She also discusses patients returning periodically for additional testing because they fear their infections may return. However, Lyme disease antibody tests can remain positive for months or years after successful treatment, and repeat serology is not a validated test of cure. Consequently, Dr. Blehle's described testing criteria should not be treated as a universally accepted definition of Lyme disease recovery. The discussion nevertheless highlights an important patient concern: How can someone regain confidence in their health after years of debilitating symptoms and uncertainty? Tick Boot Camp's PARM Framework for Healing Rich introduces Dr. Blehle to Tick Boot Camp's PARM framework, developed from patterns observed across hundreds of patient interviews. PARM stands for: P — Prehabilitation Preparing the body and mind for the recovery process. This phase emphasizes understanding the patient's health status and addressing barriers that may affect their ability to participate in care. A — Assist Using appropriate medical treatment and supportive strategies to address diagnosed infections and other relevant health concerns. R — Rehabilitation Supporting recovery of physical function, cognitive abilities, and overall quality of life. Depending on the patient's needs, rehabilitation may involve physical therapy, occupational therapy, cognitive rehabilitation, or other individualized interventions. M — Maintenance Maintaining healthy habits, monitoring for new concerns, and reducing the risk of future tick exposure. This includes practical prevention strategies to help protect against reinfection. Dr. Blehle explains that the general structure is consistent with the way she approaches her patients. She also describes using an additional period of herbal treatment toward the end of some treatment plans. Her endorsement reflects her clinical perspective. PARM is a patient-informed framework for organizing recovery experiences, not a validated medical protocol. For practical tick prevention and post-bite guidance, visit Tick Boot Camp's Tick Bite Blueprint. The Importance of International Collaboration Through ILADS Dr. Blehle explains that she has attended approximately 10 ILADS conferences in the United States and Europe. She values the opportunity to learn from physicians and researchers who work with patients experiencing complex symptoms. At the 2025 conference, she was particularly interested in presentations addressing: Mold and environmental exposures Brain metabolism Neurological function Emerging clinical and scientific perspectives Education for physicians treating tick-borne diseases Dr. Blehle also discusses her efforts to expand physician education in Germany and other European countries. She believes that more doctors need opportunities to learn about tick-borne diseases and complex chronic illness. Her goal is to help build a larger network of clinicians who can recognize relevant conditions, evaluate patients thoroughly, and provide appropriate care. Explore additional conversations with healthcare professionals through the Tick Boot Camp Doctors Podcast Collection. International Lyme Disease Care at Alviasana Although Dr. Blehle practices in Augsburg, Germany, she explains that Alviasana works with patients from around the world. Her clinic has welcomed individuals from: Germany and other European countries The United States Africa Asia She notes that the clinic's website is available in multiple languages, including English, German, and French. Patients interested in learning more about her medical practice can visit the Alviasana official website. The interview does not establish whether particular treatments are available or appropriate for every international patient. Individuals considering care abroad should evaluate the provider's credentials, proposed treatment evidence, risks, costs, and follow-up arrangements. Key Takeaways From Dr. Sigrid Blehle A detailed medical history matters. Dr. Blehle begins with patients' symptoms, exposures, travel, previous diagnoses, and treatment experiences. Complex symptoms may have multiple contributors. She evaluates potential infections alongside other medical and environmental concerns. Mold and environmental exposures deserve appropriate consideration. The interview explores how living conditions may affect health, while the effectiveness of mold-directed treatments for Lyme disease remains unproven. Gut health is part of her clinical approach. Dr. Blehle considers gastrointestinal symptoms, previous antibiotic use, and stool testing. Infectious disease testing should be individualized. She selects tests based on patient history rather than relying on one standard panel. Not every positive infectious disease test indicates active illness. Clinical interpretation is essential. Treatment decisions vary among patients. Dr. Blehle discusses antibiotics, herbal medicine, and other interventions offered at her clinic. Prolonged treatment requires careful evaluation. Her reported treatment timelines are not standard recommendations and must be considered in light of available evidence and potential risks. Recovery involves more than a laboratory result. Symptoms, function, quality of life, and clinically appropriate follow-up all matter. Physician education is important. Dr. Blehle works to expand professional learning opportunities in Germany and Europe. International collaboration can encourage new research questions. ILADS brings together clinicians and researchers from different countries. Patients deserve to be heard. Her story about becoming one patient's 49th physician underscores the challenges faced by people seeking answers. Resources Mentioned in This Episode Guest and Clinical Resources Alviasana – Dr. Sigrid Blehle's Medical Clinic in Augsburg, Germany International Lyme and Associated Diseases Society (ILADS) ArminLabs – Laboratory Testing Tick Boot Camp Educational Resources Lyme Disease Testing: Understanding Diagnostic Challenges Tick Bite Blueprint: What to Do After a Tick Bite Tick Boot Camp Doctors Podcast Collection Tick Boot Camp Lyme Disease Podcast About This LIVE from ILADS Episode Recorded at the 2025 ILADS Conference in San Antonio, Texas, this episode features Dr. Sigrid Blehle, MD, MBA, PhD, Medical Director of Alviasana in Augsburg, Germany. Together with Tick Boot Camp co-host Rich Johannesen, Dr. Blehle explores comprehensive patient evaluations, Lyme disease testing, tick-borne coinfections, mold exposure, heavy metals, gut microbiome health, immune function, antibiotic and herbal treatment approaches, and the importance of individualized care. The conversation also examines Tick Boot Camp's PARM framework and the need for continued physician education and international collaboration. For patients who have visited countless doctors without finding answers, this episode reinforces an important message: Your symptoms deserve thoughtful investigation, your experiences deserve to be heard, and meaningful improvements in health and quality of life remain possible. Listen to more patient stories and expert conversations on the Tick Boot Camp Podcast.

  • S1 · E625
    November 10 · 25 min

    Episode 625: 25 Doctors, 10 Misdiagnoses: From Lyme Patient to Advocate – Melinda Elliott Sander | LIVE from ILADS

    After seeing 25 doctors, receiving 10 misdiagnoses, and facing the possibility of ALS, multiple sclerosis, or early-onset Alzheimer's disease, Melinda Elliott Sander finally discovered that tick-borne illness was behind her devastating health journey. Today, she's helping change the future of Lyme disease advocacy across America. In this LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen welcomes Melinda Elliott Sander, a Missouri Lyme disease patient advocate and Community Engagement Fellow with Center for Lyme Action, to discuss her journey from seriously ill mother of three to national advocate fighting for improved Lyme disease research, awareness, funding, and patient protections. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation explores the challenges of diagnosing tick-borne diseases in the Midwest, the growing impact of alpha-gal syndrome, and how grassroots advocacy is influencing federal legislation. Melinda shares how she began contacting lawmakers while bedridden, eventually becoming involved in a national movement that grew from approximately 30–40 early advocates to more than 10,000 participants at the time of the interview. Rich and Melinda also discuss five federal legislative proposals designed to improve tick-borne disease research, prevention, public health infrastructure, patient protections, and access to information. Their message is empowering: You don't have to be healthy, wealthy, or politically connected to make a difference. Even when chronic illness has taken so much from you, your voice can help create meaningful change. Meet Melinda Elliott Sander: Lyme Disease Patient Advocate Melinda Elliott Sander is a Lyme disease patient advocate from north-central Missouri who has spent approximately a decade raising awareness about Lyme disease and other tick-borne illnesses. She serves as a Community Engagement Fellow with Center for Lyme Action, a national advocacy organization dedicated to increasing federal funding and advancing policy solutions for Lyme disease, alpha-gal syndrome, and other tick-borne conditions. Melinda has participated in Center for Lyme Action's advocacy efforts since the organization's early days in 2020. She now works to strengthen state-level advocacy teams, connect patients with opportunities to participate in public policy, and help expand the organization's national network. At the time of the interview, Melinda was completing a public health degree at Western Governors University. Her mission is deeply personal. After experiencing years of debilitating illness and struggling to obtain an accurate diagnosis, she committed herself to helping other patients avoid the same challenges. 25 Doctors, 10 Misdiagnoses, and Eight Medical Specialties Approximately 10 years before this interview, Melinda became seriously ill while raising three young children. Her symptoms were severe, but physicians struggled to determine what was causing them. During her diagnostic journey, she consulted: 25 physicians Eight medical specialties 10 different diagnoses Doctors considered serious neurological conditions, including ALS, multiple sclerosis, and early-onset Alzheimer's disease. Melinda describes how frightening this experience was, especially while caring for her children and trying to maintain hope for her future. Eventually, she learned that tick-borne illness was involved. The diagnosis surprised her. She had already considered and ruled out numerous possibilities, and tick-borne disease was not something she initially believed could explain her symptoms. Her experience illustrates the emotional and physical toll of a prolonged diagnostic journey. It also highlights the importance of comprehensive medical evaluation when patients experience persistent, unexplained symptoms. Why Lyme Disease Awareness Matters in Missouri Melinda lives approximately 30 miles north of Columbia, Missouri. She explains that people in her region are sometimes told Lyme disease does not exist in their state. Yet Missouri has extensive outdoor activity involving farming, hunting, hiking, and recreation. Residents regularly encounter ticks in fields, forests, backyards, and other everyday environments. Melinda believes greater awareness of tick-borne diseases is needed among healthcare professionals and the public. Rich contrasts her experience with living on Long Island, New York, where Lyme disease is widely recognized. He explains that patients in highly endemic areas may face different diagnostic challenges than patients in regions where Lyme disease is considered less common. Importantly, tick-borne disease risks vary by geography and tick species. Missouri is associated with several significant tick-borne health concerns, including ehrlichiosis, spotted fever group rickettsioses, and alpha-gal syndrome. Melinda's message is that tick exposure should not be dismissed simply because someone lives outside a traditionally recognized Lyme disease hotspot. For guidance following a tick bite, explore Tick Boot Camp's Tick Bite Blueprint. Alpha-Gal Syndrome: A Major Public Health Concern in Missouri One of the most important topics in this interview is alpha-gal syndrome (AGS), a potentially serious allergy associated with certain tick bites. In the United States, alpha-gal syndrome is strongly associated with bites from the lone star tick. The condition involves an immune response to alpha-gal, a sugar found in most non-primate mammals. People with alpha-gal syndrome may experience allergic reactions after consuming certain mammalian foods or encountering other products containing alpha-gal. Symptoms can include: Hives and itching Gastrointestinal distress Swelling Breathing difficulties Severe allergic reactions, including anaphylaxis Melinda describes Missouri as a significant area of concern for alpha-gal syndrome. She discusses how the condition can affect farmers, hunters, and families whose livelihoods involve livestock. Some people may experience serious lifestyle changes as they learn to navigate food ingredients, medications, and other potential exposures. Melinda's Personal Experience With Alpha-Gal Melinda reveals that she also developed alpha-gal syndrome. After years of dealing with Lyme disease and other tick-borne illnesses, she noticed alpha-gal-related symptoms following a COVID-19 infection. She discusses her physician's hypothesis that changes in immune function may have contributed to the timing of her symptoms. However, the interview does not establish that COVID-19 caused her alpha-gal syndrome. Her experience reinforces the importance of further research into tick-associated allergies and immune responses. Why the Lone Star Tick Is an Important Public Health Concern Rich and Melinda discuss the aggressive behavior of lone star ticks. Unlike some tick species that primarily wait on vegetation for a host, lone star ticks can actively move toward potential hosts. Rich recalls observing this behavior firsthand after removing a lone star tick from his body. He describes placing the tick on his bathroom sink and watching it repeatedly move toward him. The conversation highlights why tick prevention matters even during ordinary outdoor activities. Lone star ticks are associated with several health concerns, including ehrlichiosis and alpha-gal syndrome. Their expanding geographic distribution has increased attention to prevention, surveillance, and public education. From Bedridden Lyme Patient to Congressional Advocate One of the most inspiring parts of Melinda's story is how she began advocating while severely ill. She recalls lying in bed and writing letters to elected officials. Even when she lacked the energy to travel or participate in traditional advocacy activities, she found ways to make her voice heard. She contacted senators, representatives, and public health officials to explain the challenges patients were experiencing. Eventually, Melinda traveled to Washington, D.C., to participate in congressional meetings. She remembers feeling nervous during her first visits. However, an interaction with former Missouri Senator Roy Blunt helped reinforce the importance of her work. He encouraged her by explaining that lawmakers need to hear directly from constituents about the challenges affecting their communities. That experience strengthened Melinda's commitment to advocacy. Today, she encourages other patients and caregivers to share their stories with elected officials. If lawmakers don't hear about the problems patients face, they may never fully understand the need for change. What Is Center for Lyme Action? Center for Lyme Action is a national advocacy organization working to increase federal funding and advance policy solutions for Lyme disease, alpha-gal syndrome, and other tick-borne conditions. Its work focuses on: Increasing federal investment in tick-borne disease research Improving diagnostic tools and treatment options Supporting prevention and public health surveillance Educating members of Congress Advocating for patients and caregivers Strengthening state-level advocacy networks Encouraging collaboration among researchers, healthcare professionals, and policymakers Melinda explains that Center for Lyme Action began with approximately 30–40 advocates participating in its early congressional outreach efforts. By the 2025 ILADS Conference, she reports that the network had grown to more than 10,000 advocates nationwide. She now helps organize and strengthen those state-level teams. The organization's goal is to turn individual patient experiences into coordinated national advocacy. How Federal Advocacy Helps Lyme Disease Patients Rich asks an important question: How does federal advocacy actually help individual patients get better? Melinda explains that advocacy can influence patient care in several ways. 1. Increasing Funding for Lyme Disease Research Federal funding supports scientific investigations into Lyme disease and other tick-borne illnesses. Research can contribute to improvements in: Diagnostic testing Understanding persistent symptoms Treatment approaches Prevention strategies Disease surveillance Medical education Recognition of additional tick-borne conditions Melinda discusses the substantial growth in federal attention and research funding that advocates have helped encourage. She references cumulative investments approaching half a billion dollars, although the interview does not specify the exact programs or years included in that figure. Her larger point is that organized patient advocacy can help direct public resources toward scientific questions that matter to patients. 2. Giving Patients a Voice Melinda believes advocacy provides patients with an opportunity to influence the systems that affect their lives. People who feel isolated by chronic illness can connect with others who understand their experiences. They can share stories, contact lawmakers, and participate in efforts to improve public policy. For some patients, advocacy becomes an important source of purpose and connection. 3. Supporting Research, Medical Education, and Patient Access Rich discusses the challenges physicians may face when caring for patients with complex or persistent symptoms. He expresses concern that professional, regulatory, and legal uncertainty may discourage some clinicians from working with these patients. Melinda agrees that advocacy is important at both the state and federal levels. Their discussion explores how research, medical education, and healthcare policy can influence clinical practice. The goal is to improve access to informed, compassionate, evidence-based care while maintaining appropriate patient safety protections. Five Federal Tick-Borne Disease Bills Discussed at ILADS 2025 Melinda explains that Center for Lyme Action was supporting five major legislative proposals during the 2025 congressional session. She describes the simultaneous consideration of these bills as an important moment for the tick-borne disease community. 1. Kay Hagan Tick Act Reauthorization H.R. 4348 — Kay Hagan Tick Act Reauthorization The original Kay Hagan Tick Act established a federal framework for improving the prevention and control of vector-borne diseases. The reauthorization proposal aimed to continue and strengthen these efforts. Key priorities included: Supporting a national vector-borne disease strategy Continuing regional Centers of Excellence Providing grants to state and local health departments Strengthening disease surveillance Improving prevention and public health responses Melinda emphasizes the importance of directing resources to state health departments and research institutions. Update since the interview: The Kay Hagan Tick Act reauthorization was signed into law on September 30, 2026, extending relevant programs through 2030. 2. Alpha-gal Allergen Inclusion Act H.R. 1178 — Alpha-gal Allergen Inclusion Act This legislation addresses challenges faced by people with alpha-gal syndrome. The proposal seeks to expand federal allergen-labeling requirements to include alpha-gal. Melinda explains that people with alpha-gal syndrome may encounter mammalian-derived ingredients in foods, medications, cosmetics, and other products. Improved labeling could help patients identify relevant ingredients and make more informed decisions. 3. Stamp Out Lyme Disease Act H.R. 4981 — Stamp Out Lyme Disease Act The Stamp Out Lyme Disease Act proposes creating a special postage stamp to generate funding for Lyme disease research. Revenue from the semipostal stamp would support research through the National Institutes of Health. Melinda and Rich discuss the proposal as a creative way to raise awareness while generating additional research funding. 4. BITE Act H.R. 4980 — Battling Infections Transmitted by Ticks and Exposure Act The BITE Act proposes improving public awareness of tick-borne and other vector-borne disease risks. Melinda describes the possibility of location-based alerts that could notify people when they enter areas associated with increased tick exposure. The proposed system would help communicate relevant public health information and support prevention efforts. 5. Tick Identification Pilot Program Act H.R. 4979 — Tick Identification Pilot Program Act This proposal would support state-level tick identification programs. Such programs could help residents identify ticks and better understand potential exposure risks. Rich connects the legislation to existing educational resources, including the University of Rhode Island's TickEncounter Resource Center. He also discusses Tick Boot Camp's Tick Bite Blueprint, which provides practical guidance for people who discover an attached tick. The discussion highlights the value of making tick identification and prevention resources more widely available. Why Tick Identification Matters Different tick species are associated with different pathogens and health risks. For example: Blacklegged ticks: Associated with Lyme disease, anaplasmosis, and babesiosis. Lone star ticks: Associated with ehrlichiosis and alpha-gal syndrome. American dog ticks: Associated with certain spotted fever group infections. Identifying a tick can help guide conversations with healthcare professionals. However, tick identification does not establish that a tick transmitted an infection. Similarly, a negative test of a removed tick does not necessarily rule out exposure to another infected tick. The interview emphasizes education, prevention, and informed medical decision-making. Meghan Bradshaw and the Growth of Federal Lyme Advocacy Melinda credits Meghan Bradshaw, Executive Director of Center for Lyme Action, with helping lead the organization's federal advocacy efforts. She describes Meghan as a central presence in Washington, D.C., building relationships with lawmakers and coordinating legislative priorities. Melinda also explains that continued organizational growth requires additional resources. As more patients become involved, Center for Lyme Action needs stronger infrastructure, sponsorships, and additional staff to support its state teams and federal initiatives. The organization's long-term goal is to transform grassroots participation into sustained public policy change. Learn more about Meghan's personal journey through Tick Boot Camp's interview with Meghan Bradshaw, The Bionic Woman. How Lyme Disease Patients Can Get Involved in Advocacy One of the most empowering messages from Melinda's story is that advocacy does not require perfect health. She began writing to lawmakers while bedridden. Her experience demonstrates that patients can participate in meaningful ways that match their abilities and circumstances. Opportunities include: Joining a Lyme disease advocacy organization Contacting elected representatives Sharing personal experiences with policymakers Participating in virtual advocacy events Supporting research initiatives Connecting with state-level advocacy teams Helping educate friends, family members, and communities Rich emphasizes that chronic illness often changes a person's sense of identity and purpose. Advocacy can provide an opportunity to turn difficult experiences into support for others. Explore ways to participate through Center for Lyme Action. Why Patient Stories Matter Tick Boot Camp was built around the belief that sharing patient experiences can educate, validate, and inspire others. Rich explains that storytelling serves two important purposes. First, it helps people recognize that they are not alone. Second, it gives individuals an opportunity to contribute to something larger than their own illness. Melinda agrees that personal stories are essential to advocacy. Lawmakers may review statistics and funding requests, but hearing directly from constituents helps them understand how public policy affects real families. Her experience illustrates how a personal health crisis can eventually lead to public service and meaningful change. Returning to School After Chronic Illness Toward the end of the interview, Melinda discusses her decision to continue her education. She is completing a public health degree at Western Governors University. After years of illness and cognitive challenges, returning to school represents an important personal milestone. Melinda explains that continuing to learn helps her challenge assumptions about what she can accomplish. She also believes additional education will make her a more effective advocate. Rich connects her academic journey to the broader concept of purpose. As Melinda gains knowledge, she develops new ways to serve patients and improve public health. Her story demonstrates that chronic illness can change someone's path without eliminating the possibility of future achievement. Key Takeaways Melinda Elliott Sander experienced a prolonged diagnostic journey. She consulted 25 physicians across eight specialties and received 10 diagnoses before identifying tick-borne illness. Missouri patients face distinctive challenges. Tick exposure is common, but the recognition and distribution of specific tick-borne diseases vary by region. Alpha-gal syndrome is a significant public health concern. Melinda discusses its impact on patients, farmers, and families. Advocacy can begin from home. Melinda started contacting lawmakers while bedridden. Center for Lyme Action has built a nationwide network. Melinda reports growth from approximately 30–40 early advocates to more than 10,000. Federal funding supports research and prevention. Advocates are working to improve diagnostics, treatments, and public health infrastructure. Five major legislative proposals were highlighted at ILADS 2025. They address research, prevention, tick identification, exposure alerts, and alpha-gal labeling. The Kay Hagan Tick Act reauthorization became law in September 2026. The remaining proposals were discussed as pending legislation at the time of recording. Patient stories can influence policy. Personal experiences help lawmakers understand gaps in healthcare. Research and advocacy work together. Scientific evidence can inform clinical practice and future policy. Chronic illness does not eliminate purpose. Patients can contribute to advocacy in ways that match their abilities. Education can be part of rebuilding life after illness. Melinda's return to school reflects her commitment to continued learning and service. Learn More and Get Involved Explore these resources to learn more about Lyme disease advocacy, tick-borne illness prevention, and the legislation discussed: Center for Lyme Action – Official Website Center for Lyme Action – Team and Community Engagement Federal Tick-Borne Disease Advocacy and Legislative Priorities Tick Boot Camp – Tick Bite Blueprint Tick Boot Camp – Lyme Disease Podcast Tick Boot Camp – LIVE from ILADS Interviews About This LIVE from ILADS Interview Recorded at the 2025 ILADS Conference in San Antonio, Texas, this conversation features Melinda Elliott Sander, a Missouri Lyme disease patient advocate and Community Engagement Fellow with Center for Lyme Action. Rich and Melinda discuss her journey through 25 physicians and 10 misdiagnoses, the challenges of tick-borne illness awareness in Missouri, alpha-gal syndrome, federal research funding, and the growing movement to improve Lyme disease policy. They also examine five federal legislative proposals and the role of patients in shaping the future of tick-borne disease prevention, diagnosis, and treatment. Melinda's story demonstrates that even when chronic illness changes everything, your experiences and your voice can help create a better future for others. Explore more conversations with patients, physicians, researchers, and advocates through the Tick Boot Camp Podcast.

  • S1 · E624
    November 8 · 14 min

    Episode 624: FDA-Cleared Lyme Disease Testing: What's New at IGeneX? – Dr. Jyotsna Shah | LIVE from ILADS

    Could a major breakthrough in Lyme disease testing help more patients get answers sooner? What does FDA clearance mean for people who have struggled with negative Lyme tests despite ongoing symptoms? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Jyotsna Shah, PhD, President and Laboratory Director of IGeneX, to discuss an important development in Lyme disease diagnostics: FDA clearance of the iDart Lyme IgM and IgG ImmunoBlot test kits. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores how expanded Borrelia antigen coverage, updated antibody interpretation criteria, and single-step immunoblot testing could improve access to Lyme disease diagnostics. Dr. Shah also discusses the importance of testing for additional tick-borne infections, including Babesia, Bartonella, Anaplasma, Ehrlichia, and Rickettsia. The interview addresses several questions that matter to the Lyme disease community: What does FDA clearance mean for IGeneX Lyme disease testing? Why are Lyme Western blot bands 31 and 34 important? How do IGeneX ImmunoBlot tests differ from conventional two-tier Lyme testing? What is the difference between Lyme Borrelia and tick-borne relapsing fever Borrelia? Why might someone with Lyme-like symptoms test negative for Lyme disease? Are Babesia and other tick-borne infections becoming more common? Will FDA clearance make specialized Lyme testing easier to obtain through insurance? The biggest takeaway: Dr. Shah believes broader diagnostic tools and improved access to testing could help more patients receive timely answers and appropriate medical care. Meet Dr. Jyotsna Shah, PhD Dr. Jyotsna S. Shah, PhD, is President and Laboratory Director of IGeneX, a specialty laboratory based in Milpitas, California, focused on diagnostic testing for Lyme disease and other tick-borne infections. She has spent decades working to advance laboratory methods for detecting infectious diseases, including Borrelia and Babesia. Dr. Shah has also been involved in developing and evaluating immunoblot testing, fluorescence in situ hybridization (FISH), and other laboratory techniques. Her work includes efforts to improve the detection of tick-borne pathogens that may not be identified through commonly used testing approaches. During this interview, she shares updates on IGeneX's diagnostic technology, FDA clearance, and efforts to expand testing availability. Learn more about the laboratory at the official IGeneX website. FDA Clearance for Lyme IgM and IgG ImmunoBlot Tests The biggest announcement in this interview is the FDA clearance of two Lyme disease immunoblot test kits. The iDart Lyme IgG ImmunoBlot Kit received FDA clearance in 2024. The iDart Lyme IgM ImmunoBlot Kit received FDA clearance in 2025. Both kits are manufactured by ID-FISH Technology, Inc., which has a licensing relationship with IGeneX. The tests use recombinant antigens from multiple Borrelia species and strains to detect antibodies associated with Lyme disease. Dr. Shah explains that the FDA clearance process included evaluation of the tests' antigen coverage and interpretation criteria. She views the clearances as an important milestone for Lyme disease diagnostics. Importantly, the clearances apply to the specific iDart immunoblot kits, not every test offered by IGeneX. Read the official announcement about FDA clearance of the Lyme IgM and IgG ImmunoBlots. What Is a Lyme Disease ImmunoBlot? An immunoblot is a laboratory test that detects antibodies directed against specific proteins, called antigens. When someone is exposed to Borrelia bacteria, their immune system may produce antibodies against different bacterial proteins. An immunoblot measures antibody reactivity to selected antigens. Dr. Shah discusses two major antibody classes: IgM antibodies: Often appear earlier during an immune response. IgG antibodies: Generally develop later and may remain detectable long after an infection. Both can provide useful information when interpreted in the context of symptoms, exposure history, and other clinical findings. However, antibody results alone cannot reliably determine whether an infection is currently active, and IgM results can be misleading when used to evaluate symptoms of long duration. Why Lyme Disease Testing Bands 31 and 34 Matter One of the most important developments discussed is the inclusion of bands 31 and 34 in the FDA-cleared immunoblot kits. These bands correspond to Borrelia outer surface proteins: Band 31: Outer surface protein A, or OspA Band 34: Outer surface protein B, or OspB Dr. Shah explains that IGeneX has long considered these bands important when evaluating Lyme disease antibody responses. She emphasizes that the FDA-cleared tests include these antigens in their interpretation criteria. The kits use antigen-group interpretation rules rather than simply adopting conventional CDC-associated Western blot band counts. This is significant because different diagnostic methods may recognize different antibody patterns. However, no individual band establishes a Lyme disease diagnosis by itself. Positive antibody findings must be interpreted alongside clinical information, and some bands can have limitations involving cross-reactivity or prior vaccination. Learn more about the IGeneX FDA-cleared immunoblot technology. Single-Step Lyme Testing vs. Traditional Two-Tier Testing Rich asks Dr. Shah to explain how the new immunoblot approach differs from conventional Lyme disease testing. Traditional standard two-tier testing generally involves two sequential steps. The first test screens for antibodies. If the screening result meets the laboratory's criteria, a second test is performed. Depending on the testing algorithm, that second test may be an immunoblot or another antibody assay. Dr. Shah explains that the FDA-cleared iDart ImmunoBlot kits are designed to function as stand-alone antibody tests within their authorized intended use. This means a laboratory does not necessarily need to follow the same two-step workflow when using these particular kits. She believes this could simplify testing and make broader diagnostic technology available to additional laboratories. Single-step testing does not eliminate the possibility of false-negative or false-positive results, and test selection should remain guided by clinical circumstances. Why IGeneX Uses Antigens From Multiple Borrelia Species Dr. Shah emphasizes the importance of recognizing diversity among Borrelia bacteria. Lyme disease is associated with multiple Borrelia species, including species found in North America and Europe. Different species and strains may vary in their antigenic characteristics. Dr. Shah explains that IGeneX incorporates antigens from multiple species and strains to broaden antibody recognition. She describes the laboratory's approach as particularly relevant for patients with potential exposure in different geographic regions. The conversation also distinguishes Lyme disease Borrelia from tick-borne relapsing fever Borrelia. These are related groups of bacteria, but they are associated with distinct infections and require appropriate diagnostic interpretation. Lyme Borrelia vs. Tick-Borne Relapsing Fever Borrelia During the interview, Dr. Shah describes IGeneX testing for two different groups of Borrelia. Lyme disease Borrelia: She discusses testing that incorporates antigens representing nine Borrelia species associated with Lyme disease. Tick-borne relapsing fever Borrelia: She describes a separate testing approach involving eight species. Together, these represent 17 species considered across the two testing categories discussed in the interview. Dr. Shah emphasizes that patients with similar symptoms may have different infections. She also explains that some people with tick-borne relapsing fever Borrelia may not describe the classic recurring fever pattern traditionally associated with the disease. An important distinction is that the FDA-cleared Lyme ImmunoBlot kits should not be described as one FDA-cleared test that detects all 17 species. The interview discusses separate Lyme disease and relapsing fever testing categories. Could Tick-Borne Relapsing Fever Be Missed in Patients With Lyme-Like Symptoms? Dr. Shah describes her laboratory's experience evaluating patients who have symptoms suggestive of tick-borne illness but negative Lyme disease testing. She explains that some have shown evidence of exposure to relapsing fever Borrelia. The conversation also touches on laboratory findings involving selected patients reporting Morgellons symptoms. Dr. Shah describes identifying relapsing fever Borrelia-related findings in some of these patients. These observations are part of her laboratory experience and do not establish that relapsing fever Borrelia causes Morgellons or explains persistent symptoms in all patients. They do, however, highlight why clinicians may consider alternative diagnoses when evaluating unexplained symptoms and relevant exposure histories. Why Lyme Disease Testing Should Consider Co-Infections Rich and Dr. Shah discuss the growing recognition of infections that can occur alongside Lyme disease. A tick may carry more than one pathogen, and people may also experience multiple exposures over time. Dr. Shah explains that patients with suspected tick-borne illness may need evaluation for additional pathogens depending on their symptoms and risk factors. She discusses several groups of organisms: Borrelia: Bacteria associated with Lyme disease and relapsing fever. Babesia: Parasites that infect red blood cells and cause babesiosis. Bartonella: Bacteria associated with several human diseases, although the role of ticks in transmitting human Bartonella infection remains unproven. Anaplasma: Bacteria responsible for anaplasmosis. Ehrlichia: Bacteria responsible for ehrlichiosis. Rickettsia: Bacteria associated with several tick-borne illnesses, including spotted fever group infections. Dr. Shah believes broader testing panels can help identify infections that might otherwise be overlooked. However, comprehensive panels are not automatically necessary for every patient. Testing decisions should reflect symptoms, geographic exposure, clinical findings, and the performance characteristics of each assay. Is Babesia Becoming More Common? One of the most interesting discussions concerns Babesia, a parasite that infects red blood cells. Rich shares observations from Tick Boot Camp interviews suggesting that Babesia is being discussed more frequently among patients with complex tick-borne illnesses. Dr. Shah agrees that Babesia has become increasingly important in laboratory testing. She references data from the IGeneX patient population in which Babesia findings were particularly common. These laboratory observations do not necessarily represent prevalence in the general population. Rich asks whether the apparent increase reflects more infections or improved testing. Dr. Shah believes both may contribute, but emphasizes that improved diagnostic methods have helped identify infections that were previously overlooked. Dr. Shah's Role in Babesia Testing in New York Dr. Shah shares a story about her work with Dr. Richard Horowitz around 1999. She recalls helping bring greater attention to Babesia in New York through laboratory testing. At that time, she was working with Babesia FISH testing, a technique designed to identify genetic material within organisms in patient samples. She describes discussing Babesia findings with researchers familiar with the parasite. Her experience illustrates how diagnostic methods and scientific collaboration can contribute to increased recognition of tick-borne diseases. Dr. Shah believes that improved testing remains an important factor in identifying Babesia infections. For additional perspectives on Lyme disease and co-infections, explore Tick Boot Camp's featured profile of Dr. Richard Horowitz. What Animals Carry Babesia? Rich asks Dr. Shah about the relationship between Babesia and wildlife populations. The conversation includes deer, horses, sheep, dogs, cats, and other animals. Dr. Shah explains that Babesia organisms occur in multiple animal species. However, different Babesia species have different host relationships. For human babesiosis caused by Babesia microti in the northeastern United States, white-footed mice and certain other small mammals are important reservoir hosts. Deer play an important role in supporting blacklegged tick populations, but they are not considered the primary reservoir for B. microti. This distinction matters when discussing how babesiosis is maintained and transmitted in the environment. Why FDA Clearance Could Improve Access to Lyme Testing Near the end of the interview, Rich asks whether FDA clearance could make IGeneX testing more accessible through health insurance. Dr. Shah explains that obtaining clearance was an important step toward expanding availability. She discusses efforts to secure billing codes and work with Medicare and other insurers. At the time of recording, these efforts were ongoing. Dr. Shah hopes the technology will eventually become available through more local laboratories rather than requiring patients to rely exclusively on specialized testing facilities. This could potentially reduce barriers involving geography, laboratory access, and insurance reimbursement. However, FDA clearance does not automatically guarantee insurance coverage. Coverage depends on factors including the insurer, medical necessity policies, billing codes, laboratory participation, and the specific test ordered. The Importance of Early and Accurate Diagnosis Dr. Shah repeatedly emphasizes the importance of identifying Lyme disease and other tick-borne infections as early as possible. Earlier diagnosis can help patients receive appropriate treatment and reduce the risk of certain complications. She believes diagnostic tools that recognize a broader range of antibody responses may contribute to that goal. At the same time, no Lyme antibody test can detect every infection, particularly in the earliest stages before antibodies have developed. Patients with a clinically characteristic erythema migrans rash may be diagnosed and treated without waiting for laboratory confirmation. Testing is one part of a broader medical evaluation. Key Takeaways IGeneX-associated Lyme ImmunoBlot technology achieved FDA clearance. The iDart Lyme IgG kit was cleared in 2024 and the IgM kit in 2025. Bands 31 and 34 are included. These represent OspA and OspB antigens used in the tests' interpretation. The kits use antigens from multiple Borrelia species and strains. This is intended to broaden antibody detection. The FDA-cleared kits are designed as stand-alone immunoblot tests. They differ from traditional two-tier testing workflows. Lyme disease and tick-borne relapsing fever are distinct infections. Dr. Shah discusses separate testing approaches for these Borrelia groups. Babesia remains an important diagnostic consideration. Dr. Shah believes improved testing has contributed to increased recognition. Other infections may coexist with Lyme disease. Clinical evaluation may include Anaplasma, Ehrlichia, Babesia, and other pathogens when appropriate. Multiple tick exposures can complicate medical histories. Some patients may acquire different infections over time. FDA clearance does not guarantee insurance reimbursement. Dr. Shah describes ongoing efforts to expand coverage. Earlier diagnosis matters. Dr. Shah hopes wider access to diagnostic technology will help patients receive timely care. Learn More About IGeneX and Lyme Disease Testing For additional information about the technologies discussed in this interview, explore: IGeneX – Official Laboratory Website FDA Clearance of Lyme IgM and IgG ImmunoBlot Kits IGeneX FDA-Cleared Lyme Testing Information IGeneX Tick-Borne Disease Test Directory Tick Boot Camp – Understanding Lyme Disease Testing About This LIVE from ILADS Interview Recorded at the 2025 ILADS Conference in San Antonio, Texas, this interview features Dr. Jyotsna Shah, PhD, President and Laboratory Director of IGeneX. Rich and Dr. Shah discuss the FDA clearance of Lyme ImmunoBlot test kits, the significance of bands 31 and 34, differences between traditional two-tier testing and stand-alone immunoblots, expanded Borrelia antigen coverage, and the importance of considering additional tick-borne infections. They also explore Babesia testing, the role of wildlife in tick-borne disease transmission, and the possibility of broader access to specialized testing through insurance and local laboratories. Discover more interviews with leading physicians and researchers through Tick Boot Camp's LIVE from ILADS podcast series. Better testing can help create a path toward earlier answers, informed treatment decisions, and better patient care.

  • S1 · E623
    November 7 · 1 hr 20 min

    Episode 623: From Bed-Bound to Ms Great Britain: Kirstie Haysman’s Lyme Disease Recovery Story

    Read transcript Kirstie Haysman went from being bed-bound, wheelchair-dependent, unable to care for herself, and wondering whether she would ever recover to walking across a pageant stage and becoming Ms Great Britain 2025/26. But the crown represents much more than a pageant victory. In this deeply personal episode of the Tick Boot Camp Podcast, Kirstie shares the decades-long health journey that preceded it: unexplained symptoms beginning in childhood, multiple diagnoses, years of immunosuppressive treatment, debilitating joint and neurological symptoms, frightening intrusive thoughts, psychiatric hospitalization, and encounters with more than 40 doctors before Lyme disease finally entered the conversation. Kirstie takes listeners through the moment a stranger in a hospital waiting room asked a life-changing question — “Do you think you’ve got Lyme disease?” — and how that question ultimately led her to Mexico, Dr. Omar Morales, testing for Lyme and other tick-borne infections, and the validation she had spent years searching for. Her story does not end with diagnosis or antimicrobial treatment. Kirstie describes the many approaches she explored, the enormous financial and emotional cost of chronic illness, and why nervous-system regulation, self-hypnosis, visualization, purpose, and changing the story she told herself eventually became important pieces of her personal recovery. Today, Kirstie is using the visibility that comes with being Ms Great Britain to advocate for people with Lyme disease and other complex chronic illnesses — including her own daughter. Years of Symptoms and Misdiagnosis Looking back, Kirstie remembers being an unwell child with chronic exhaustion, recurring infections, severe “growing pains,” insomnia, low iron, and other unexplained symptoms. Her health deteriorated significantly as an adult. After testing positive for ANA following the birth of her daughter, Kirstie says doctors initially suspected lupus. Over the years, she received or was considered for numerous diagnoses, including rheumatoid arthritis, connective tissue disease, Raynaud’s, fibromyalgia, osteopenia, osteoporosis, and other conditions. She was treated with steroids for approximately 12 years and later received additional immunosuppressive medications. Instead of recovering, Kirstie says she became progressively sicker. Eventually, the joints in her hands became so damaged that she could no longer perform her work as a chiropodist. She lost her business, her independence, and ultimately her ability to care for herself. When Lyme Disease Affected Her Brain Some of the most difficult parts of Kirstie’s illness were neurological and psychiatric. She describes severe insomnia, panic, OCD symptoms, brain fog, intrusive thoughts, overwhelming anxiety, and periods when she felt as though her own mind was no longer under her control. At one of her lowest points, she entered a psychiatric hospital because she and her family believed she was experiencing a severe mental health crisis. Kirstie emphasizes an important distinction: she wanted to live, but was terrified by intrusive thoughts telling her to harm herself. Her experience is an important reminder that patients experiencing psychiatric or neurological symptoms deserve to be heard, taken seriously, and thoroughly evaluated rather than dismissed. The Stranger Who Changed Everything After collapsing during another hospital visit, Kirstie says she felt dismissed by a physician who characterized her symptoms as attention-seeking. Then another woman in the waiting room approached her with a question Kirstie had never been asked before: Could this be Lyme disease? Kirstie had barely heard of Lyme. She went home and began researching. As she read patient stories and symptom lists, she recognized experiences she had been struggling to explain for years. When she subsequently requested Lyme testing, Kirstie says she encountered resistance because she did not remember a tick bite or an erythema migrans rash. That experience ultimately pushed her outside the healthcare system she had relied upon throughout her life. Traveling to Mexico for Answers The woman Kirstie met in the hospital was preparing to travel to Mexico for Lyme disease care and encouraged Kirstie to speak with Dr. Omar Morales. That conversation changed the direction of Kirstie’s journey. Kirstie describes Dr. Morales as one of the first physicians who listened to her entire history and made her feel that her experiences were real and worth investigating. She traveled to Mexico, where she says specialty testing identified Lyme disease along with infections including Bartonella, Babesia, and Anaplasma. Receiving those results brought two very different emotions. There was relief: after years of searching, Kirstie finally felt she had an explanation. But there was also fear. She had spent nights reading stories from people who remained chronically ill and suddenly wondered whether she would ever recover — and how she could possibly afford the care she believed she needed. Tick Boot Camp previously interviewed Dr. Morales about his approach to complex Lyme disease in Lyme Mexico: An Interview with Dr. Omar Morales. Stem Cells, Plasmapheresis, Ozone and Antibiotics Kirstie ultimately pursued treatment at another facility in Mexico, where she reports receiving interventions including stem cell procedures, plasmapheresis, and ozone therapy. She describes experiencing meaningful improvement, including increased energy and changes in the mobility of her severely affected hands. After returning to the United Kingdom, however, her health declined again. Kirstie later found a UK physician who prescribed an extended combination antibiotic protocol. She credits that period of treatment with helping resolve some of her most frightening intrusive thoughts and neurological symptoms, although gastrointestinal complications eventually led her to discontinue antibiotics. Over the course of her illness, Kirstie estimates that she spent approximately £70,000 pursuing recovery. She experimented with dramatically different diets and explored numerous conventional, integrative, and alternative approaches. Her experience illustrates a reality familiar to many people with complex chronic illness: the search for answers can become financially, physically, and emotionally consuming. From Wheelchair and Bed-Bound to Rebuilding Her Life Despite everything she had tried, Kirstie eventually reached another devastating low. She describes periods when she could barely move, severe pain throughout her body, swollen joints, weakness and loss of sensation in her legs, bladder problems, and dependence on carers for basic daily activities. She could no longer work. She was missing important moments in her daughter's childhood. And she felt that the person she had once been had disappeared. That was when Kirstie began examining another part of recovery: her nervous system and the way she thought about her body. Primal Trust, Nervous-System Regulation and Self-Hypnosis Kirstie discovered the work of Dr. Cathleen King and Primal Trust, which introduced her to concepts involving nervous-system regulation, limbic system retraining, and moving the body away from a persistent state of perceived danger. This became an important shift in Kirstie’s personal recovery strategy. Rather than continually reinforcing the message that her body was broken and needed another intervention, she began practicing self-hypnosis and visualization. From bed, Kirstie imagined herself walking. She imagined herself healthy. And she imagined herself standing on the Miss Great Britain stage while an audience applauded. She even played recordings of crowds cheering while visualizing that future. Kirstie is careful to describe this as part of a much larger journey that also included extensive medical treatment. Looking back, she believes she encountered nervous-system work at the point when she was finally ready to embrace it. Her experiences also inspired her to train as a hypnotherapist and help others explore the relationship between thoughts, emotions, nervous-system regulation, and personal well-being. Kirstie has now launched Queen of Consciousness, her hypnotherapy website, where listeners can learn more about her work and approach. Learn more about nervous-system regulation and chronic illness in Tick Boot Camp’s interview with Dr. Cathleen King: Primal Trust. “Bed Bound to Beauty Queen” Years earlier, Kirstie had competed in Miss Great Britain after becoming Miss Hertfordshire. When her illness later became severe and her story received widespread media attention, Miss Great Britain reached out with a message of encouragement: if she recovered enough, she should consider returning. For someone lying in bed wondering what her future would look like, that invitation became a goal. Kirstie created a social media identity around “Bed Bound to Beauty Queen” and gave herself 365 days to get back onto the pageant stage. Progress came gradually. First came standing. Then a Zimmer frame. Then walking outside. Then a walking stick. Finally, Kirstie returned to the stage. In 2024, only months after leaving her wheelchair, she returned to Miss Great Britain and placed second runner-up in the Ms Great Britain category. One year later, she returned again. This time, Kirstie Haysman became Ms Great Britain 2025/26. For Kirstie, the crown represented the future she had visualized during some of the darkest days of her illness. Turning the Crown Into Lyme Disease Advocacy Kirstie promised that if she recovered, she would use her voice to help other people facing Lyme disease. She has made that promise a central part of her reign as Ms Great Britain. Her advocacy has included speaking at the ILADS European Scientific Conference, traveling to the United States with fellow UK Lyme advocate Hannah Green, visiting Lyme, Connecticut and the Plum Island area, participating in Lyme community events, and attending the Lyme Warrior 10th Anniversary Gala, where Tick Boot Camp first met Kirstie in person. She and Hannah also spent Lyme Disease Awareness Month wearing green every day as a conversation starter about Lyme disease. Kirstie has additionally launched a UK Parliament petition calling for a review of Lyme disease testing, part of her effort to encourage earlier recognition and reduce the kind of diagnostic journey she experienced. Lymelight: Making Disability Visible Kirstie has also collaborated with mobility-aid company NeoWalk on Lymelight, a clear acrylic walking stick featuring vivid lime-green stripes. The design grew out of Kirstie’s experience with Lyme disease and her belief that mobility aids do not have to be hidden. For Kirstie, the walking stick that once represented disability can instead become a visible conversation starter about Lyme disease, resilience, and identity. Learn more about the Lymelight walking stick from NeoWalk. Lyme Disease Across Generations One of the most emotional themes in Kirstie’s story is her concern about Lyme disease across generations of her family. She discusses the unexplained illnesses experienced by her grandmother and mother, questions whether she may have been exposed before birth, and shares that her daughter has also been diagnosed with Lyme disease. Kirstie believes congenital transmission may help explain portions of her family's medical history and says advocating for her daughter is one of the reasons she remains so committed to Lyme disease awareness. The conversation explores these possibilities as part of Kirstie’s personal and family history rather than assuming that every proposed transmission route discussed during the interview has been established in her individual case. Finding Purpose After Chronic Illness Perhaps the most powerful part of Kirstie’s story is not the crown itself. It is what the crown represents. Chronic illness took away her career, independence, mobility, confidence, and the identity she had built for herself. Recovery required Kirstie to build a new one. She now describes herself not simply as someone who has been sick, but as someone who can use what she experienced to help others feel seen. She has retrained in hypnotherapy and is developing her work around trauma, limiting beliefs, nervous-system regulation, and pain management. Through her newly launched Queen of Consciousness website, Kirstie is sharing this next chapter of her journey and her passion for helping others. She has also written Bed Bound to Beauty Queen, a children's story inspired by disability, hope, and pursuing dreams despite enormous obstacles. The book follows a young girl facing mobility challenges who dreams of becoming a beauty queen, reflecting Kirstie's own experience of rebuilding her life and pursuing a goal that once seemed impossible. Listeners can find Kirstie's children's book here: Bed Bound to Beauty Queen — Amazon USA Bed Bound to Beauty Queen — Amazon UK Her message to the Lyme community is simple: A diagnosis does not have to determine your destiny. In This Episode, You’ll Learn How Kirstie went from Miss Hertfordshire and pageantry to severe chronic illness and eventually Ms Great Britain Why she believes symptoms of illness may have been present since childhood How lupus, rheumatoid arthritis, fibromyalgia and other diagnoses became part of her medical journey What happened after years of steroids and immunosuppressive treatment How severe insomnia, OCD symptoms, anxiety and intrusive thoughts affected her life Why she was admitted to a psychiatric hospital How a stranger in a hospital waiting room first introduced her to Lyme disease Why not remembering a tick bite or bullseye rash became an obstacle to testing How Kirstie eventually connected with Dr. Omar Morales in Mexico Her reported diagnoses involving Lyme disease, Bartonella, Babesia and Anaplasma Her experiences with antibiotics, stem cells, plasmapheresis, ozone and other interventions The financial burden of pursuing treatment for complex chronic illness Why Kirstie eventually focused more heavily on nervous-system regulation How Primal Trust, self-hypnosis and visualization became part of her personal recovery strategy How she progressed from bed-bound to a Zimmer frame, walking stick and pageant stage Why becoming Ms Great Britain was about far more than winning a crown How she is using her title to raise Lyme disease awareness internationally Her advocacy around Lyme disease testing and congenital Lyme How she turned her experience into a new career in hypnotherapy through Queen of Consciousness Why she wrote the children's book Bed Bound to Beauty Queen Why purpose, identity, community and hope became essential parts of her recovery Connect With Kirstie Haysman Learn more about Kirstie's hypnotherapy work, personal journey, and approach to well-being through Queen of Consciousness. Discover her children's book, Bed Bound to Beauty Queen, available through Amazon USA and Amazon UK. More From Tick Boot Camp Explore more stories of recovery, clinicians, researchers, advocates, and people working to improve understanding of Lyme and tick-borne disease on the Tick Boot Camp Podcast. For listeners who are struggling to understand Lyme disease testing and why different tests can produce different results, visit the Tick Boot Camp guide to Lyme disease testing.

    • Transcript
  • S1 · E622
    November 6 · 25 min

    Episode 622: 12 Steps to Healing from Chronic Lyme Disease – Dr. Chris Winfrey on Faith, Trauma & Community | LIVE from ILADS

    What if healing from chronic Lyme disease requires more than finding the right medication? What if learning to stop fighting yourself, reconnect with your purpose, and build meaningful relationships could become an important part of your recovery journey? In this powerful LIVE from ILADS interview, Tick Boot Camp co-host Rich Johannesen reunites with fan-favorite Dr. Chris Winfrey, MD, a board-certified psychiatrist, psychoanalyst, and ILADS board member, to explore the spiritual, emotional, and psychological dimensions of healing from Lyme disease and complex chronic illness. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation introduces Dr. Winfrey's 12 Steps for Chronic Illness, a framework inspired by addiction recovery programs, his professional experience in psychiatry, his personal health journey, and the role faith has played throughout his life. Dr. Winfrey challenges the belief that healing must always involve fighting harder. Instead, he encourages patients to explore acceptance, surrender, self-compassion, nervous system regulation, meaningful relationships, and community support. The conversation examines several important questions: Why can chronic illness leave patients feeling trapped in fight-or-flight mode? What is the difference between surrendering to reality and giving up on recovery? How can faith, spirituality, and personal purpose support people facing serious illness? Why are self-compassion and forgiveness important when chronic illness changes your life? How can patients rebuild relationships affected by years of suffering? What can the 12-step recovery model teach people living with Lyme disease? Dr. Winfrey's central message is that patients deserve more than a life defined by illness. They deserve connection, purpose, compassion, and the opportunity to build a meaningful future while continuing to pursue appropriate medical care. Meet Dr. Chris Winfrey, MD Dr. Chris Winfrey, MD, is a board-certified psychiatrist and founder of New Image Wellness, a neuropsychiatric practice in New Jersey. His work integrates traditional psychiatry, psychoanalysis, functional medicine, environmental medicine, and approaches to complex neurological and psychiatric conditions. His clinical interests include: Lyme disease and tick-borne infections PANS/PANDAS Neuropsychiatric symptoms Chronic fatigue and cognitive dysfunction Mold-related health concerns Trauma and post-traumatic stress disorder Brain health and nervous system regulation The relationship between physical illness and mental health Dr. Winfrey also serves on the board of ILADS, where he hopes to make complex medical information more understandable and expand awareness of Lyme disease in underserved communities. He explains that Lyme disease is sometimes incorrectly perceived as affecting only certain racial or socioeconomic groups. One of his goals is to help make education, resources, and conversations about tick-borne illness more accessible. Learn more about his background and approach through Tick Boot Camp's featured profile of Dr. Chris Winfrey. A Tick Boot Camp Fan Favorite Returns Rich opens the interview by welcoming Dr. Winfrey back to the podcast. The two originally connected through Tick Boot Camp's LIVE from ILADS interview series. Despite the relatively short format of their first conference interview, Dr. Winfrey became one of the podcast's most popular guests. He subsequently joined Tick Boot Camp for a longer conversation about Lyme disease, brain health, psychiatric symptoms, and nervous system recovery. Rich credits Dr. Winfrey's ability to explain complicated medical concepts in language patients can understand. This new interview expands on an important subject they had not previously explored in depth: the spiritual dimension of healing. For more from Dr. Winfrey, listen to: Episode 521: Lyme Disease, Brain Health, and Nervous System Recovery Episode 563: At the Frontlines of Chronic Illness – ILADS Expert Panel Webinar How Dr. Winfrey's Grandmother Shaped His Understanding of Faith Dr. Winfrey begins by honoring his grandmother. He shares that he experienced PANDAS during childhood and struggled with behavioral, organizational, and emotional challenges. While others doubted his future, his grandmother continued to believe in him. She prayed for him and maintained faith that he could overcome the difficulties he was experiencing. Dr. Winfrey recalls an especially meaningful childhood memory of his grandmother placing olive oil on his head and praying before he went to school. Her belief in him became an important part of his understanding of faith, hope, and perseverance. He credits those early experiences with influencing how he now approaches healing. What Addiction Recovery Taught Dr. Winfrey About Chronic Illness Dr. Winfrey explains that his interest in 12-step programs began long before he developed his chronic illness framework. During his early years, he completed community service at an Alcoholics Anonymous facility. He listened to people describe their experiences with addiction, recovery, accountability, and personal transformation. His understanding deepened during medical school, residency, and subsequent professional training. He also worked as a medical director at a drug and alcohol treatment facility. Over time, he began recognizing parallels between addiction recovery and the psychological challenges faced by people living with chronic illness. Both experiences can involve: Loss of control Fear and uncertainty Changes in identity Shame and isolation Strained relationships Difficulty accepting reality The need for community support Rebuilding meaning and purpose Drawing on these observations, Dr. Winfrey developed his 12 Steps for Chronic Illness. He describes the framework as a way to help patients address the emotional, relational, and spiritual consequences of prolonged illness. It is a supportive framework rather than a validated medical treatment for Lyme disease. Fight-or-Flight vs. Rest-and-Digest: Understanding the Nervous System Before introducing the 12 steps, Dr. Winfrey discusses the autonomic nervous system. He explains the distinction between two important branches: The sympathetic nervous system helps the body respond to perceived threats through fight-or-flight responses. The parasympathetic nervous system supports functions associated with rest, digestion, and recovery. Dr. Winfrey observes that many people with chronic illness spend significant time feeling threatened, overwhelmed, or constantly on guard. They may find themselves fighting symptoms, doctors, medications, family members, treatment plans, or the circumstances of their illness. He compares this experience to struggling in quicksand. The harder someone fights against every aspect of their circumstances, the more exhausted and overwhelmed they may become. His message is not that patients should stop advocating for themselves. Rather, he encourages them to recognize when constant conflict may be adding to their emotional and physical burden. Stress management and nervous system regulation can support well-being, but patients do not have to achieve a particular emotional state for medical treatment to work. Being stressed, frightened, or overwhelmed does not mean someone is preventing their own recovery. Dr. Chris Winfrey's 12 Steps for Chronic Illness The centerpiece of this interview is Dr. Winfrey's 12-step framework. Each step encourages patients to explore a different part of the chronic illness experience. Step 1: Acceptance Recognize that chronic illness has changed your life and that fighting reality can deepen suffering. Dr. Winfrey begins with acceptance. He explains that patients may spend years resisting the reality of their circumstances. They may be angry about their symptoms, frustrated by treatment failures, or grieving the life they had before becoming ill. These emotions are understandable. Acceptance does not mean approving of the illness, abandoning treatment, or giving up hope. It means acknowledging the present situation so that decisions can be made from a clearer understanding of reality. Dr. Winfrey distinguishes between survival mode and growth. He believes recognizing what has happened is an important foundation for moving forward. Step 2: Finding Meaning and Purpose Believe that life can still hold meaning, peace, and joy, even in the presence of illness. Dr. Winfrey explains that chronic illness can disrupt a person's sense of identity. Someone who previously defined themselves through work, parenting, caregiving, or physical activity may struggle when those roles change. He recalls a patient questioning the purpose of getting better because her children had grown up and she no longer had the responsibilities that once gave her life meaning. Dr. Winfrey believes patients benefit from identifying a reason to keep moving forward. Rich connects this idea to Tick Boot Camp's belief that people can discover new aspects of their identity and purpose through the recovery journey. The discussion emphasizes that meaning does not have to wait until symptoms disappear. Purpose can evolve alongside illness. Step 3: Surrender Stop battling what cannot be controlled and focus on the choices, attitudes, and actions that remain available. Dr. Winfrey distinguishes surrender from defeat. He describes surrender as acknowledging that a challenge may be too great to navigate alone. For patients who have already lost careers, relationships, financial stability, or physical abilities, the idea of giving up anything else can feel unbearable. Dr. Winfrey encourages patients to consider releasing patterns that may be increasing their suffering. These might include unrealistic expectations, relentless self-criticism, or the belief that they must handle everything independently. Surrender, in his framework, creates room to ask for help. It allows patients to recognize the need for medical professionals, caregivers, supportive relationships, and community. Surrendering to the reality of illness is not the same as surrendering the possibility of a better future. Step 4: Self-Reflection Take an honest look at how illness has affected your body, mind, emotions, and relationships. Dr. Winfrey encourages patients to examine the full impact of chronic illness. The consequences often extend beyond physical symptoms. Illness can change how people communicate, respond to stress, maintain relationships, and perceive themselves. He believes self-reflection can help patients identify both their suffering and the ways they have adapted to it. This process should be approached with compassion rather than blame. A person is not responsible for becoming ill simply because their illness has affected others. Step 5: Sharing the Struggle Speak openly with trusted people rather than carrying the entire burden of illness alone. Dr. Winfrey discusses the isolation that can accompany chronic illness. Patients may withdraw because they feel misunderstood, ashamed, exhausted, or concerned about burdening others. Some may struggle to explain symptoms that are invisible or difficult to describe. Dr. Winfrey believes sharing these experiences with trustworthy people can help reduce isolation. That support may come from family members, friends, counselors, support groups, or other people living with similar conditions. The goal is not to disclose everything to everyone. It is to find relationships where honesty and vulnerability can be met with understanding. Step 6: Willingness to Change Become willing to release destructive patterns, unhelpful comparisons, and unrealistic expectations. Chronic illness often creates pressure to compare progress with others. Patients may wonder why someone else recovered more quickly or responded to a treatment that did not help them. Dr. Winfrey encourages patients to recognize when these comparisons are causing additional distress. He also discusses the importance of reconsidering expectations about productivity, independence, and recovery timelines. Willingness means remaining open to change without demanding perfection. Step 7: Self-Compassion and Grace Acknowledge personal limitations and practice gentleness instead of judgment. This is one of the most emotionally powerful parts of the interview. Dr. Winfrey discusses the harsh internal criticism he encounters among patients. Some people blame themselves for becoming ill. Others feel guilty about the financial, emotional, or practical consequences their illness has had on their families. Dr. Winfrey compares this internal dialogue to a courtroom where the patient becomes their own judge, jury, and prosecutor. He argues that many people impose punishments on themselves that they would never consider appropriate for someone else. His response is to encourage self-mercy, self-compassion, and grace. Rich connects this to negative self-talk and the importance of treating ourselves with the same kindness we would extend to a loved one. Patients deserve compassion even when they cannot work, complete daily responsibilities, or make the progress they hoped for. Step 8: Healing Relationships Identify relationships affected by illness and consider opportunities for reconnection. Dr. Winfrey believes chronic illness can create distance between patients and the people closest to them. Years of pain, fatigue, emotional distress, and uncertainty can strain marriages, friendships, and family relationships. He encourages patients to reflect on these changes without assuming that every damaged relationship is their responsibility. Where appropriate, reconnecting with supportive people may help restore a sense of belonging. Dr. Winfrey emphasizes that relationships are important sources of emotional support and resilience. Step 9: Making Amends and Setting Boundaries When appropriate, work toward repairing strained relationships while protecting your health. Dr. Winfrey explains that relationship repair must be balanced with healthy boundaries. Reconnection is not always possible or advisable. Some relationships may be unsafe, dismissive, or emotionally harmful. His framework encourages patients to consider opportunities for reconciliation while recognizing the importance of protecting their well-being. The goal is not to force forgiveness or contact. It is to approach relationships intentionally and thoughtfully. Step 10: Daily Check-Ins Continue reflecting on your emotional and physical state while acknowledging your needs without guilt or shame. Dr. Winfrey encourages ongoing self-awareness. Patients can benefit from periodically asking themselves how they are feeling, what they need, and whether their current routines are sustainable. A daily check-in might include reflecting on: Physical symptoms and energy levels Emotional well-being Stress and sleep Personal boundaries Support needs Activities that bring comfort or meaning This practice can help patients communicate their needs and recognize changes over time. It should remain flexible rather than becoming another obligation that creates pressure. Step 11: Mind, Body, and Spirit Connection Explore practices that nourish the spirit and support resilience. Dr. Winfrey discusses several activities that may help patients reconnect with themselves and their sense of meaning. Examples include: Meditation Prayer Spending time in nature Journaling Creative activities Personal reflection For Dr. Winfrey, spirituality has been a major source of strength throughout his life. He encourages patients to explore practices that align with their own beliefs and values. Spirituality is personal, and meaningful support does not require adherence to any particular religious tradition. These practices may complement medical and mental health care, but they do not replace treatment for infection or other underlying conditions. Step 12: Service and Community Share your experiences and offer encouragement to others living with chronic illness. The final step brings the framework back to community. Dr. Winfrey believes people can find meaning by supporting others who are facing similar challenges. That support might involve listening to another patient, sharing helpful information, participating in advocacy, or offering encouragement. Rich connects this principle to Tick Boot Camp's mission of helping people liberate themselves and others from Lyme disease. Both emphasize the value of community, shared experience, and modeling hope. Service does not have to be physically demanding. For someone experiencing severe symptoms, a kind message or brief conversation may be meaningful. Even while living with illness, people can have value, purpose, and a positive impact on others. How Lyme Disease May Affect Identity and the Brain's Default Mode Network During the discussion of meaning and purpose, Dr. Winfrey introduces the brain's default mode network. This network involves several interconnected brain regions associated with self-referential thinking, autobiographical memory, and aspects of personal identity. Dr. Winfrey discusses his view that Lyme disease and related neuroinflammatory processes may disrupt brain network connectivity. He believes these disruptions could contribute to difficulties with identity, meaning, and emotional processing in some patients. This is an area requiring further research. Although neurological Lyme disease can affect the nervous system, the interview's proposed relationship between Borrelia infection and specific default mode network disruptions should not be interpreted as an established mechanism in every patient. For a more extensive conversation about neurological symptoms, listen to Dr. Winfrey's earlier interview on Lyme disease, brain health, and nervous system recovery. Why Community Matters in Chronic Illness Recovery One of Dr. Winfrey's strongest messages concerns the importance of relationships. He believes meaningful healing involves connection with other people. Rich expands on this idea by discussing the relationship between serving others and allowing others to provide support. For many patients, accepting help can be difficult. Someone who was previously independent may struggle with relying on family members, caregivers, or friends. Dr. Winfrey encourages patients to recognize that needing support is part of being human. Social connection can benefit mental health, reduce isolation, and provide practical assistance during illness. However, patients without strong social networks are not incapable of recovering. Community is a valuable source of support, not a prerequisite that determines whether medical healing is possible. Faith, Spirituality, and the Chronic Illness Journey Dr. Winfrey's framework includes a strong spiritual component. He credits his grandmother's faith with helping shape his understanding of hope and perseverance. He also draws from the spiritual principles commonly associated with 12-step recovery programs. For him, surrender involves recognizing personal limitations and accepting help beyond what one individual can accomplish alone. Rich shares his own perspective on faith, purpose, and the importance of serving others. Together, they explore how spiritual practices can help patients navigate uncertainty and find meaning. The conversation offers a perspective on spirituality as a source of comfort, connection, and resilience. It does not suggest that patients must have religious faith to recover or that illness results from inadequate belief. Does Nervous System Regulation Help Lyme Disease Recovery? Dr. Winfrey discusses the relationship between chronic stress and autonomic nervous system activity. He believes that learning to recognize and respond to prolonged stress may help patients improve their overall well-being. The interview explores the importance of moving away from constant hypervigilance when possible. Supportive practices may include appropriate psychological care, relaxation techniques, meditation, and other individualized approaches. These strategies can help some people manage stress and improve quality of life. However, nervous system regulation is not a substitute for appropriate medical evaluation or treatment. Patients should not interpret ongoing symptoms as evidence that they have failed to relax, surrender, or think positively enough. For related conversations, explore: Primal Trust with Cathleen King: Nervous System Regulation and Neuroplasticity Vital-Side with Lindsay Mitchell: Brain Retraining and Nervous System Support Re-Origin with Ben Ahrens: Understanding Neuroplasticity Why Dr. Winfrey Wants to Make Lyme Education More Accessible Dr. Winfrey also discusses his responsibilities as an ILADS board member. He identifies two major priorities. First, he wants to help translate complex medical information into language patients and the public can understand. His background in psychiatry and psychoanalysis has taught him the importance of making difficult subjects accessible. Second, he wants to expand awareness of Lyme disease among minority and underserved communities. Dr. Winfrey explains that some people incorrectly perceive Lyme disease as an illness that primarily affects white patients. He wants to challenge that perception and help more people understand that tick-borne diseases can affect individuals across different communities. His advocacy reflects a commitment to improving access to information, education, and appropriate care. What's Next for Dr. Winfrey and Tick Boot Camp? At the conclusion of the interview, Rich proposes continuing the conversation in greater depth. Because LIVE from ILADS interviews are relatively short, they can introduce important ideas without allowing time to explore every detail. Rich suggests that Dr. Winfrey return for an extended discussion, potentially including an in-studio video series dedicated to the 12 Steps for Chronic Illness. The goal would be to expand the framework, explore practical applications, and provide the community with additional opportunities to learn. Dr. Winfrey welcomes the idea. The conversation leaves open the possibility of future educational content exploring the relationship between chronic illness, spirituality, psychological well-being, and community. Key Takeaways Dr. Chris Winfrey introduces his 12 Steps for Chronic Illness. The framework draws inspiration from addiction recovery, psychiatry, faith, and his personal experiences. Healing involves more than physical symptoms. Chronic illness can affect identity, relationships, emotions, and a person's sense of purpose. Acceptance is not giving up. Recognizing reality can help patients make decisions and identify their needs. Surrender can create room for support. Patients do not have to navigate every challenge independently. Finding meaning matters. Purpose and meaningful activities can support emotional resilience. Self-compassion is essential. Patients deserve kindness rather than relentless guilt or self-criticism. Chronic illness can strain relationships. Reconnection may be valuable when it is safe and appropriate. Healthy boundaries remain important. Forgiveness and reconciliation should never require tolerating harmful behavior. Nervous system regulation may support well-being. Stress management can complement, but not replace, medical treatment. Faith and spirituality can provide comfort. Patients may draw strength from religious or nonreligious sources of meaning. Community reduces isolation. Supportive relationships can help patients feel understood and connected. Helping others can create purpose. Sharing experiences and offering encouragement may benefit both patients and their communities. Dr. Winfrey advocates for greater access to Lyme education. His ILADS work includes improving communication and outreach to underserved populations. Learn More About Dr. Chris Winfrey Dr. Winfrey is a board-certified psychiatrist and founder of New Image Wellness, with clinical interests in complex neuropsychiatric conditions, Lyme disease, PANS/PANDAS, trauma, and brain health. To explore his work and previous Tick Boot Camp appearances, visit: Dr. Chris Winfrey – Tick Boot Camp Featured Doctor Profile Episode 521 – Lyme Disease, Brain Health, and Nervous System Recovery Episode 563 – At the Frontlines of Chronic Illness: ILADS Expert Panel New Image Wellness – Dr. Chris Winfrey's Practice About This LIVE from ILADS Interview Recorded at the 2025 ILADS Conference in San Antonio, Texas, this interview features Dr. Chris Winfrey discussing his 12-step framework for people living with chronic illness. Rich and Dr. Winfrey explore the psychological, emotional, relational, and spiritual challenges that can accompany Lyme disease. From acceptance and surrender to self-compassion, faith, and community, the conversation provides a framework for thinking about life and personal growth during illness. The episode also highlights Dr. Winfrey's work to improve Lyme disease education and his commitment to making complex medical concepts accessible to patients. Explore more conversations from the conference through Tick Boot Camp's LIVE from ILADS podcast series. You are more than your diagnosis. Your illness may have changed your life, but it does not erase your value, your purpose, or your ability to make a difference.

  • S1 · E621
    November 5 · 23 min

    Episode 621: Morgellons Disease, Lyme & Medical Gaslighting – Cindy Casey-Holman | LIVE from ILADS

    What if you developed painful, non-healing skin lesions, experienced sensations of something crawling beneath your skin, and then were told by a doctor that your symptoms were a psychiatric problem? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich welcomes Cindy Casey-Holman, RN, Executive Director of the Charles E. Holman Morgellons Disease Foundation, to discuss Morgellons disease, its proposed connection to Lyme disease, emerging research, and the devastating impact of medical dismissal. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores one of the most controversial and misunderstood conditions discussed within the Lyme disease community. Cindy is a former critical care nurse who developed Morgellons symptoms while working in California. Despite her medical background, she describes being diagnosed with a psychiatric condition after seeking help for painful skin lesions and unusual skin sensations. Her husband, Charles E. Holman, became an important advocate during her illness. His support ultimately inspired the creation of a nonprofit foundation dedicated to Morgellons research, education, and patient advocacy. Throughout the interview, Rich and Cindy explore important questions: What is Morgellons disease, and what symptoms do patients report? Is there a connection between Morgellons and Lyme disease? What have researchers discovered about Borrelia bacteria and skin fibers? Why do some patients receive psychiatric diagnoses when seeking dermatological care? What role can research and patient advocacy play in improving medical understanding? For patients who have experienced unexplained symptoms, social isolation, or dismissive medical encounters, this conversation offers validation, education, and a reminder that their suffering deserves compassionate attention and careful investigation. Meet Cindy Casey-Holman, RN Cindy Casey-Holman, RN, is the Executive Director of the Charles E. Holman Morgellons Disease Foundation, a Texas-based nonprofit organization supporting scientific research, education, and advocacy related to Morgellons disease. Before becoming a patient advocate, Cindy worked as a registered nurse in critical care, including high-acuity intensive care settings. Her experience with Morgellons changed her life. After developing persistent skin symptoms, Cindy struggled to obtain answers from medical professionals. She describes the experience as particularly painful because she had spent her career caring for critically ill patients and working alongside physicians. Her husband, Charles, became one of her strongest advocates. When Cindy was too ill to advocate effectively for herself, he helped her navigate the medical system and seek answers. The foundation was named in his honor. Today, Cindy works with researchers, healthcare professionals, and patients to improve awareness and understanding of Morgellons disease. Learn more about Cindy Casey-Holman and the foundation's leadership. What Is Morgellons Disease? Morgellons disease is a term used to describe a collection of skin-related symptoms, often involving reports of unusual fibers or filaments associated with skin lesions. Patients may experience persistent itching, pain, abnormal skin sensations, and wounds that are slow to heal. Cindy describes Morgellons as a dermopathy, meaning a condition affecting the skin. During the interview, she explains that some patients develop lesions on their arms, legs, face, scalp, back, or other parts of the body. She also describes the presence of colored fibers associated with affected skin. The cause of Morgellons remains scientifically contested. Some researchers have proposed an infectious association, including a possible connection with Borrelia bacteria. Other investigations have not demonstrated an infectious cause and have examined dermatological, neurological, and psychiatric explanations. Regardless of the underlying cause, the pain, itching, wounds, and distress reported by patients deserve appropriate medical evaluation. Common Morgellons Symptoms Cindy describes several symptoms that patients report. Painful, Slow-Healing Skin Lesions One of the most prominent complaints involves skin wounds that may persist for extended periods. Cindy explains that some lesions can become disfiguring, particularly when they appear on visible areas such as the face. Severe Itching and Burning Patients may experience intense itching, irritation, and pain. These symptoms can interfere with sleep, concentration, and daily activities. Crawling Sensations Beneath the Skin Cindy describes sensations that patients compare to something crawling on or beneath their skin. This type of abnormal sensation is sometimes called formication. Formication can occur in several medical and neurological conditions and does not, by itself, establish the presence of parasites or infection. Fibers or Filaments Associated With Skin Lesions Cindy discusses patients reporting unusual colored fibers within or emerging from affected skin. The origin and significance of these materials remain disputed in the medical literature. Emotional and Social Isolation Visible skin lesions can create significant embarrassment and anxiety. Cindy explains that some patients avoid social situations because they are concerned about how others will react to their appearance. The combination of physical symptoms, uncertainty, and stigma can profoundly affect quality of life. Is Morgellons Disease Connected to Lyme Disease? One of the interview's central questions concerns the relationship between Morgellons and Lyme disease. Cindy believes Morgellons may represent a skin manifestation associated with Borrelia infection. She explains that she was not initially aware of having Lyme disease when her Morgellons symptoms developed. She also discusses research reporting Borrelia organisms or genetic material in some skin samples from people identified as having Morgellons. Other microorganisms discussed include: Bartonella henselae Helicobacter pylori Treponema denticola Cindy believes Borrelia may play a particularly important role. However, the presence of microbial material in selected research samples does not establish that these organisms cause Morgellons or explain every patient's symptoms. The proposed connection remains controversial, and larger, independently replicated studies are needed. For more information about research exploring Morgellons, visit the foundation's research resources. Could Morgellons Be a Manifestation of Lyme Disease? Rich raises an important question about medical terminology. If Morgellons symptoms are associated with Lyme disease in some patients, should Morgellons be classified as a separate condition or considered a manifestation of another illness? Cindy explains that some advocates and researchers have discussed whether Morgellons might be more appropriately described as a syndrome. Rich argues that separating Morgellons from Lyme disease could create additional confusion when patients seek medical care. He worries that clinicians may overlook possible tick-borne infections if they view skin symptoms as unrelated. Cindy agrees that understanding potential connections is important. However, Morgellons has not been established as a diagnostic sign of Lyme disease, and not everyone reporting Morgellons symptoms has confirmed Lyme disease. Determining the appropriate classification requires additional research. What Are the Fibers Associated With Morgellons? One of the most unusual features discussed in the interview is the presence of colored fibers or filaments. Cindy describes how difficult it can be for patients to explain these observations to healthcare professionals. She believes the fibers are an important part of the condition and should be investigated. Some published studies have proposed that fibers associated with Morgellons involve biological materials produced within the skin. Other investigations have identified textile fibers and other environmental materials. The CDC's investigation of unexplained dermopathy did not identify a common infectious cause among the patients studied. The disagreement illustrates why carefully designed research, appropriate sampling methods, and independent replication are important. Morgellons, Medical Gaslighting, and Psychiatric Diagnoses One of the most emotional portions of the interview concerns Cindy's experiences seeking medical care. She recalls visiting a dermatologist while experiencing severe skin symptoms. Despite her professional background as an intensive care nurse, she says she was diagnosed with delusional parasitosis. Cindy describes feeling devastated. She had spent years caring for patients, trusting medical professionals, and working within the healthcare system. Suddenly, she found herself questioning whether her own concerns would be taken seriously. She also recalls reviewing medical records that suggested her husband shared her alleged delusion. For Cindy, these experiences were deeply damaging. She believes they contributed to the isolation and frustration experienced by many Morgellons patients. The interview highlights why clinicians should approach unexplained symptoms with compassion, conduct appropriate evaluations, and communicate diagnoses respectfully. Psychiatric and neurological conditions are legitimate medical conditions that also deserve evidence-based treatment. A psychiatric diagnosis should never be used as an excuse to dismiss physical suffering or avoid evaluating other possible causes. When Medical Professionals Become Patients Rich explores why Cindy's experience may have been especially traumatic because she was a nurse. As a critical care professional, Cindy was accustomed to working with physicians and caring for patients experiencing life-threatening conditions. She understood the medical system from the inside. Yet when she became ill, she struggled to obtain the kind of support she had expected. Rich observes that losing confidence in the healthcare system can be painful for anyone. For someone who has devoted a career to healthcare, that loss of trust may be particularly difficult. Cindy agrees. Her story illustrates how becoming a patient can dramatically change a healthcare professional's perspective. How Cindy's Husband Inspired the Charles E. Holman Foundation Cindy explains that her husband played a central role in helping her through the most difficult periods of illness. When she struggled to advocate for herself, he stepped forward. He helped her pursue answers and supported her efforts to understand the condition. The foundation was eventually named in his honor. The Charles E. Holman Morgellons Disease Foundation was established to advance scientific understanding and support people experiencing Morgellons symptoms. Its work focuses on: Funding scientific research Educating healthcare professionals Raising public awareness Supporting patients and caregivers Encouraging additional research into possible causes Advocating for greater attention to Morgellons-related concerns Cindy explains that scientific research became especially important because patients needed credible information to bring to medical appointments. She believes published studies can help patients communicate their concerns and encourage further investigation. Why Morgellons Research Matters Cindy discusses how the foundation has supported research into Morgellons disease. At the time of the interview, she estimated that approximately 20 or more relevant scientific papers had been published. She describes the importance of peer-reviewed research in a field where patients frequently encounter skepticism. For Cindy, research serves two purposes. First, it may help clarify the biological mechanisms responsible for reported symptoms. Second, it provides patients and clinicians with information that can support more informed conversations. The foundation continues to encourage research and collaboration. Explore the Charles E. Holman Foundation's research initiatives. What Does Current Research Say About Morgellons? Morgellons remains a subject of scientific disagreement. Research supporting an infectious hypothesis has reported associations with Borrelia and other microorganisms in selected patients. Other studies, including the CDC's investigation, have not established an infectious cause. A 2024 review of Morgellons disease describes the conflicting literature and the challenges involved in understanding the condition. These disagreements make further research important. At present, there is no universally accepted infectious explanation, validated Morgellons-specific diagnostic test, or established antibiotic regimen for the condition. Patients experiencing persistent skin lesions, abnormal sensations, or other unexplained symptoms should receive appropriate medical evaluation to identify treatable causes and manage their symptoms. Cindy's Experience With Long-Term Antibiotic Treatment Cindy also discusses her personal treatment history. She explains that she has used oral antibiotics for many years and reports that her skin symptoms worsen when she discontinues them. She describes combinations of medications sometimes used by clinicians treating patients with suspected tick-borne infections. The conversation includes references to rifampin, trimethoprim-sulfamethoxazole, and other antibiotics. Cindy also discusses using probiotics while taking antibiotics. These statements describe her individual experience and the practices she has encountered. They do not establish that long-term antibiotics are safe or effective for Morgellons disease. Prolonged antibiotic treatment can carry significant risks, including medication interactions, liver injury, antibiotic-associated infections, and antimicrobial resistance. Patients should not begin, combine, or discontinue antibiotics based on this interview. Could Tick Saliva Help Explain Morgellons Symptoms? Rich introduces a hypothesis about the relationship between tick bites and skin symptoms. He discusses how ticks release saliva into the skin while feeding. Tick saliva contains biologically active substances that help ticks feed and interact with the host's immune response. Rich wonders whether Borrelia introduced during a tick bite could contribute to skin changes that later appear as Morgellons symptoms. Cindy finds the question interesting but acknowledges that the proposed mechanism has not been studied sufficiently. This is an exploratory discussion, not an established explanation. Tick-borne infection risk depends on factors including tick species, pathogen, and attachment duration. A proposed mechanism involving tick saliva does not establish that Morgellons is transmitted by ticks or caused by Borrelia. Why Morgellons Patients Need Compassion and Community Beyond the medical questions, Cindy emphasizes the emotional burden of living with a poorly understood condition. Patients may experience severe symptoms while also struggling with disbelief from family members, friends, or healthcare professionals. Some withdraw from social activities because of visible lesions. Others become discouraged after repeated unsuccessful medical appointments. Cindy believes patient advocacy organizations can help reduce that isolation. The foundation works to connect patients with information, research, and community resources. Her message reinforces an important Tick Boot Camp principle: People experiencing difficult-to-explain symptoms deserve respect, support, and the opportunity to pursue appropriate medical care. How to Support Morgellons Research and Advocacy Cindy encourages listeners to learn more about the Charles E. Holman Morgellons Disease Foundation. The organization supports scientific research and patient education while advocating for greater awareness. People interested in learning more can explore: Charles E. Holman Morgellons Disease Foundation Foundation leadership and mission Morgellons research initiatives Patients and caregivers can also explore the foundation's educational resources and community initiatives. Key Takeaways Morgellons involves distressing skin-related symptoms. Patients report painful lesions, itching, abnormal skin sensations, and fibers associated with affected skin. Cindy Casey-Holman is a registered nurse and patient advocate. Her personal experiences led her to become Executive Director of the Charles E. Holman Foundation. Her husband played a central role in her advocacy journey. The foundation was named in his honor. A possible connection between Morgellons and Borrelia has been investigated. Some researchers report associations, but causation has not been established. The cause of Morgellons remains contested. Published studies have reached different conclusions. Medical dismissal can be profoundly damaging. Cindy describes the emotional impact of receiving psychiatric diagnoses while seeking help for physical symptoms. Patients deserve compassionate medical evaluation. Unexplained symptoms should be investigated rather than automatically dismissed. Scientific research is essential. The foundation supports studies intended to clarify the condition. Long-term antibiotics are not an established Morgellons treatment. Cindy's experience should not be interpreted as a general treatment recommendation. Patient advocacy can create meaningful change. Research funding, education, and community support can help address gaps in understanding. No one should have to navigate unexplained illness alone. Compassion and community remain essential even when medical questions are unresolved. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Cindy Casey-Holman, RN, Executive Director of the Charles E. Holman Morgellons Disease Foundation. Rich and Cindy discuss Morgellons symptoms, research investigating possible associations with Lyme disease, the controversy surrounding psychiatric diagnoses, and Cindy's personal journey from critical care nurse to patient advocate. The interview also explores the foundation's efforts to support scientific research and educate patients and healthcare professionals. Explore more conversations with physicians, researchers, and advocates through Tick Boot Camp's LIVE from ILADS podcast series. For additional information about Lyme disease testing and diagnostic challenges, visit Tick Boot Camp's Lyme Disease Testing Resource.

  • S1 · E620
    November 4 · 19 min

    Episode 620: How to Find the Right Lyme Disease Doctor: Integrative Medicine & Patient Advocacy – Dr. Marina Rasnow-Hill | LIVE from ILADS

    What happens when you're living with chronic Lyme disease, your symptoms are real, but your doctor doesn't have all the answers? And what can patients and physicians do to build a better relationship that leads to better care? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich welcomes Dr. Marina Rasnow-Hill, MD, a board-certified family and integrative medicine physician, to explore the challenges of treating complex chronic illness, the limitations of traditional medical training, and the importance of building a healthy doctor-patient relationship. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores why patients with Lyme disease, chronic fatigue, long COVID, mold-related health concerns, and other complex conditions may struggle to find answers. Dr. Rasnow-Hill shares how her own health challenges led her beyond conventional medical training to explore integrative medicine, acupuncture, herbal therapies, and individualized approaches to chronic illness. Rich and Dr. Rasnow-Hill also examine a topic that rarely receives enough attention: the responsibilities, expectations, vulnerabilities, and communication challenges on both sides of the doctor-patient relationship. The conversation concludes with practical advice for patients who want to prepare for appointments, advocate for themselves, and find healthcare professionals who will work collaboratively with them. Meet Dr. Marina Rasnow-Hill, MD Dr. Marina Rasnow-Hill, MD, is a California-based physician with approximately 20 years of experience in medicine. She began her career in family medicine before transitioning toward integrative medicine. Her professional background includes board certifications in family medicine, integrative medicine, lifestyle medicine, obesity medicine, and medical acupuncture. Dr. Rasnow-Hill also completed training through the Institute for Functional Medicine. During the interview, she explains that she has focused exclusively on integrative medicine for approximately seven years. She currently offers telehealth consultations in six western states: California, Washington, Nevada, Arizona, Colorado, and Idaho. Her clinical interests include chronic fatigue, chronic pain, immune health, gastrointestinal health, and complex chronic illness. Learn more through her Institute for Functional Medicine practitioner profile. Why an Integrative Medicine Physician Attended ILADS Dr. Rasnow-Hill explains that although she has been involved with ILADS for years, the 2025 conference was her first opportunity to attend in person. She traveled from California to San Antonio to learn from clinicians and researchers working with Lyme and other tick-borne diseases. She describes herself as a lifelong learner who continually looks for ways to improve patient care. Dr. Rasnow-Hill explains that she already works with patients experiencing Lyme disease and other complex illnesses, but wants to continue expanding her knowledge. Her motivation is practical: she attends medical conferences with specific patients in mind, looking for information that may help guide their future care. Treating Complex Chronic Illness One Layer at a Time One of Dr. Rasnow-Hill's biggest takeaways from ILADS involves recognizing that complex chronic illness may require evaluating multiple contributing conditions. She discusses patients with overlapping concerns involving: Lyme disease and other tick-borne infections Chronic fatigue Long COVID Mold-related health concerns Immune dysfunction Other medical conditions that may complicate recovery Rather than assuming that one diagnosis explains every symptom, she emphasizes the importance of reassessing the patient's condition as new information becomes available. Dr. Rasnow-Hill also discusses conference presentations involving antifungal medications, antiviral therapies, and herbal approaches. These interventions require appropriate medical indications, and their effectiveness varies by condition. Her broader message is that clinicians should remain curious and willing to reconsider their approach when a patient's progress is limited. From Conventional Medicine to Integrative Medicine Rich asks Dr. Rasnow-Hill why she chose to pursue integrative medicine after completing conventional medical training. She explains that her interest began early in her career. Even while practicing traditional medicine, she incorporated acupuncture into patient care. She recalls carrying acupuncture needles in her coat pocket so she could offer treatment when appropriate. Her interest in complementary approaches was also influenced by her upbringing. Dr. Rasnow-Hill grew up in a family that was open to what would now be called integrative or complementary medicine. However, her own health challenges played an especially important role. She describes experiencing medical problems that were not being adequately addressed through the approaches available to her. Those experiences encouraged her to explore additional training. She also began recognizing similar frustrations among her patients. What Is Integrative Medicine? Integrative medicine combines conventional medical care with selected complementary approaches when appropriate. Depending on the condition and available evidence, these may include: Nutrition and lifestyle interventions Acupuncture Stress management Physical activity and rehabilitation Selected herbal or botanical therapies Other supportive interventions Dr. Rasnow-Hill believes this broader perspective can be valuable when caring for patients with complex medical histories. She explains that conventional medical education often emphasizes structured diagnostic and treatment frameworks. While these frameworks are essential, she believes clinicians also need to understand the individual circumstances of the person receiving care. Importantly, integrative medicine should not mean replacing proven treatments with unvalidated alternatives. The goal is to consider evidence, patient preferences, safety, and the full clinical picture. Why Medical School May Not Prepare Doctors for Every Chronic Illness Rich and Dr. Rasnow-Hill discuss the challenges physicians face when treating conditions that do not fit neatly into established diagnostic categories. Dr. Rasnow-Hill explains that medical school provides extensive scientific and clinical training. However, she believes some important aspects of caring for people with complex chronic illness receive less attention. These include: Navigating diagnostic uncertainty Managing complicated symptom patterns Building long-term therapeutic relationships Addressing emotional and social concerns Understanding patient experiences Recognizing the limits of existing medical knowledge She explains that postgraduate education allowed her to explore subjects that were not central to her original medical training. Her experience reinforces the importance of continuing medical education and professional curiosity. What Happens When Doctors Don't Have All the Answers? One of the most compelling parts of the interview focuses on the emotional challenges physicians face when they cannot explain or resolve a patient's symptoms. Rich observes that many physicians have spent much of their lives succeeding academically and solving difficult problems. Patients often expect them to provide clear diagnoses and effective solutions. But complex chronic illness does not always offer straightforward answers. Dr. Rasnow-Hill acknowledges that uncertainty can be difficult for clinicians. She believes an important quality of a good physician is the ability to admit when they do not know something. Rather than pretending to have every answer, she values doctors who remain curious, seek additional information, and collaborate with patients. Medical humility is not a weakness. It can be one of the foundations of effective care. Why Patients Need Confidence and Honesty From Their Doctors Rich raises an interesting dilemma. Patients want doctors who are confident and capable. When someone has been sick for years, hearing a physician express confidence can provide tremendous reassurance. However, excessive certainty can become problematic when the underlying diagnosis or treatment plan remains unclear. Dr. Rasnow-Hill agrees that clinicians must balance confidence with honesty. A physician can communicate competence while acknowledging uncertainty. The goal is not to promise a cure or guarantee an outcome. It is to establish trust through clear communication, realistic expectations, and a willingness to work together. Understanding Medical Gaslighting and Patient Frustration Rich and Dr. Rasnow-Hill discuss the frustration many patients experience when their symptoms are dismissed or misunderstood. People living with chronic Lyme disease and other complex conditions may have spent years searching for explanations. Some have experienced medical encounters that left them feeling unheard, invalidated, or discouraged. Dr. Rasnow-Hill recognizes how vulnerable patients can feel when seeking help. She also explains that healthcare professionals may experience uncertainty and frustration when they cannot determine what is causing a patient's symptoms. Understanding both perspectives can support more productive communication. However, empathy for clinicians does not mean patients must accept dismissive behavior or inadequate care. Patients deserve to have their symptoms taken seriously, their concerns evaluated, and their questions answered respectfully. Why the Doctor-Patient Relationship Is a Partnership A central theme of the interview is that effective healthcare requires collaboration. Rich compares the doctor-patient relationship to other important relationships in life. Both parties have responsibilities. Physicians must listen carefully, communicate clearly, and provide appropriate medical care. Patients can contribute by sharing relevant symptoms, describing treatment responses, asking questions, and communicating their goals. Dr. Rasnow-Hill agrees that a collaborative relationship can improve the care experience. She emphasizes that patients should feel empowered to participate in decisions rather than viewing themselves as passive recipients of treatment. Why Communication Matters in Chronic Lyme Disease Care Patients with complex illnesses often have extensive medical histories. They may have seen multiple specialists, undergone numerous tests, and tried different treatments. Communicating this information can be difficult, especially when appointments are short. Dr. Rasnow-Hill explains that clinicians also face challenges when reviewing complicated medical histories. She encourages patients to recognize that building a complete understanding of their health may take time. At the same time, clinicians should make reasonable efforts to understand patients' experiences and explain their recommendations. Clear communication can help both parties identify priorities and make informed decisions. Three Ways to Build a Better Relationship With Your Lyme Disease Doctor Toward the end of the interview, Rich asks Dr. Rasnow-Hill what patients can do before an appointment to help create a healthier therapeutic relationship. Her advice centers on three important principles. 1. Understand That Complex Chronic Illness Care Is a Process Dr. Rasnow-Hill encourages patients to approach a new medical relationship with realistic expectations. A physician meeting someone for the first time may need time to understand years of symptoms, testing, and previous treatment. She believes patients can benefit from viewing healthcare as an ongoing collaborative process rather than expecting every question to be answered during a single appointment. This does not mean accepting unnecessary delays or dismissive care. It means recognizing that complex medical evaluation often requires multiple steps. 2. Organize Your Medical History and Participate in Your Care Dr. Rasnow-Hill encourages patients to think of themselves as the central member of their healthcare team. When several physicians or specialists are involved, communication between offices may be incomplete. Keeping track of important medical information can help. Useful preparation may include: Maintaining a current medication and supplement list Organizing relevant laboratory results Keeping a timeline of major symptoms Documenting previous diagnoses and treatments Identifying the most important questions for the appointment Sharing changes in symptoms or treatment tolerance Dr. Rasnow-Hill recognizes that this can be a significant burden, especially for people experiencing fatigue, cognitive difficulties, or disability. Patients may benefit from assistance from caregivers, patient advocates, or care coordinators when available. 3. Don't Give Up If a Doctor Isn't the Right Fit Dr. Rasnow-Hill emphasizes that patients should not feel trapped in an ineffective therapeutic relationship. Sometimes communication styles do not align. Sometimes a physician lacks the expertise needed for a particular condition. And sometimes a patient simply does not feel heard. She encourages patients to continue seeking appropriate care rather than allowing one disappointing experience to discourage them. A second opinion or referral to another qualified specialist may provide additional perspective. The patient is the center of the healthcare team. Finding a clinician who respects that relationship matters. Why Patients and Doctors Both Need Empathy One of the interview's most meaningful messages is that compassion should extend in both directions. Patients may be frightened, exhausted, financially strained, or overwhelmed by their symptoms. Doctors may face demanding schedules, uncertainty, administrative pressures, and the emotional weight of caring for people they cannot always help as quickly as they would like. Dr. Rasnow-Hill believes recognizing these realities can create space for more honest conversations. She encourages patients to communicate openly while allowing relationships to develop over time. She also emphasizes the importance of finding clinicians who demonstrate humility, curiosity, and respect. Mutual empathy can strengthen a therapeutic relationship without minimizing the patient's needs or the physician's professional responsibilities. The Importance of Continuing Medical Education Dr. Rasnow-Hill's enthusiasm for attending ILADS reflects another central theme: medicine continues to evolve. No physician can know everything. Research advances, clinical evidence changes, and new questions emerge. Dr. Rasnow-Hill believes physicians should remain open to learning throughout their careers. She values opportunities to exchange ideas with colleagues and consider new research. For patients, this reinforces the importance of working with healthcare professionals who are willing to reassess their conclusions when new evidence becomes available. Explore more conversations with physicians through Tick Boot Camp's doctor interview collection. How to Work With Dr. Marina Rasnow-Hill Dr. Rasnow-Hill offers integrative medicine consultations through telehealth. Her professional profile lists availability in: California Washington Nevada Arizona Colorado Idaho Her areas of interest include chronic fatigue, chronic pain, immune health, gastrointestinal concerns, and complex chronic illness. For current availability, services, and appointment information, visit Dr. Marina Rasnow-Hill's Institute for Functional Medicine profile. Key Takeaways Dr. Marina Rasnow-Hill combines conventional and integrative medicine. Her background includes family medicine, medical acupuncture, and additional integrative training. Her own health challenges influenced her medical career. Personal experience encouraged her to explore additional approaches to complex illness. Lyme disease care can involve overlapping medical conditions. Careful assessment is essential when symptoms have multiple potential causes. Medical education cannot provide every answer. Physicians need continuing education, curiosity, and clinical humility. Patients deserve validation. Unexplained symptoms should not be dismissed simply because a diagnosis is difficult. Doctors can be confident without pretending to know everything. Honest communication supports trust. The doctor-patient relationship is a partnership. Collaboration and mutual respect can improve the healthcare experience. Preparing for appointments can help. Organized records, symptom histories, and questions support communication. Complex care often takes time. Building a therapeutic relationship may require more than one visit. Patients should remain active participants in their care. Understanding treatment options and communicating concerns are important. A poor medical encounter should not end the search for help. Seeking another qualified clinician or a second opinion may be appropriate. Empathy matters on both sides. Patients and physicians benefit from respectful, honest conversations. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Marina Rasnow-Hill, MD, a California-based physician specializing in integrative medicine. Rich and Dr. Rasnow-Hill explore the challenges of treating Lyme disease and complex chronic illness, the limitations of medical training, the role of integrative approaches, and the importance of building collaborative doctor-patient relationships. The discussion offers practical guidance for patients who want to improve communication with their physicians, organize their medical information, and advocate for appropriate care. Explore more interviews from the conference through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E619
    November 3 · 16 min

    Episode 619: Sequential Antibiotic Therapy for Chronic Lyme Disease – Dr. Louis Teulières | LIVE from ILADS

    Could changing how antibiotics are administered help address some of the biggest challenges in treating chronic and disseminated Lyme disease? What if the timing, combination, and delivery of antibiotics matter as much as the medications themselves? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Louis C. Teulières, MD, PhD, a French physician and Lyme disease researcher, to explore his approach to sequential antibiotic therapy, Borrelia persistence, biofilms, neurological Lyme disease, antibiotic combinations, and treatment-related inflammation. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation follows Dr. Teulières' presentation, Antibiotic Rotational Combination Sequential Therapies in Chronic and Disseminated Disease TBD. Dr. Teulières challenges conventional approaches to prolonged antibiotic treatment and explains why he believes carefully structured treatment sequences may offer advantages for selected patients with complex tick-borne illnesses. Rather than administering antibiotics continuously for extended periods, he describes a strategy involving shorter treatment windows, planned breaks, and carefully selected antibiotic combinations. He also discusses the importance of matching antibiotics to the tissues affected by infection, considering the blood-brain barrier in neurological Lyme disease, and addressing potential complications involving the gut microbiome, liver, and kidneys. Rich and Dr. Teulières explore three major questions: Can sequential antibiotic treatment help clinicians better evaluate treatment responses? Could planned treatment breaks reduce some of the burdens associated with prolonged antibiotic exposure? How might clinicians select antibiotic combinations based on bacterial behavior, tissue penetration, and patient symptoms? The central message is that Lyme disease treatment requires thoughtful clinical decision-making, individualized care, and an understanding of both the potential benefits and risks of antimicrobial therapy. The sequential antibiotic approach discussed in this interview represents Dr. Teulières' clinical perspective. Its effectiveness and safety compared with established Lyme disease treatment regimens have not been demonstrated in high-quality comparative clinical trials. Meet Dr. Louis C. Teulières, MD, PhD Dr. Louis C. Teulières, MD, PhD, is a French physician and researcher whose work includes infectious diseases, complex chronic illness, and approaches to treating Lyme and other tick-borne diseases. At the 2025 ILADS Conference, Dr. Teulières presented Antibiotic Rotational Combination Sequential Therapies in Chronic and Disseminated Disease TBD. His presentation explores the use of antibiotic combinations and sequential treatment strategies in patients with complex tick-borne illnesses. In this interview, he explains his clinical reasoning and discusses why he believes antibiotic timing, medication selection, and treatment intervals deserve greater attention. Dr. Teulières has been a returning guest on Tick Boot Camp, sharing his perspectives on Lyme disease treatment and the challenges of managing complex infections. What Is Sequential Antibiotic Therapy for Lyme Disease? One of the main topics of the interview is Dr. Teulières' proposed sequential antibiotic treatment strategy. He distinguishes this approach from three other methods of administering antibiotics: Continuous treatment: Antibiotics are administered without planned breaks for a prescribed period. Pulsed treatment: Antibiotics are administered intermittently according to a predetermined schedule. Rotational treatment: Different antibiotics are used in rotation. Sequential treatment: Dr. Teulières describes administering selected antibiotic combinations for a defined period, followed by a treatment break, with subsequent treatment decisions informed by the patient's response. During the interview, he discusses an example involving approximately 14 days of antibiotic therapy followed by a planned break of approximately 14 days. He explains that these intervals may allow clinicians to assess symptoms, review treatment tolerance, and adjust medication combinations. Dr. Teulières believes the strategy may also provide opportunities for supportive care between antibiotic courses. However, this specific schedule has not been established as an effective or safer treatment protocol for persistent Lyme disease through controlled clinical trials. Patients should never independently interrupt or modify prescribed antibiotic treatment. Why Dr. Teulières Questions Long-Term Continuous Antibiotics Dr. Teulières explains that he has concerns about prolonged, uninterrupted antibiotic exposure. He identifies several potential challenges: Antibiotic-associated adverse effects Disruption of the intestinal microbiome Selection of antibiotic-resistant organisms Difficulty identifying which medications are producing benefits Possible bacterial survival mechanisms Additional physical stress during treatment He believes these concerns warrant consideration of alternative dosing strategies. His proposed sequential approach is intended to create opportunities for reassessment rather than maintaining the same treatment continuously. The discussion highlights an important distinction between the established effectiveness of antibiotics for Lyme disease and ongoing debates about additional antimicrobial treatment for persistent symptoms after standard therapy. Borrelia Persistence: Round Bodies, Biofilms, and Tissue Survival Rich asks Dr. Teulières about the ability of Borrelia bacteria to survive under challenging conditions. Dr. Teulières describes several mechanisms that he believes may contribute to bacterial persistence. Round-Body Forms He explains that Borrelia can change its morphology under certain environmental conditions. These changes, sometimes described as round-body forms, have been observed in laboratory research. Dr. Teulières believes such changes may influence bacterial susceptibility to antimicrobial treatment. Biofilms Dr. Teulières also discusses biofilms, which are structured communities of microorganisms surrounded by protective material. Biofilms can influence how certain microorganisms respond to environmental conditions and antimicrobial exposure. He raises the possibility that biofilm-related mechanisms could complicate treatment in some patients. Tissue Localization The interview explores whether bacteria occupying certain tissues may be less accessible to particular medications. Dr. Teulières emphasizes that antibiotic selection should account for where an infection is located. Although Borrelia morphology, biofilm formation, and persister states are active research topics, their role in persistent human Lyme disease symptoms remains incompletely understood. Laboratory findings do not establish that these mechanisms explain every case of persistent symptoms or that sequential antibiotic treatment overcomes them in patients. Antibiotic Resistance vs. Bacterial Persistence Dr. Teulières discusses the possibility that prolonged antibiotic exposure may contribute to the selection of resistant organisms. He also describes bacterial forms that may survive exposure through mechanisms distinct from conventional antibiotic resistance. These concepts are related but not identical. Antibiotic resistance involves mechanisms that allow bacteria to withstand antimicrobial activity. Antibiotic tolerance or persistence can involve survival during treatment without conventional inherited resistance. Dr. Teulières believes understanding these differences may help clinicians develop more targeted approaches. The clinical significance of proposed Borrelia persister forms remains an area of investigation, and the interview does not establish that sequential therapy prevents antibiotic resistance. Why Dr. Teulières Recommends Treatment Breaks A central feature of Dr. Teulières' proposed strategy is incorporating planned intervals between antibiotic courses. He identifies three potential advantages. 1. Allowing Time for Recovery Dr. Teulières believes treatment breaks may allow patients to recover from some medication-related burdens. He discusses the liver and kidneys, which play essential roles in processing and eliminating many medications and their metabolites. He also describes the potential importance of reducing treatment-related discomfort. 2. Evaluating Treatment Response Dr. Teulières believes a defined treatment period followed by observation may help clinicians determine whether a particular antibiotic combination is producing meaningful changes. He suggests monitoring whether symptoms improve, remain unchanged, or return during a treatment break. 3. Adjusting Antibiotic Combinations Sequential treatment may also provide opportunities to reassess the medications being used. Dr. Teulières proposes adjusting combinations based on the patient's symptoms, suspected infections, and clinical response. These are the potential advantages he describes, not benefits established through comparative clinical trials. Scheduled antibiotic breaks have not been proven to provide a specific detoxification benefit or prevent organ injury. What Happens When Antibiotics Kill Bacteria? Rich asks Dr. Teulières why some patients experience increased symptoms during antimicrobial treatment. Dr. Teulières describes how bacterial components can stimulate inflammatory responses as organisms are affected by treatment. He discusses microbial debris and inflammatory molecules that may contribute to discomfort. The conversation connects this process to concerns about treatment-related inflammation. However, symptom worsening during Lyme disease treatment is not automatically evidence of bacterial die-off. Medication reactions, allergic responses, unrelated illnesses, and other complications can produce similar symptoms. A true Jarisch-Herxheimer reaction is a recognized acute inflammatory response associated with treatment of certain infections, including some spirochetal diseases. Severe or persistent symptoms during treatment require medical evaluation rather than an assumption that the medication is working. Bacteriostatic vs. Bactericidal Antibiotics Dr. Teulières explains why he considers the mechanisms of different antibiotics when selecting treatment combinations. Bacteriostatic Antibiotics Bacteriostatic antibiotics primarily inhibit bacterial growth under particular conditions. Some interfere with bacterial protein synthesis. Dr. Teulières discusses azithromycin as an example. Bactericidal Antibiotics Bactericidal antibiotics kill susceptible bacteria under particular conditions. Different medications accomplish this through different mechanisms, including disruption of bacterial cell wall synthesis. Dr. Teulières discusses ceftriaxone as an example. Why Combine Both Types? Dr. Teulières proposes combining selected bacteriostatic and bactericidal medications. He believes that targeting bacteria through different mechanisms may improve treatment effectiveness in certain circumstances. He discusses combinations such as azithromycin and ceftriaxone to illustrate his approach. However, combining these antibiotic categories does not automatically improve clinical outcomes. Some combinations may introduce additional adverse effects or drug interactions, and certain combinations can interfere with one another. Antibiotic selection must be based on the specific infection, patient characteristics, and available evidence. Selecting Antibiotics Based on Tissue Penetration Another important concept in the interview is the distribution of antibiotics throughout the body. Dr. Teulières emphasizes that different medications reach different tissues at different concentrations. He discusses selecting antibiotics according to the location of suspected infection. Relevant considerations may include: Skin and connective tissue involvement Joint manifestations Neurological symptoms Central nervous system infection The presence of other diagnosed infections Medication absorption and distribution Patient-specific contraindications Dr. Teulières believes these factors are especially important in patients with complex or disseminated disease. The broader medical principle is that treatment selection should account for both the organism being treated and the anatomical site of infection. Neurological Lyme Disease and the Blood-Brain Barrier Rich and Dr. Teulières discuss how treatment decisions may differ when Lyme disease affects the nervous system. Dr. Teulières emphasizes the importance of selecting antibiotics capable of reaching the relevant site of infection. He identifies several antibiotic families and discusses their potential tissue penetration. The blood-brain barrier helps regulate which substances enter the central nervous system. Certain medications penetrate this barrier more effectively than others, depending on factors such as drug properties and inflammation. However, neurological symptoms alone do not establish central nervous system infection. Similarly, the ability of a medication to penetrate the blood-brain barrier does not automatically make it effective or appropriate for Lyme neuroborreliosis. Treatment depends on the specific neurological manifestation and clinical evaluation. For additional education, listen to Tick Boot Camp's interview with Dr. Medeya Tsnobiladze on the neurological and cardiovascular impacts of Lyme disease. Oral vs. Intravenous vs. Intramuscular Antibiotics Dr. Teulières discusses the advantages and limitations of different antibiotic administration routes. Oral antibiotics are taken by mouth and absorbed through the gastrointestinal tract. Intravenous antibiotics are delivered directly into a vein. Intramuscular antibiotics are administered through injection into muscle tissue. He explains that his proposed treatment strategy may involve different administration routes depending on the patient's symptoms and clinical circumstances. Dr. Teulières expresses concern about the gastrointestinal effects of prolonged oral antibiotic use. He also discusses considering injectable medications for certain neurological presentations. However, intravenous or intramuscular antibiotics are not inherently more effective than oral medications. For many manifestations of Lyme disease, appropriately selected oral antibiotics are effective. Injectable therapies can introduce additional risks, including line infections, blood clots, and administration complications. Protecting the Gut Microbiome During Lyme Disease Treatment Dr. Teulières emphasizes the importance of considering intestinal microbiome health during antibiotic treatment. The gut microbiome contains diverse microorganisms that contribute to digestion, metabolism, and other biological processes. Antibiotics can disrupt these microbial communities. Potential consequences may include gastrointestinal symptoms and antibiotic-associated infections. Dr. Teulières believes his proposed treatment breaks may provide opportunities for the microbiome to recover. However, evidence has not established that his sequential approach reliably prevents microbiome disruption. The effects of antibiotics depend on the specific medication, duration, dose, and patient. Treating Lyme Disease and Co-Infections The conversation also addresses the possibility of multiple infections contributing to complex illness. Dr. Teulières explains that clinicians may need to consider bacterial, parasitic, or viral conditions when evaluating patients. He believes sequential treatment strategies could provide opportunities to address different diagnosed infections at different times. However, the presence of Lyme disease does not automatically establish additional infections. Each suspected infection requires appropriate evaluation. Treatment choices should be based on clinical findings and reliable diagnostic information rather than assuming that every symptom represents an additional pathogen. Can Antibiotics Have Antiviral Effects? Dr. Teulières briefly discusses research into possible antiviral effects of certain antibiotic classes. He specifically mentions macrolides. Some antibiotics have demonstrated antiviral or immunomodulatory activity in laboratory settings. However, these findings do not establish that antibiotics are effective clinical treatments for viral infections. Antibiotics should not be used to treat viral illnesses without a specific evidence-supported indication. This portion of the interview reflects an area of scientific interest rather than a validated treatment recommendation. Intravenous Immunoglobulin and Complex Chronic Illness Dr. Teulières also discusses the possibility of using intravenous immunoglobulin, or IVIG, alongside other treatments in selected patients. IVIG is made from pooled antibodies collected from donated human plasma. It is used for certain immune deficiencies, autoimmune conditions, and neurological disorders. Dr. Teulières describes how intravenous treatment may allow clinicians to coordinate different therapies when medically appropriate. However, IVIG is not a routine or established treatment for Lyme disease itself. Its use requires a specific medical indication and careful consideration of risks. Sequential Antibiotics and the Rehabilitation Process Toward the end of the interview, Rich connects Dr. Teulières' approach to Tick Boot Camp's broader observations about chronic illness recovery. Rich emphasizes that the goal of treatment should not be limited to reducing an infectious burden. Patients may also need to recover from the physical and emotional consequences of prolonged illness. He discusses how aggressive interventions can create additional challenges if they produce significant adverse effects or functional setbacks. Dr. Teulières agrees that treatment should be used carefully and thoughtfully. Their conversation reinforces the importance of balancing medical treatment with patient safety, tolerability, and quality of life. How Does Dr. Teulières' Approach Compare With Lyme Disease Guidelines? Sequential antibiotic therapy, combination regimens, and treatment strategies for persistent symptoms remain subjects of debate and research. The specific sequential approach described by Dr. Teulières has not been established as superior to guideline-supported Lyme disease treatment through high-quality comparative clinical trials. Professional organizations also differ in their recommendations for managing persistent symptoms following Lyme disease treatment. ILADS treatment guidelines emphasize individualized clinical judgment and shared decision-making. Other guidelines recommend against additional antibiotics for persistent nonspecific symptoms when there is no objective evidence of reinfection or treatment failure. These differences underscore the need for continued research into persistent symptoms, treatment effectiveness, and long-term patient outcomes. Learn More About Dr. Louis Teulières' ILADS Presentation Dr. Teulières presented Antibiotic Rotational Combination Sequential Therapies in Chronic and Disseminated Disease TBD at the 2025 ILADS Conference. His presentation explores the rationale for sequential antibiotic strategies and combination treatment approaches in complex tick-borne disease. The interview offers a conversational overview of his clinical thinking, including how he approaches medication selection, treatment timing, and patient response. For additional conference interviews, visit Tick Boot Camp's LIVE from ILADS podcast series. Key Takeaways Dr. Louis Teulières proposes a sequential antibiotic strategy. His approach involves defined treatment periods followed by planned breaks. He questions prolonged, uninterrupted antibiotic exposure. His concerns include adverse effects, microbiome disruption, and antibiotic resistance. Borrelia persistence is a central research topic. He discusses round-body forms, biofilms, and tissue localization. Antibiotics have different mechanisms of action. Dr. Teulières describes combining bacteriostatic and bactericidal medications. Tissue penetration influences treatment selection. The anatomical site of infection matters when choosing an antibiotic. Neurological Lyme disease requires careful evaluation. Blood-brain barrier penetration is one consideration, but not the only factor. Oral and injectable antibiotics have different benefits and risks. The route of administration should be chosen based on clinical need. Gut microbiome health matters. Antibiotic exposure can affect intestinal microbial communities. Treatment breaks are not proven detoxification methods. Their proposed benefits require further research. Co-infections require individual assessment. Different pathogens may require different treatment approaches. Rehabilitation is an important consideration. Managing adverse effects and restoring function are relevant to overall recovery. More research is needed. The safety and effectiveness of Dr. Teulières' sequential regimen have not been established through high-quality comparative clinical trials. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this interview features Dr. Louis C. Teulières, MD, PhD, a French physician and researcher discussing his presentation on sequential antibiotic therapy. Rich and Dr. Teulières explore the challenges of treating complex Lyme disease, including bacterial persistence, antibiotic combinations, tissue penetration, neurological involvement, and the potential advantages and limitations of alternating treatment periods with breaks. The conversation provides insight into Dr. Teulières' clinical approach and raises important questions about how Lyme disease treatment strategies might be evaluated and improved. Explore more physician interviews and conference conversations through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E618
    November 2 · 20 min

    Episode 618: Are Lyme Herxheimer Reactions Necessary for Healing? Dr. Casey Kelley | LIVE from ILADS

    Do you have to feel worse before you get better from Lyme disease? And could pushing through severe Herxheimer reactions actually make recovery more difficult? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich reunites with Dr. Casey Kelley, MD, a functional medicine physician, Lyme disease survivor, and founder of Case Integrative Health in the Chicago area, for an important conversation about Jarisch-Herxheimer reactions, Lyme disease treatment, inflammation, neuroplasticity, and the physical and emotional rehabilitation involved in chronic illness recovery. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the discussion explores one of the most debated questions in the Lyme disease community: Is a Herxheimer reaction a necessary sign that treatment is working, or can excessive inflammation interfere with healing? Dr. Kelley draws on her experience as both a physician and former Lyme disease patient to explain what a Herxheimer reaction is, why symptoms may temporarily worsen during treatment, and why she believes aggressive treatment should not come at the expense of a patient's ability to function. Rich also introduces Tick Boot Camp's PARM healing framework: Prehabilitation, Assist, Rehabilitate, and Maintenance, which reflects patterns observed through hundreds of patient interviews. Together, they explore why recovery is rarely linear, why patients need individualized treatment plans, and how nervous system regulation and neuroplasticity may play a role in rehabilitation. The conversation also celebrates an encouraging milestone: Dr. Kelley is expanding Case Integrative Health to improve patient access to care. Meet Dr. Casey Kelley, MD Dr. Casey Kelley, MD, is a functional medicine physician and founder of Case Integrative Health, a Chicago-area practice focused on complex chronic illnesses. Her clinical interests include Lyme disease and associated infections, immune dysfunction, inflammation, and integrative approaches to patient care. Dr. Kelley also brings personal experience to her work. As a former Lyme disease patient, she understands what it feels like to experience debilitating symptoms while appearing outwardly healthy. During the interview, she recalls living with postural orthostatic tachycardia syndrome (POTS), which made standing and everyday activities difficult. Her recovery journey helped shape her approach to individualized treatment and rehabilitation. Dr. Kelley has appeared on Tick Boot Camp multiple times, sharing her experiences and insights into chronic illness recovery. Case Integrative Health Is Expanding Rich begins by congratulating Dr. Kelley on the growth of her medical practice. At the time of the interview, Case Integrative Health had two locations, with plans to open a third. Dr. Kelley explains that the expansion is primarily about improving access to care. Her practice offers intravenous therapies, which may require patients to attend appointments regularly. In the Chicago area, traffic and travel distances can make frequent visits challenging, especially for people experiencing significant fatigue or other chronic symptoms. She hopes additional locations will reduce some of those barriers. The conversation highlights an important issue for people with chronic illness: treatment access involves more than finding a healthcare provider. Transportation, physical limitations, appointment frequency, and financial resources can all affect a patient's ability to receive care. What Is a Jarisch-Herxheimer Reaction? One of the main topics of the interview is the Jarisch-Herxheimer reaction, commonly called a Herx. Dr. Kelley explains that the reaction was originally described in patients receiving treatment for syphilis, another infection caused by spirochete bacteria. A Jarisch-Herxheimer reaction is an acute inflammatory response that can occur after antimicrobial treatment for certain bacterial infections. In Lyme disease, it may involve a temporary worsening of symptoms after antibiotics are started. Dr. Kelley describes patients experiencing: Increased fatigue Worsening pain Flu-like symptoms Generalized discomfort A feeling resembling a severe hangover Temporary worsening of existing symptoms She explains that these reactions can vary considerably between individuals. Some people experience relatively mild discomfort, while others report more significant symptoms. Importantly, not every symptom flare during treatment is a Jarisch-Herxheimer reaction. Medication side effects, allergic reactions, disease progression, and other medical complications can also cause worsening symptoms. Is Herxing a Good Sign That Lyme Treatment Is Working? Rich asks Dr. Kelley about a common belief in the Lyme disease community: that experiencing a strong Herxheimer reaction means treatment is successfully eliminating an infection. Some patients believe they need to push through increasingly severe symptoms to make progress. Dr. Kelley challenges that assumption. She explains that although inflammatory reactions can occur during treatment, more intense symptoms do not necessarily mean better outcomes. In her clinical approach, the goal is not to make patients as uncomfortable as possible. Instead, she tries to balance treatment with the patient's ability to tolerate it. A severe Herxheimer reaction is not required for successful Lyme disease treatment, and the intensity of a reaction is not a reliable measure of treatment effectiveness. Dr. Kelley emphasizes that treatment should be individualized and that patients should communicate significant symptom changes to their healthcare professionals. Can You Recover From Lyme Disease Without Herxing? Dr. Kelley describes patients who improve without experiencing noticeable Herxheimer reactions. She acknowledges that some people become concerned when treatment does not cause an obvious symptom flare. They may wonder whether their medication is working or whether they need a more aggressive approach. Dr. Kelley explains that she has seen patients make progress without experiencing significant treatment-related worsening. Her message is encouraging for patients who fear they must endure severe discomfort to recover. Not experiencing a Herxheimer reaction does not mean treatment is failing. Likewise, experiencing a reaction does not establish that a treatment is effective. Treatment response should be evaluated through appropriate clinical assessment rather than symptom worsening alone. How Much Herxing Is Too Much? Rich asks Dr. Kelley where she draws the line between manageable treatment-related discomfort and symptoms that warrant changing the treatment plan. Dr. Kelley explains that she becomes concerned when patients experience severe functional limitations. Examples include being unable to get out of bed, care for children, complete essential activities, or think clearly. She believes prolonged, debilitating symptom flares should prompt reassessment rather than automatic encouragement to push harder. In the interview, Dr. Kelley discusses supportive approaches used in her practice, including measures intended to address discomfort and inflammation. However, supplements, detoxification products, and other supportive therapies should not be assumed to prevent or treat a true Jarisch-Herxheimer reaction. Severe, persistent, or unexpected symptoms during treatment require medical evaluation. Patients should not independently stop, increase, or reduce prescribed medications without appropriate clinical guidance. Why More Aggressive Treatment Is Not Always Better Dr. Kelley explains that patients differ significantly in their tolerance of medications and other interventions. Some patients can tolerate complex treatment regimens. Others experience substantial symptoms or adverse effects from relatively small changes. She emphasizes that treatment decisions should account for the individual patient's medical history, symptoms, functional status, and response. Rich asks whether reducing treatment intensity might slow the process of addressing an infection. Dr. Kelley suggests that treatment intensity and overall recovery are not always the same thing. Her concern is that excessive symptom burden may create additional challenges that patients must overcome during rehabilitation. The broader takeaway is that successful care requires balancing effectiveness, safety, and tolerability. Patients should not interpret worsening symptoms as a reason to continue an intervention without reassessment. Why Dr. Kelley's Personal Lyme Disease Experience Matters Rich asks whether physicians who have personally experienced Lyme disease bring a different perspective to patient care. Dr. Kelley believes lived experience can deepen a clinician's empathy and understanding. She recalls struggling to sit upright, think clearly, and complete ordinary activities while appearing healthy to others. Those experiences helped her understand how difficult invisible illnesses can be. However, she also emphasizes that physicians do not need to have experienced a particular disease to treat it effectively. She believes the most important qualities include clinical knowledge, compassion, careful observation, and the ability to tailor care to each patient. Her perspective highlights the value of combining medical expertise with genuine understanding of the patient's experience. Why Lyme Disease Recovery Is Not Linear Rich and Dr. Kelley discuss how recovery from prolonged illness often involves periods of progress followed by setbacks. Some patients improve steadily. Others experience fluctuating symptoms, changing functional abilities, or periods when additional medical evaluation is needed. Dr. Kelley explains that these experiences can be especially frustrating when patients expect recovery to follow a predictable timeline. She encourages recognizing progress even when it occurs gradually. The discussion also emphasizes that patients may need different forms of support at different stages of their journey. Medical treatment, physical rehabilitation, psychological support, and ongoing prevention can all have roles depending on the individual's circumstances. Introducing Tick Boot Camp's PARM Healing Framework Rich introduces a framework developed from patterns observed through Tick Boot Camp's extensive patient interviews. The framework is called PARM, representing four interconnected stages of recovery. P — Prehabilitation Prehabilitation involves preparing and supporting the patient before or alongside more intensive treatment. Depending on the person's medical needs, this may include addressing nutritional concerns, sleep disturbances, physical limitations, or other health conditions. The goal is to improve readiness and tolerance for appropriate medical care. A — Assist Rich uses the term Assist to emphasize supporting the body's response to illness rather than viewing treatment exclusively as a battle against microbes. For infections requiring antimicrobial therapy, appropriate medications remain essential. Other supportive interventions may help address symptoms or coexisting health concerns. R — Rehabilitate Rehabilitation involves addressing functional limitations that may remain during or after treatment. This can include physical conditioning when medically appropriate, occupational rehabilitation, and support for cognitive or emotional challenges. For some patients, rehabilitation may require a gradual, individualized approach. M — Maintenance Maintenance focuses on sustaining improvements, managing ongoing health needs, and reducing preventable risks. For Lyme disease, this includes continued tick bite prevention and prompt evaluation of possible reinfection. Rich emphasizes that the framework is not necessarily linear. Patients may need to revisit different aspects of care as their circumstances change. PARM is Tick Boot Camp's observational framework, not a clinically validated Lyme disease treatment protocol. Celebrating Recovery: Dr. Kelley's Disco Balls Dr. Kelley shares a tradition from her medical practice. Her team refers to patients who have made meaningful progress in rehabilitation as disco balls. The name reflects their desire to celebrate recovery milestones. Dr. Kelley explains that working with complex chronic illness can be emotionally demanding for patients and healthcare professionals alike. Recognizing meaningful improvements helps reinforce hope and acknowledges the work patients have invested in their recovery. For someone who has spent years struggling with basic activities, being able to walk, exercise, work, or participate in family life can represent an extraordinary achievement. Dr. Kelley believes these milestones deserve celebration. Recovering From POTS: Learning to Trust the Body Again Dr. Kelley shares a personal example from her experience with POTS. At one point, standing was frightening because she feared fainting and injuring herself. Even after her physical condition improved, she needed time to regain confidence in activities that had previously felt unsafe. She describes gradually becoming more comfortable standing, walking, and eventually returning to exercise. Her experience illustrates how recovery from a prolonged medical condition can involve both physical and emotional adjustment. The fear of symptoms returning may persist even after substantial improvement. For patients with POTS or other conditions involving exercise intolerance, rehabilitation must be adapted to their medical status and should not involve pushing through unsafe symptoms. Fear of Relapse After Lyme Disease Rich discusses another challenge that can arise after significant recovery: the fear of becoming seriously ill again. He shares Tick Boot Camp co-founder Matt Sabatello's experience of progressing from long-distance running to being bedbound during his Lyme disease journey. After a prolonged period of illness, Matt gradually regained significant physical function and returned to running. Rich celebrates that progress while acknowledging that the fear of relapse can remain. The discussion highlights an important reality for people recovering from chronic illness. Regaining physical abilities does not automatically eliminate the emotional impact of having lost them. Dr. Kelley recognizes that rebuilding confidence may take time. Supportive rehabilitation can help patients gradually resume activities when medically appropriate. Neuroplasticity and Brain Retraining During Rehabilitation Rich asks Dr. Kelley about the role of neuroplasticity in recovery. Neuroplasticity refers to the nervous system's ability to adapt and change through experience, learning, and repeated activity. Dr. Kelley discusses how prolonged pain, illness, and stressful experiences may influence patterns of attention, fear, and symptom perception. She believes some patients may benefit from learning to respond differently to certain sensations and situations. Rich and Dr. Kelley emphasize that these experiences do not mean symptoms are imaginary. Pain and other symptoms are real, even when nervous system processes influence how they are experienced. Research supports certain psychologically informed approaches for managing chronic pain and related functional difficulties. However, brain retraining is not an established cure for Lyme disease, persistent infection, POTS, or all symptoms following treatment. Its potential role should be evaluated alongside appropriate medical assessment and individualized care. For related conversations, explore Tick Boot Camp's interview with Ben Ahrens about neuroplasticity. Why Medical Validation Matters When Discussing Brain Retraining Dr. Kelley acknowledges that conversations about the brain and nervous system can be difficult for people who have experienced medical dismissal. Many patients have previously been told that their symptoms are psychological or that nothing is physically wrong. As a result, suggestions involving brain retraining may feel invalidating. Dr. Kelley makes an important distinction. She recognizes that patients can experience genuine physiological illness while also benefiting from strategies that address pain processing, fear, stress responses, or functional limitations. These approaches are not mutually exclusive. A patient can need medical treatment for a physical condition and also benefit from supportive rehabilitation. The key is ensuring that brain-based interventions are not used to dismiss symptoms or discourage further medical investigation when appropriate. Finding Purpose After Chronic Illness Rich and Dr. Kelley also discuss how difficult health experiences can change a person's perspective on life. For some patients, recovery creates opportunities to reconsider priorities, relationships, and personal goals. Rich reflects on how the Lyme disease journey has influenced Tick Boot Camp's advocacy mission. Dr. Kelley's experience similarly shaped her decision to help others navigating complex illnesses. They acknowledge that finding meaning can be an important part of some people's recovery stories. However, patients should not feel obligated to discover a greater purpose in their suffering. Everyone deserves compassionate care regardless of how they interpret their illness. How to Learn More About Dr. Casey Kelley Dr. Kelley is the founder of Case Integrative Health, serving patients in the Chicago area. Her practice focuses on functional and integrative approaches to complex chronic illness. During the interview, she discusses the practice's expansion and its efforts to improve access to services for patients who may struggle with frequent travel. Visit Case Integrative Health for information about the medical team, available services, locations, and appointments. Key Takeaways A Herxheimer reaction is an inflammatory response associated with treatment of certain infections. It can cause temporary worsening of symptoms. Herxing is not required for recovery. Patients can improve without experiencing a noticeable Jarisch-Herxheimer reaction. More severe symptoms do not prove treatment is more effective. Significant or prolonged worsening should prompt medical reassessment. Treatment must be individualized. Patients differ in medical history, medication tolerance, symptoms, and rehabilitation needs. Dr. Kelley's lived experience informs her care. Her history with Lyme disease and POTS gives her personal insight into invisible illness. Recovery may involve several overlapping stages. Tick Boot Camp's PARM framework describes prehabilitation, assistance, rehabilitation, and maintenance. Physical rehabilitation can be important. Regaining strength, mobility, and confidence may take time. The fear of relapse can persist after improvement. Emotional recovery may require support alongside physical rehabilitation. Neuroplasticity may contribute to symptom management. Evidence varies by condition, and brain retraining should not replace medical treatment. Progress deserves celebration. Dr. Kelley's disco ball tradition recognizes meaningful patient recovery milestones. Hope and realistic expectations can coexist. Improvement is possible, but recovery pathways differ and no treatment guarantees a particular outcome. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Casey Kelley, MD, founder of Case Integrative Health and a returning Tick Boot Camp guest. Rich and Dr. Kelley discuss Jarisch-Herxheimer reactions, the risks of overly aggressive treatment, individualized Lyme disease care, rehabilitation, neuroplasticity, and the importance of celebrating recovery milestones. The interview also introduces Tick Boot Camp's PARM framework and explores why healing from prolonged illness may involve much more than addressing an infection alone. Discover additional physician interviews and conference conversations through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E617
    November 1 · 20 min

    Episode 617: Healing Chronic Lyme: Mind-Body Connection & Nervous System Regulation – Dr. Jacey Goddard | LIVE from ILADS

    What if healing from chronic Lyme disease involves more than treating infections—and includes learning how to reconnect with your body, regulate your nervous system, and support your natural capacity for recovery? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Dr. Jacey Goddard, DO, a triple board-certified osteopathic physician from Maine, to explore the connection between Lyme disease, nervous system dysregulation, chronic pain, medical trauma, mind-body healing, and neuroplasticity. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, this conversation challenges the idea that recovering from complex chronic illness is simply about finding the next medication, supplement, or treatment protocol. Dr. Goddard shares how her own difficult health journey shaped her approach to medicine and inspired her to help patients develop a healthier relationship with their bodies. She explains why people living with Lyme disease, fibromyalgia, POTS, migraines, post-COVID conditions, and other complex illnesses may benefit from addressing nervous system regulation alongside appropriate medical care. Rich and Dr. Goddard also discuss the sympathetic and parasympathetic nervous systems, the influence of chronic stress, the importance of emotional and physical connection, and why no two patients should be expected to follow identical healing journeys. Throughout the conversation, Dr. Goddard emphasizes a message of hope: Even when an illness is complicated and answers are difficult to find, there may still be meaningful ways to support healing and improve quality of life. Meet Dr. Jacey Goddard, DO Dr. Jacey E. Goddard, DO is a triple board-certified osteopathic physician practicing in Topsham, Maine. Her medical training includes board certification in: Family Medicine Integrative Medicine Neuromusculoskeletal Medicine and Osteopathic Manipulative Medicine Dr. Goddard practices at RiverTree Osteopathic Health, where she focuses on hands-on osteopathic treatment and individualized approaches to complex health conditions. Her patients include people experiencing: Lyme disease and other tick-borne illnesses Fibromyalgia Chronic migraines Persistent pain Postural orthostatic tachycardia syndrome (POTS) Post-COVID symptoms Other difficult-to-treat conditions Dr. Goddard combines her medical training with an interest in the relationship between physical health, emotional well-being, and nervous system function. She is also the creator of The Art & Science of Healing from Within, an educational program focused on reconnecting with the body and developing practical mind-body awareness skills. When Even a Doctor Is Told There's Nothing More to Do Dr. Goddard begins by sharing that her interest in complex chronic illness is deeply personal. She has experienced her own prolonged health challenges and understands the frustration of seeking answers when medical professionals cannot explain what is happening. Despite being a physician herself, she encountered responses suggesting that her symptoms were psychological or that nothing more could be done. Those experiences influenced how she now approaches patients. She recognizes that people living with chronic illness may already have spent years searching for explanations, undergoing treatments, and trying to regain their health. Being told there are no additional options can be especially discouraging. Dr. Goddard believes clinicians should remain curious, compassionate, and open to helping patients improve their well-being, even when a condition is not fully understood. Her experience reinforces an important message for the Lyme disease community: A patient deserves to be heard and supported even when the answers are incomplete. Lyme Disease in Maine: Borrelia, Bartonella, and Babesia Rich asks Dr. Goddard about the prevalence of tick-borne diseases in Maine. She describes tick exposure as a significant concern and recalls particularly high tick activity during the preceding spring. Their conversation turns to three pathogen groups frequently discussed in the Lyme disease community: Borrelia: Bacteria associated with Lyme disease and certain relapsing fever illnesses. Bartonella: Bacteria responsible for several different infectious diseases, including cat-scratch disease. Babesia: Tick-borne parasites that infect red blood cells and can cause babesiosis. Rich explains that Tick Boot Camp has interviewed an increasing number of patients who report diagnoses involving multiple infections. He asks whether this reflects changes in tick populations, greater awareness, better diagnostic testing, or improvements in clinical recognition. Dr. Goddard believes several factors may contribute. She also emphasizes that patients often experience multiple overlapping health challenges. Although co-infections can occur, not every person with Lyme disease has Bartonella or Babesia, and the frequency of co-infections varies by region and exposure history. What Is Terrain Theory, and How Does It Relate to Lyme Disease? One of the central themes of the interview is Dr. Goddard's interest in what she calls terrain theory. She uses the term to describe the factors that may influence a person's vulnerability to illness and capacity to recover. Rather than focusing exclusively on an infectious organism, she encourages patients and clinicians to consider the broader conditions affecting health. These may include: Sleep and recovery Chronic stress Nervous system regulation Environmental exposures Nutrition and general health Previous trauma Existing medical conditions Individual physiological differences Dr. Goddard explains that some patients report becoming more symptomatic during periods of significant physical or emotional stress. She believes that understanding these patterns can help patients identify areas where additional support may be beneficial. This perspective does not mean that stress causes Lyme disease or that improving lifestyle factors can eliminate an established infection. Lyme disease is caused by infection with Borrelia bacteria. Supportive care may complement appropriate diagnosis and treatment but does not replace it. Understanding Threat, Vulnerability, and Chronic Illness Rich introduces an analogy from retired U.S. General Stanley McChrystal's book Risk. He describes risk as the interaction between a threat and a person's vulnerability. Applied to tick-borne illness, the threat might involve exposure to an infected tick. Vulnerability could involve individual health circumstances or other factors influencing the body's response. Rich connects this framework to Dr. Goddard's discussion of terrain. They explore how environmental changes, expanding tick activity, and wildlife populations may influence opportunities for exposure. Dr. Goddard then shifts the conversation toward the aspects of health that people may be able to support in their everyday lives. Her goal is to help patients recognize that while they cannot control every exposure or medical outcome, they may still have opportunities to improve their comfort, coping skills, and overall well-being. Nervous System Dysregulation and Chronic Lyme Disease Dr. Goddard discusses how chronic illness can affect a person's relationship with their body. People experiencing persistent symptoms may become highly attentive to pain, fatigue, dizziness, or other physical sensations. Over time, illness-related stress can contribute to patterns of heightened vigilance and difficulty relaxing. Rich introduces the sympathetic and parasympathetic branches of the autonomic nervous system. The sympathetic nervous system helps coordinate responses to stress and perceived threats. The parasympathetic nervous system supports functions such as digestion, recovery, and aspects of rest. Both systems are essential, and healthy regulation involves flexibility rather than remaining permanently in one state. Dr. Goddard believes learning to recognize and respond to nervous system patterns can help some patients manage symptoms and improve their daily functioning. However, nervous system dysregulation is not an established explanation for every symptom of Lyme disease, and nervous system exercises cannot substitute for treating an active infection. Are We Becoming Disconnected From Our Bodies? Dr. Goddard argues that modern life often encourages people to remain constantly busy and focused on external expectations. Work, technology, social obligations, and everyday responsibilities can make it difficult to recognize physical and emotional needs. She describes how people may become disconnected from their own internal experiences. Rather than noticing fatigue and responding with appropriate rest, someone may continue pushing through demanding schedules. Rather than recognizing stress, they may become accustomed to living in a heightened state of tension. Dr. Goddard believes reconnecting with the body begins with developing awareness of these patterns. She encourages people to approach their bodies with curiosity and compassion instead of frustration or fear. Her message is not that patients have created their illnesses through their behavior. Instead, she believes that learning to respond more supportively to the body may be valuable during recovery. Your Body Is Not Your Enemy One of Dr. Goddard's most memorable messages is that the body should be treated as an ally rather than an enemy. She recognizes that people living with chronic pain or unpredictable symptoms can develop a difficult relationship with their bodies. When symptoms repeatedly interfere with daily life, it is understandable to feel frustrated, frightened, or discouraged. Dr. Goddard encourages a different approach. Instead of interpreting every sensation as a battle against the body, she suggests asking what support might be helpful in that moment. That might involve rest, medical attention, adjusting an activity, practicing a calming exercise, or recognizing a physical limitation. She believes that developing a more compassionate relationship with the body can help reduce some of the emotional distress associated with chronic illness. This approach does not require patients to ignore symptoms or assume that positive thinking will resolve a medical condition. Mind-Body-Spirit Healing: Treating the Whole Person Rich and Dr. Goddard explore the relationship between physical, emotional, mental, and spiritual well-being. Rich questions whether dividing human experience into separate categories sometimes prevents people from understanding how closely these aspects of life interact. Dr. Goddard agrees that health involves interconnected processes. She emphasizes that thoughts, emotions, physical sensations, and nervous system activity influence one another. For example, persistent pain can affect mood and sleep. Poor sleep may worsen pain sensitivity or emotional distress. Stress can influence breathing patterns, muscle tension, and other physiological responses. These relationships are real, but they do not mean that every physical symptom originates in thoughts or emotions. Dr. Goddard's broader message is that comprehensive care should recognize the whole person. Mindfulness or Bodyfulness? Learning to Be Present Dr. Goddard introduces an interesting alternative to conventional discussions of mindfulness. She suggests that some people might benefit from thinking about bodyfulness. Rather than focusing exclusively on thoughts, her approach encourages awareness of physical sensations and the experience of being present in the body. She describes simple practices such as: Pausing briefly during the day Noticing physical sensations without immediately judging them Becoming aware of breathing Recognizing signs of tension or fatigue Allowing moments of physical comfort Responding to personal needs with patience Dr. Goddard emphasizes that these practices do not require elaborate equipment or lengthy meditation sessions. She believes small moments of awareness, repeated throughout daily life, can help people develop more supportive habits. For patients with trauma histories or conditions that make body awareness uncomfortable, these practices may need to be adapted with professional guidance. Neuroplasticity: Can We Change Our Patterns? Rich and Dr. Goddard discuss the concept of neuroplasticity, the nervous system's capacity to change through experience and learning. Dr. Goddard believes that repeated patterns of attention, behavior, and emotional response can influence how people experience and respond to their bodies. She describes working with patients who have experienced panic attacks, palpitations, chronic pain, and post-traumatic stress symptoms. According to Dr. Goddard, some patients have reported improvements after learning mind-body awareness techniques. These are her clinical observations rather than controlled evidence that the techniques treat the underlying causes of those conditions. Neuroplasticity is a well-established biological phenomenon, but specific brain-retraining or mind-body programs vary in their supporting evidence. For additional perspectives, explore Tick Boot Camp's interview with Ben Ahrens about neuroplasticity. Why Healing Is Not One-Size-Fits-All Rich raises concerns about patients adopting identical treatment protocols simply because someone else reported success. He describes how groups of patients sometimes begin using the same supplements or treatment approaches together. While community support can be valuable, Rich emphasizes that people may have very different diagnoses, symptoms, medical histories, and treatment needs. Dr. Goddard agrees. She believes individualized care is essential because no two people have identical experiences. An intervention that helps one person may not be appropriate for another. This applies to medications, supplements, rehabilitation, and mind-body practices. Their discussion encourages patients to seek personalized medical guidance rather than assuming that a treatment will work because it helped someone else. Medical Trauma and Feeling Dismissed by Healthcare Professionals Rich returns to Dr. Goddard's personal experience of seeking medical help. He notes that even physicians can encounter dismissive responses when they experience poorly understood symptoms. Dr. Goddard acknowledges how painful and frustrating those experiences can be. They discuss the term medical gaslighting, including whether every dismissive encounter involves deliberate manipulation or whether some clinicians simply lack sufficient knowledge. Dr. Goddard believes intent and understanding matter when evaluating these interactions. At the same time, she recognizes that patients may experience real emotional harm regardless of a clinician's intentions. The conversation emphasizes the importance of validating patient experiences without allowing painful encounters to define every future healthcare interaction. Patients deserve respectful communication, appropriate investigation, and honest discussions about uncertainty. Trauma, Stress, and the Healing Process Dr. Goddard explains that prolonged illness can itself be traumatic. People may experience fear, isolation, financial strain, repeated medical appointments, and uncertainty about their future. Some also have previous traumatic experiences that influence how they respond to stress. She believes helping patients develop greater emotional and physical awareness may support their ability to cope with these challenges. Rich discusses how learning about nervous system responses changed his own understanding of health and personal development. Together, they explore the importance of recognizing patterns without judging oneself for having them. Trauma-informed care can be an important part of supporting people with chronic illness, but trauma is not a prerequisite for developing Lyme disease, and resolving trauma is not a cure for infection. The Art & Science of Healing from Within Dr. Goddard discusses the development of her educational course, The Art & Science of Healing from Within. She explains that the program originally had a different title: The Art and Science of Being Human. Her goal was to teach skills she wishes she had learned earlier in life. These include reconnecting with the body, recognizing habitual patterns, and practicing self-awareness throughout ordinary daily activities. She ultimately changed the title to emphasize healing and make the purpose of the course clearer. Dr. Goddard believes that meaningful change does not always require expensive devices, complicated routines, or spending hours meditating. Instead, she encourages people to practice brief moments of connection with themselves throughout the day. The course reflects her educational philosophy and personal clinical experience. Its effectiveness as a treatment for Lyme disease has not been established through clinical trials. How Osteopathic Medicine Fits Into Her Approach As an osteopathic physician, Dr. Goddard emphasizes the relationship between the body's structure and function. Her primary clinical focus is osteopathic manipulative treatment, a hands-on approach used by some physicians to evaluate and address musculoskeletal dysfunction. She integrates this work with her interest in whole-person care. Patients may seek osteopathic treatment for concerns involving pain, movement, or physical discomfort. The effectiveness of osteopathic manipulative treatment varies by condition, and it should not be considered a substitute for antimicrobial treatment when an active bacterial infection requires it. Dr. Goddard's approach reflects her belief that patients may benefit from attention to both their diagnosed medical conditions and their overall functioning. How to Work With Dr. Jacey Goddard Dr. Goddard practices at RiverTree Osteopathic Health in Topsham, Maine. Her work focuses on osteopathic manipulative treatment, integrative medicine, and supporting patients with complex health challenges. For more information about her medical background and philosophy, visit her official physician biography. Patients and healthcare professionals interested in her educational approach to nervous system regulation and mind-body awareness can also explore The Art & Science of Healing from Within. Key Takeaways Healing from chronic illness can involve multiple dimensions of health. Dr. Goddard emphasizes physical, emotional, and nervous system support alongside appropriate medical care. Dr. Goddard understands medical uncertainty firsthand. Her personal healing journey shaped her compassionate approach to patients with difficult-to-treat conditions. Lyme disease is a significant concern in Maine. Rich and Dr. Goddard discuss Borrelia, Bartonella, Babesia, and changing patterns of tick exposure. Individual vulnerability is complex. Sleep, stress, medical history, environmental exposures, and other factors can influence overall health. Nervous system regulation may support symptom management. Learning about autonomic responses can help some people better understand their experiences. The body deserves compassion. Dr. Goddard encourages patients to develop a more supportive relationship with their physical sensations and needs. Mind-body practices do not need to be complicated. Brief moments of awareness may be more practical than elaborate daily routines. Neuroplasticity offers opportunities for learning and adaptation. However, specific brain-retraining programs should not be assumed to cure infectious diseases. Medical trauma deserves recognition. Patients can experience emotional harm when symptoms are dismissed or poorly understood. Individualized treatment matters. No single supplement, protocol, or nervous system technique is appropriate for every patient. Healing is possible, but no method guarantees recovery. Dr. Goddard encourages hope, curiosity, and compassionate self-care. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Dr. Jacey Goddard, DO, a triple board-certified osteopathic physician practicing in Topsham, Maine. Rich and Dr. Goddard explore the relationship between chronic Lyme disease, nervous system regulation, mind-body healing, medical trauma, neuroplasticity, and individualized healthcare. Their discussion challenges patients and practitioners to consider how physical health, emotional experiences, and nervous system function interact—while recognizing the importance of appropriate medical diagnosis and treatment. Discover more interviews with physicians, researchers, and patient advocates through Tick Boot Camp's LIVE from ILADS podcast series.

  • S1 · E616
    October 31 · 1 hr 24 min

    Episode 616: How Tick Bites Cause Disease: Monica Cipriani on Lyme Disease, Alpha-Gal & Tick Saliva

    Read transcript What actually happens when a tick bites you—and how can something so small manipulate the human immune system long enough to feed and potentially transmit disease? Tick-borne disease researcher Monica Cipriani joins Rich Johannesen, co-founder of Tick Boot Camp Podcast, for an in-depth exploration of the biology of the tick bite, Lyme disease, alpha-gal syndrome, tick saliva, immune modulation, and tick-borne disease transmission. This conversation was recorded in person at the Tick Boot Camp studio immediately after Monica led our team on a tick-dragging field day across Long Island, where we collected hundreds of ticks from a farm, public trail, and residential environment—including clusters of nearly invisible lone star tick larvae known as “tick bombs,” blacklegged ticks, and an invasive Asian longhorned tick. See what we found while dragging for ticks on Long Island. From Lyme Disease Caregiver to Tick-Borne Disease Researcher Monica's work is deeply personal. With bachelor's and master's training in microbiology, she transitioned into epidemiology to focus on research, public health, education, advocacy, and policy surrounding tick-borne diseases. Her mother endured years of unexplained symptoms—including hives, joint pain, brain fog, and cognitive changes—before eventually receiving a Lyme disease diagnosis. Years later, Monica watched her young daughter develop concerning neurological, behavioral, sleep, and physical symptoms while living in Kentucky. After numerous medical appointments, her family traveled to New York, where her daughter was diagnosed with Lyme disease. Those experiences helped shape Monica's determination to study why tick-borne diseases can be missed, misclassified, and misunderstood—and how research can help patients receive answers sooner. How Does a Tick Find and Bite a Human? Monica takes listeners inside the remarkable biology of ticks. Ticks are arachnids, not insects, and different species can act as vectors for different pathogens. The episode explores three important species: Blacklegged tick ( Ixodes scapularis ) — associated with Lyme disease and other tick-borne infections Lone star tick ( Amblyomma americanum ) — strongly associated with alpha-gal syndrome and capable of transmitting several pathogens American dog tick ( Dermacentor variabilis ) — another common human-biting tick Using a specialized sensory structure called the Haller's organ, ticks can detect environmental signals associated with potential hosts. Some ticks wait for a host to pass close enough to grab onto, while lone star ticks can be particularly aggressive in seeking hosts. Once aboard, ticks crawl toward locations where they can establish a successful blood meal. Tick Saliva: An Evolutionary Tool for Feeding One of the most fascinating parts of the conversation focuses on tick saliva. A tick needs to remain attached long enough to complete its blood meal, but the human body has numerous defenses designed to detect an injury or foreign organism. Monica explains how components of tick saliva can interfere with those defenses. The discussion explores how ticks can: Reduce pain at the bite site Suppress itching and histamine-related responses Interfere with blood clotting Affect blood vessels and platelet activity Modulate local immune responses Anchor themselves using specialized mouthparts and cement-like substances Alter salivary molecules throughout the feeding process Rather than simply suppressing the immune system completely, Monica describes how ticks can modulate the local immune environment in ways that help preserve viable tissue and allow feeding to continue. That means a tick bite isn't simply a tiny wound through which a pathogen enters. The tick itself may help create the biological environment in which transmission occurs. Why Tick-Borne Disease Is About More Than Lyme Ticks may acquire microorganisms during earlier blood meals from wildlife and subsequently expose another host during feeding. The conversation examines the ecological relationship among ticks, wildlife, pathogens, and humans and why understanding the vector is critical to understanding tick-borne illness. Monica and Rich discuss Lyme disease and Borrelia, along with other tick-associated threats including: Ehrlichiosis STARI Powassan virus Bourbon virus Heartland virus Alpha-gal syndrome The discussion also explores why the length of attachment matters while emphasizing an important point: people frequently do not know exactly when a tick attached. Larval and nymphal ticks can be extraordinarily difficult to see. During Tick Boot Camp's Long Island field work, the team collected larvae so small that hundreds looked almost like specks of pepper. Learn more about ticks and tick-borne disease in this University of Kentucky resource co-authored by Monica. Alpha-Gal Syndrome and the Lone Star Tick A major focus of Monica's current research is alpha-gal syndrome (AGS), sometimes called the red meat allergy. Alpha-gal syndrome is associated with tick bites—particularly bites from the lone star tick in the United States—and can cause an immune reaction to alpha-gal, a sugar found in most non-primate mammals and mammal-derived products. For some people, reactions may be relatively mild. For others, exposure can potentially result in severe allergic reactions, including anaphylaxis. But one of the biggest scientific questions remains: Why can two people be bitten by similar ticks and have completely different outcomes? Monica discusses the unanswered questions surrounding individual immune responses, sensitization, demographics, environmental exposures, and the unusual way a tick bite introduces alpha-gal alongside a complex mixture of salivary molecules. Her research aims to better understand those patterns and the patient experience surrounding this emerging condition. Learn more about Monica Cipriani's epidemiology and alpha-gal research. Lyme Disease, Research, and the Questions Patients Are Asking The episode also tackles difficult questions that remain important to the Lyme community, including the possibility of congenital transmission of Lyme disease. Monica explains why researchers must remain willing to investigate unanswered questions rather than dismiss possibilities before adequate research exists. As both a scientist and a mother whose family has been affected by Lyme disease, she brings a rare perspective to the conversation: understanding the scientific process while also understanding what it feels like when a patient or parent believes something important is being missed. Why Better Tick Research Matters Monica argues that improving Lyme and tick-borne disease care requires stronger communication among researchers, public health professionals, clinicians, and patients. Research ultimately helps create the evidence clinicians can use to recognize disease, improve diagnosis, develop treatments, and establish better standards of care. For Monica, that work comes back to one goal: helping people feel heard while asking the scientific questions that could lead to better answers. From the Field to the Tick Boot Camp Studio This interview capped an extraordinary day of hands-on tick research on Long Island. Monica, her husband Dr. Andre Ene, Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen, filmmaker Reece Robinson, and the production team dragged for ticks at Malik Farms in Coram, the Rails to Trails path in Rocky Point, and a residential property and nearby groundwater recharge basin. The team encountered hundreds of lone star tick larvae, blacklegged ticks, multiple “tick bombs,” and an invasive Asian longhorned tick identified by Monica. The experience made the subject of this interview tangible: ticks capable of affecting human and animal health aren't only deep in the woods. They can be present where people live, work, walk, farm, exercise, and spend time with their families. Explore the Long Island tick-dragging field day, photos, videos, species, and findings. Tick Boot Camp Resources Tick Boot Camp Tick Bite Blueprint Lyme Disease Testing More Tick-Borne Disease Researcher Interviews

    • Transcript
  • S1 · E615
    October 30 · 21 min

    Episode 615: From Chronic Lyme to Lyme Disease Advocacy – Eva Scarano of LymeLnk | LIVE from ILADS

    What happens when someone living with chronic Lyme disease uses their own experience to tackle one of the biggest challenges facing the Lyme community: a lack of public awareness, understanding, and compassion? In this LIVE from ILADS interview, Tick Boot Camp co-host Rich sits down with Eva Scarano, founder of LymeLnk, to discuss her personal Lyme disease journey, the creation of a patient-centered advocacy organization, and her mission to make Lyme disease education accessible to the general public. Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation explores how Eva transformed her experiences with Lyme disease into a nonprofit organization focused on storytelling, community engagement, tick prevention, early detection, and public education. Eva shares how she was diagnosed with Lyme disease in 2016 after developing a bull's-eye rash and flu-like symptoms, how her health deteriorated following a period of improvement, and how reaching her lowest point during graduate school inspired her to rethink her relationship with chronic illness. Through her graduate studies at Parsons School of Design, Eva began researching the Lyme disease community and interviewing patients, advocates, and organizations to better understand where education and awareness efforts could have the greatest impact. That research ultimately led to the creation of LymeLnk, an organization working to make basic Lyme disease knowledge as familiar to the public as other common health and safety information. Rich and Eva discuss Lyme disease stigma, the importance of patient stories, community-centered design, tick-borne disease awareness in California, the role of climate and environmental changes, and innovative approaches to educating children and families. Meet Eva Scarano: Founder of LymeLnk Eva Scarano is the founder of LymeLnk, a community-focused Lyme disease education and awareness organization developed through her graduate studies at Parsons School of Design in New York City. Before launching LymeLnk, Eva spent approximately six years working in corporate technology, including sales and product marketing. She later pursued graduate studies in strategic design and management, a discipline that applies human-centered design principles to complex organizational and social challenges. Eva's own experiences with Lyme disease inspired her to apply these methods to public health education and community advocacy. Rather than building another organization focused primarily on research funding, clinical education, or legislative advocacy, she identified an opportunity to reach people who know very little about Lyme disease. Her goal is straightforward: Help the general public understand the basics of Lyme disease so more people can recognize risks, take preventive action, and respond compassionately to those living with the illness. A Textbook Lyme Disease Diagnosis in 2016 Eva's Lyme disease story begins in 2016 during her senior year of college in Ann Arbor, Michigan. She developed symptoms commonly associated with early Lyme disease, including: A bull's-eye rash Flu-like symptoms Significant fatigue Cognitive difficulties Eva visited an urgent care facility, where her symptoms were recognized and she received a Lyme disease diagnosis. She subsequently worked with a practitioner experienced in treating Lyme disease. Eva describes undergoing approximately three months of treatment involving antibiotics and herbal therapies. The experience was difficult. She recalls waking up to take an economics final exam and realizing she could not read the material. With assistance from her university's disability services, she was able to complete her academic responsibilities. Following treatment, Eva experienced approximately two years of significant improvement. At the time, she believed the worst of her Lyme disease journey might be behind her. When Symptoms Returned After Moving to San Francisco In 2019, Eva moved into an apartment in San Francisco that she describes as having significant mold problems. She associates that environmental exposure with a deterioration in her health. After experiencing a period of relative stability, she began struggling with recurring symptoms and increasing health challenges. Eva describes the following years as an unpredictable cycle of improvements and setbacks. She continued working, traveling, and maintaining an active lifestyle while simultaneously managing her health. Although Eva believes the mold exposure contributed to her decline, the interview does not establish a medical cause-and-effect relationship between the apartment and her subsequent symptoms. Her experience reflects the difficulty many patients face when trying to understand which factors may be contributing to a complex illness. Reaching Her Lowest Point During Graduate School By 2023, Eva was attending graduate school at Parsons School of Design in New York City. She was also teaching Pilates part-time, traveling for friends' weddings, and trying to maintain the active lifestyle she had enjoyed before becoming ill. At the same time, she was managing multiple health conditions and ongoing symptoms. Eva describes herself as someone who naturally enjoys staying busy. Slowing down did not come easily. Eventually, her health deteriorated to the point that she could no longer continue at the same pace. She describes 2023 as the sickest period of her life. During the interview, Eva discusses several possible contributing factors, including travel, demanding schedules, immune-related health concerns, and receiving influenza and COVID-19 vaccinations on the same day. She explicitly acknowledges that she cannot identify a single cause of her decline. Her experience does not establish that vaccination caused her symptoms or that receiving both vaccines together is generally unsafe. Receiving recommended influenza and COVID-19 vaccines during the same visit is considered acceptable for most eligible people, with individual medical circumstances discussed with a healthcare professional. Eva's broader point is that complex illnesses can make it difficult to determine why symptoms worsen or improve. Turning Pain Into Purpose Through Parsons School of Design During her most difficult period, Eva began applying her graduate coursework to the challenges facing the Lyme disease community. Her academic program focused on strategic design and management, including human-centered problem-solving and community research. Rather than abandoning graduate school, she used her education to investigate how Lyme disease awareness could be improved. Eva and her collaborators interviewed more than 100 people connected to the Lyme disease community. These conversations helped identify common frustrations involving diagnosis, treatment, education, public awareness, and social support. Eva concluded that many organizations were already doing valuable work in specialized areas. However, she believed an important opportunity remained: reaching people who had never experienced Lyme disease and knew little about it. This realization became the foundation for LymeLnk. Why Eva Founded LymeLnk Eva explains that the Lyme disease community includes numerous organizations addressing different parts of a complicated healthcare and public health landscape. She highlights organizations such as: ILADS, which provides education and professional development for healthcare practitioners Center for Lyme Action, which focuses on legislative advocacy and public policy Global Lyme Alliance, which supports research and education Bay Area Lyme Foundation, which funds scientific research and advances awareness Eva believes these organizations provide important specialized services. Rather than duplicating their work, she wanted LymeLnk to complement it. Her organization focuses on expanding basic Lyme disease knowledge among people outside the established patient community. She argues that public education can help create a stronger foundation for prevention, earlier recognition, and greater compassion. The ABCs of Lyme Disease Awareness Eva describes LymeLnk's educational mission as helping people understand the ABCs of Lyme disease. These include basic knowledge about: Prevention: Understanding where ticks live, how exposure occurs, and how to reduce the risk of tick bites. Early detection: Recognizing potential signs and symptoms and knowing when to seek medical evaluation. Diagnosis: Understanding that Lyme disease testing has limitations and that clinical history matters. Treatment: Knowing that early evaluation and appropriate treatment are important. Eva believes people should not have to become seriously ill before learning these fundamentals. She wants Lyme disease awareness to become part of everyday health education. For practical prevention guidance, explore Tick Boot Camp's Tick Bite Blueprint. Why Patient Compassion Matters as Much as Awareness One of the most powerful moments in the interview comes when Eva describes feedback from Lyme disease patients participating in her research. Her team asked what successful public education would look like. Many patients did not begin by asking for complicated policy changes or scientific breakthroughs. They wanted something much simpler. They wanted to be able to tell someone they had Lyme disease and receive a response demonstrating basic understanding and compassion. Eva explains that patients often feel isolated because people around them do not understand the illness. This lack of understanding can make it harder to discuss symptoms, ask for accommodations, or feel supported. She believes that improving public literacy could help reduce stigma and strengthen community support. People living with Lyme disease deserve to be heard, believed, and treated with compassion. Storytelling as a Public Health Education Strategy Eva believes storytelling is one of the most effective ways to reach people who are unfamiliar with Lyme disease. Statistics and medical information are important, but personal experiences can make an unfamiliar issue feel relevant. Her approach combines patient stories with educational campaigns tailored to specific communities. Rather than delivering identical messages to everyone, LymeLnk aims to understand what different groups need to know. Potential audiences include: Parents seeking to protect their children Pet owners concerned about tick exposure Outdoor enthusiasts and recreational groups People working outdoors Communities affected by changing tick habitats Environmental and public health advocates Eva believes educational programs become more effective when they are developed with the people they are intended to serve. What Is Community-Centered Design? Eva introduces the concept of co-design, a method of developing programs collaboratively with the people who will use them. Instead of creating a campaign and asking a community to accept it, LymeLnk begins by learning about the community's experiences, concerns, and existing knowledge. The organization then works with local partners to create appropriate educational materials. Depending on the audience, these may include: Public service announcements Social media campaigns Community workshops Hands-on tick prevention demonstrations Educational programs for children Outdoor safety events Storytelling initiatives featuring patient experiences Eva explains that the organization intends to test these approaches, measure their effectiveness, and improve them before expanding. Her goal is to develop a model that can be adapted across different communities. Why LymeLnk Launched in San Diego Although Eva developed the concept while attending Parsons in New York City, LymeLnk was incorporated in California. Eva explains that the organization established a presence in both San Diego and New York. These locations offer contrasting opportunities for Lyme disease education. New York has a long history of public awareness because Lyme disease is well established in the Northeast. San Diego, by comparison, offers opportunities to educate communities that may be less familiar with local tick-borne disease risks. Eva also grew up in California and had personal connections that could help support the organization's launch. She believes Southern California is an important place to address misconceptions about where tick-borne diseases occur. Lyme Disease and Tick Exposure in Southern California Eva challenges the misconception that Lyme disease and other tick-borne illnesses are exclusively East Coast problems. She explains that California has its own tick populations and documented tick-borne disease risks. People who spend time outdoors, travel to other regions, or interact with pets may encounter ticks. Eva believes a lack of awareness can contribute to missed opportunities for prevention and appropriate medical evaluation. Her organization aims to educate Southern California communities without creating unnecessary fear. The message is not that every tick carries Lyme disease. It is that people should understand their local risks and know how to protect themselves. The San Diego Launch Event: Bringing the Community Together Eva describes LymeLnk's launch event in San Diego's Little Italy neighborhood. Approximately 150 people attended. The event combined social connection with education and featured food options designed to accommodate different dietary needs. Eva shared her personal Lyme disease journey and explained the mission behind LymeLnk. The event also featured a discussion with: Dr. Liz Horn, principal investigator of the Lyme Disease Biobank, and Dr. Sharon Wampler of the San Diego Lyme Alliance. Together, they addressed misconceptions about tick-borne disease in California. Eva describes the event as an opportunity to connect patients, advocates, researchers, and community members in a welcoming environment. A Tick Encounter at a La Jolla Coffee Shop Eva shares a memorable story from the days leading up to LymeLnk's launch. While working at a coffee shop in La Jolla, she overheard someone discussing a tick found on her body. The woman explained that she had begun finding ticks regularly after walking her German Shepherd. She mentioned areas around San Diego, including Nautilus Street and Kate Sessions Park. Having lived in the area for many years, the woman was surprised by what she perceived as an increase in tick encounters. Eva introduced herself and explained her work with LymeLnk. The conversation became an unexpected opportunity for public education. Eva describes the encounter as a perfect example of why her organization exists. People may encounter ticks in places they do not associate with Lyme disease. A simple conversation can help someone recognize a risk and learn how to respond. Climate Change, Habitat Changes, and Tick Populations Eva and Rich discuss environmental factors that may influence tick distribution. Eva raises concerns about climate change, habitat fragmentation, and changing conditions that affect tick survival and activity. Scientific research has identified relationships between climate, habitat, wildlife populations, and the distribution of certain tick species. However, local changes in tick encounters can have multiple causes, and an individual observation cannot establish why a particular area has more ticks. Eva believes environmental education and Lyme disease awareness should increasingly work together. Her approach encourages communities to understand how human activity and ecological conditions influence public health. Measuring Whether Lyme Disease Education Works Eva explains that LymeLnk wants to measure the effectiveness of its educational programs rather than simply count event attendance. Following the San Diego launch, the organization surveyed participants. Eva reports a 76% increase in an education-related measure among attendees. The interview does not specify the survey methodology or how that percentage was calculated. Nevertheless, Eva sees the early feedback as encouraging. She believes that gathering information before and after educational programs can help identify which approaches are most effective. This emphasis on measurement reflects her background in strategic design. Bringing Tick Prevention Education Into Schools One of LymeLnk's first proposed initiatives involves partnering with an organization that provides after-school STEM programming to children in San Diego. Eva explains that the project was still in development at the time of the interview. The goal is to incorporate tick-borne disease education into existing science and outdoor learning programs. Potential topics include: Tick biology and ecology Wildlife and tick habitats Outdoor safety Tick checks and prevention Understanding how infectious diseases spread Recognizing when to seek help after a tick bite Eva believes teaching children about ticks through familiar science concepts can make prevention education engaging and practical. Rather than creating an entirely new curriculum, LymeLnk hopes to collaborate with established organizations and adapt existing educational resources. Scaling Lyme Disease Education One Community at a Time Eva explains that LymeLnk intends to begin with smaller educational programs and gradually expand. The initial focus is San Diego. The organization hopes to develop programs with local partners, evaluate the results, and refine its approach. If the early programs are successful, Eva envisions expanding to additional schools, outdoor organizations, and community groups. She mentions potential opportunities to engage outdoor enthusiasts and organizations such as the Sierra Club and REI communities. Her long-term goal is to increase Lyme disease literacy throughout San Diego County and eventually adapt the model for other regions. Why Collaboration Is Essential Eva emphasizes that LymeLnk does not want to reinvent educational resources that other organizations have already developed. Instead, she hopes to collaborate with researchers, advocacy groups, and community organizations. These partners may provide existing educational materials, scientific expertise, and local knowledge. LymeLnk can then help adapt that information for audiences who may otherwise never encounter it. This approach recognizes that effective advocacy requires different organizations to contribute their unique strengths. For more conversations with researchers, advocates, and community leaders, explore the Tick Boot Camp Podcast. Key Takeaways Eva Scarano was diagnosed with Lyme disease in 2016. Her symptoms included a bull's-eye rash and flu-like illness while attending college in Michigan. Her health challenges continued after initial improvement. Eva describes renewed symptoms beginning in 2019 and a particularly difficult period in 2023. Graduate school became a turning point. She applied strategic design principles to the challenges facing the Lyme disease community. LymeLnk grew from community research. Eva and her collaborators interviewed more than 100 people to understand unmet educational needs. Public awareness is the organization's primary focus. LymeLnk aims to help people understand prevention, early detection, diagnosis, and treatment basics. Patient compassion is central to the mission. Eva believes greater public understanding can reduce stigma and isolation. Storytelling is a powerful educational tool. Personal experiences can help make Lyme disease information more relatable. San Diego became the organization's launch location. Approximately 150 people attended the inaugural event. Community partnerships will drive future programs. LymeLnk hopes to develop educational campaigns collaboratively with schools and other organizations. The long-term goal is scalable Lyme disease literacy. Eva envisions expanding successful educational models from one community to another. About This LIVE from ILADS Interview Recorded at the 2025 International Lyme and Associated Diseases Society Conference in San Antonio, Texas, this conversation features Eva Scarano, founder of LymeLnk, discussing her personal Lyme disease journey and her mission to transform public understanding of tick-borne illness. Rich and Eva explore the power of storytelling, patient compassion, community-centered design, Lyme disease education in California, and the importance of reaching people before they become patients. The conversation highlights how lived experience, creativity, and collaboration can help strengthen Lyme disease advocacy. Discover additional conversations with patient advocates, researchers, and healthcare professionals through Tick Boot Camp's LIVE from ILADS podcast series.

Showing 1–20 of 79 episodes